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ABSTRACT 
 
 
 
The recent advances in medical imaging and in computer technologies have improved the 
prediction capabilities of biomechanical models.  
In order to replicate physiological, pathological or surgically corrected portions of the 
cardiovascular system, several engineering methodologies and their combinations can be 
adopted. Specifically, in this thesis, 3D reconstructions of patient-specific implanted devices 
and cardiovascular anatomies have been realised using both volumetric and biplanar 
visualisation methods, such as CT, MR, 4D-MR Flow and fluoroscopy. Finite Element 
techniques have been used to computationally deploy cardiovascular endoprosthesis, such as 
stents and percutaneous pulmonary valve devices, under patient-specific boundary conditions. 
To analyse pressure and velocity fields occurring in patient-specific vessel anatomies under 
patient-specific conditions, Lumped Parameter Networks and Computational Fluid Dynamics 
simulations have been employed. 
In this thesis, the above mentioned engineering tools have been applied to address three clinical 
topics: 
1 - Percutaneous pulmonary valve implantation (PPVI) 
Nowadays, more than 5,000 patients with pulmonary valve dysfunctions have been treated 
successfully with a percutaneous device, consisting in a bovine jugular venous valve sewn 
inside a balloon expandable stent. However, 25% of the treated patients experienced stent 
fracture. Using a novel methodological patient-specific approach that combines 3D 
reconstructions of the implanted stent from patients’ biplane fluoroscopy images and FE 
analyses, I carried out a risk stratification for stent fracture prediction. 
2 - Transposition of the Great Arteries (TGA)  
Patients born with the congenital heart defect TGA need a surgical correction, which however, 
is associated with long term complications: the enlargement of the aortic root, and the 
development of a unilateral pulmonary stenosis. These may originate a complex hemodynamics 
that I tried to investigate by using patient-specific LPN and CFD models. 
3 - Aortic Coarctation (CoA) 
Finally, combinations of FE and CFD-LPN models have been used to plan treatment in a patient 
with CoA and aberrant right subclavian.  
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1.1 INTRODUCTION 
The primary goal of medical care is the increase of life expectancy and quality of life, 
through the development of preventive and curative measures, the minimisation of poor 
living conditions associated with chronic diseases, and the rescue of lives in life-
threatening emergencies. In the last century, a marked improvement of the medical care 
has largely contributed to the partial achievement of these never-fulfilled aims, and a 
significant role in such improvement has been played by the science of biomedical 
engineering. 
Biomedical engineering is an interdisciplinary field that aims to reduce the gap between 
engineering and medicine to advance healthcare treatment. Indeed, it integrates the 
technological background and problem solving skills of the former, with the medical 
and biological knowledge of the latter. Several scientific branches are involved in the 
understanding and modelling of the physical processes of the living system under both 
physiological and pathological conditions, and to implement devices, tools and 
machines to be used by doctors for diagnosis, monitoring and therapeutic purposes. The 
fields of mechanics, informatics, electronics, material science, signal processing are 
only some of the included subjects.  
The development and the broadening of this relatively new science has acquired 
increasing importance on the medical care achievements, not only in terms of 
treatments, but also in terms of discovering causes of diseases, analysing consequences 
of palliative and surgical choices, and providing didactic platforms for the clinicians to 
practice their skills.  
The recognised utility of biomedical products favoured the financing of research 
projects in this area, with increasing interests and money being invested in several 
sectors of the bioengineering. Between the others, the cardiovascular field covers a large 
slice of the market; this being easily explained considering that cardiovascular diseases 
are the leading cause of death worldwide, accounting for approximately 40% of deaths 
in Europe. The European Commission allocated over €600 million to the Framework 7th 
HEALTH Programme (2007-2013) aiming at improving the health of European citizens 
and strengthen competitiveness of European health-related industries; the area of 
cardiovascular disease was considered a priority. 
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It is in the context of this Framework 7
th
 HEALTH that my PhD was funded. In 
particular, the research presented in this Thesis is part of the Marie Curie Initial 
Training Network (MC ITN) project MeDDiCA, focused on Cardiovascular 
Engineering and Medical Devices. Being based in the Cardiorespiratory Unit of the 
Great Ormond Street Hospital for Children, the focus of my research was specifically 
on congenital heart disease. The groundwork of this Thesis is the collaboration between 
clinicians and engineers for the development of computational models able to provide 
answers to specific clinical questions. 
1.2 AIMS OF THE THESIS 
The main aim of the research presented in this Thesis was to use conventional 
engineering methodologies as a tool to answer specific clinical questions in the sphere 
of personalised medicine.  
The objectives of this research were to develop and validate a framework based on 
routinely clinically acquired data in order to: 
- Predict stent fracture in each individual undergoing CP (NuMed Inc, Hopkinton, NY, 
USA) stent implantation 
- Characterise and quantify proximal and peripheral resistances that develop in the 
presence of pulmonary artery stenosis to help plan each patient’s treatment strategy 
- Define the optimal treatment in a case study of aortic re-coarctation.         
1.3 OUTLINE OF THE THESIS 
The following Chapters, 2 and 3, provide a general clinical and engineering introduction 
to the Thesis. Chapter 2 illustrates the physiology of the cardiovascular system in the 
adult and in the fetus, to show how an abnormal development of the heart and 
circulatory system gives rise to congenital heart disease. A brief summary on the most 
common congenital heart defects and the current options for repair or palliation is 
provided, with specific focus on the clinical problems addressed in this Thesis. Chapter 
3 reviews the concept of modelling in bioengineering and particularly of patient-specific 
modelling. The principal engineering methodologies exploited in this Thesis for the 
implementation and validation of patient-specific cardiovascular models are discussed, 
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from medical data acquisition to computational and experimental tools. An overview of 
the imaging methods and the in-vivo pressure acquisitions is presented, followed by the 
definition of finite element (FE) method and finite volume method (FVM), lumped 
parameter networks (LPN) and multi-domain simulations. Hints on the rapid-
prototyping technique and its applications, and on the components used in mock-
circulatory loops follow. 
After the overview of the general methodologies applied in this Thesis, Chapters 4 to 8 
explain how these tools were employed during my PhD to study specific clinical cases.  
Chapters 4 and 5 focus on the percutaneous pulmonary valve implantation (PPVI) 
device and outcomes, with the first chapter describing the methodology implementation 
and validation, followed by the second chapter related to the patient-specific clinical 
application. PPVI is nowadays an established technique to treat pulmonary valve 
dysfunction which, however, still presents high incidence of stent fracture (25%). 
Chapter 4 presents a quantitative assessment of uncertainty for the 3D reconstruction of 
stents using available imaging techniques. The shape of an in-vitro deformed PPVI stent 
was reconstructed from micro-computed tomography (CT) acquisitions, CT images 
with two different radiation doses, an experimental optical technique, and biplane 
fluoroscopy images. Geometric parameters were used to evaluate the accuracy and the 
repeatability of each technique along with variation to micro-CT data, assumed to 
represent the gold standard imaging method. The aim of this chapter was the validation 
of the stent reconstruction method from fluoroscopy acquisitions that was then used for 
the study presented in Chapter 5 focused on PPVI stent fracture prediction. In this 
chapter, I created a statistical model, based also on FE simulation results, able to predict 
fracture/no fracture of the device after implantation in a specific patient using only 
procedural fluoroscopy acquisitions data as input.  
 
The clinical subject of Chapter 6 and 7 is transposition of the great arteries (TGA). 
Patients born with such defect undergo surgical correction, which, however, is 
associated with long term complications: the enlargement of the neoaortic root, and the 
development of a unilateral pulmonary stenosis amongst others. These may translate in 
both sites in complex hemodynamics conditions which I investigated in this Thesis 
using patient-specific computational models. Chapter 6 shows the creation of a 
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computational fluid dynamic (CFD) multi-domain model of the neoaorta following 
arterial switch operation (ASO) in a patient born with TGA, validated with in-vitro data 
generated by an experimental set-up and acquired through 4D magnetic resonance (MR) 
Flow imaging method. In Chapter 7, this validated multi-domain approach coupled with 
a LPN simplified methodology was applied to study the flow distribution in the 
pulmonary artery bifurcation in the presence of unilateral stenosis in patients born with 
TGA and treated with ASO. 
Chapter 8 presents the combination of CFD, LPN and structural patient-specific realistic 
models to plan treatment in a patient with aortic re-coarctation and aberrant right 
subclavian artery. 
Finally, Chapter 9 summarises the results of this Thesis and outlines a number of 
remaining research issues, which have been identified as areas for future work. 
 
In terms of engineering methodologies, the different imaging techniques employed in 
this Thesis are described mainly in Chapter 4: 3D reconstructions of patient-specific 
implanted devices and cardiovascular anatomies were realised using both volumetric 
and biplanar visualisation methods, such as CT, MR, and fluoroscopy. Chapter 5 
introduces FE structural simulations which are utilised also in Chapter 7 and 8 to 
computationally deploy cardiovascular stents, under patient-specific boundary 
conditions. Chapter 6 introduces the first fluid dynamic problem where CFD and multi-
domain analyses were used together with an experimental mock circuit to analyse 
pressure and velocity fields occurring in patient-specific vessel anatomies under patient-
specific conditions. CFD coupled with LPN and multi-domain modelling were the 
methodologies adopted also in Chapter 7. Finally, Chapter 8 presents a case study in 
which all the previously described, implemented and validated structural and fluid 
dynamics techniques were applied. 
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2.1 INTRODUCTION 
In this chapter, the physiological adult and fetal cardiovascular system are briefly 
introduced followed by some of the defects that can affect heart and circulation in the 
newborns. Particular focus will be given to those congenital heart defects treated in the 
remainder of this Thesis: Section 2.4 described right ventricular outflow tract (RVOT) 
obstruction and relative treatments with particular emphasis on the percutaneous repair. 
Section 2.5 provides information on transposition of the great arteries, surgical 
correction and long-term complications both in the systemic and pulmonary side. The 
chapter concludes with the description of aortic coarctation and the options currently 
available for its treatment (Section 2.6).  
2.2 NORMAL CIRCULATION 
2.2.1 Adult circulation 
The main components of the human cardiovascular system are blood, vessels and heart. 
Through the flowing of the blood into the vessels’ network, the cardiovascular system 
provides the tissues with nutrients, delivers oxygen, transports hormones, removes 
metabolic waste, stabilises body temperature and pH, and maintains homeostasis. 
The heart is the pulsatile pump that permits the blood to circulate in all body. It is a 
hollow muscular organ composed anatomically by four chambers (Figure 2.1): two 
upper chambers called atria (right and left) and two lower chambers called ventricles 
(right and left). The right and left sides of the heart are divided through two muscular 
walls, the atrial and the ventricular septum. The upper and lower chambers of each side 
are in communication through two non-return valves: the tricuspid valve on the right, 
and the mitral valve on the left. Blood is transferred from the atria to the ventricles 
when the atrio-ventricular valves are open; while, when they are closed, their function is 
to avoid blood regurgitation from the ventricles.   
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Figure 2.1 - Graphic representation of a physiological human heart with its valves, atria and 
ventricles, and the arteries/veins attached to them. Image taken from Wapcaplet 
(http://upload.wikimedia.org/wikipedia/commons/e/e5/Diagram_of_the_human
_heart_%28cropped%29.svg). 
Two other non-return cardiac valves are present at both outlets of the heart: the 
pulmonary valve that puts in communication the right ventricle with the main 
pulmonary artery, and the aortic valve located between the left ventricle and the aorta. 
The right heart receives deoxygenated blood from the body and pumps it towards the 
lungs, where carbon dioxide is released and oxygen is absorbed. Deoxygenated blood 
coming from the upper and lower body enters the right atrium through the superior and 
inferior vena cava, respectively; while blood resulting from the myocardium irroration 
is conveyed here through the coronary sinus. The left heart receives oxygenated blood 
from the pulmonary veins and pumps it to the systemic circulation, where the oxygen 
supply is delivered to the tissues through the capillary network (Figure 2.2). Both 
cardiac halves function as two flanked pumps in series, with a synchronised contraction 
that affects the oscillations of flows and pressures in the vessels directly connected with 
the outlet chambers, such as aorta and pulmonary artery.  
Chapter 2  Clinical Problems 
 36 
 
Figure 2.2 - The physiological human circulatory system. In red the vessels perfused by blood 
rich in oxygen, in blue those with deoxygenated blood. Image adjusted from 
http://www.medicalook.com/human_anatomy/organs/Routes_of_Circulation.ht
ml. 
The aorta is the main systemic vessel, and it arises from the upper part of the left 
ventricle (Figure 2.1). Its first tract ascends for about 5 cm and then arches backward 
and to the left side. The aortic valve delineates its origin with three small dilatations, 
each corresponding to one of the three leaflets, called the sinuses of Valsalva or aortic 
sinuses. The only vessels departing from the ascending aorta are the left and right 
coronary arteries originating at the level of the aortic root (Figure 2.3), from the left and 
right aortic sinuses respectively. 
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Figure 2.3 - Image of the physiological human heart with the coronaries departing from the 
ascending tract of the aorta. Image taken from 
http://droualb.faculty.mjc.edu/Lecture%20Notes/Unit%204/FG21_09a.jpg. 
The calibre of the aorta increases at the level of the aortic arch, where a bulging outward 
of its right wall is present. Usually, three branches depart from the highest part of the 
arch: the innominate artery, the left common carotid, and the left subclavian. 
Finally, the descending part of the aorta can be divided into two portions: the thoracic 
and the abdominal. The former does not present a considerable diminishment in size, 
the latter shows a marked reduction in size as further branches bifurcate. 
The main pulmonary artery, or pulmonary trunk, originates from the right ventricle and 
it extends obliquely upward and backward passing in front of the first tract of the 
ascending aorta (Figure 2.1). Its dimensions are about 5 cm in length and 3 cm in 
diameter. It then divides into two horizontal branches, the right and the left pulmonary 
arteries. The right branch is longer and larger than the left branch and runs behind the 
ascending aorta to the root of the right lung. The left branch passes in front of the 
descending aorta to the root of the left lung.  
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The pulmonary valve is a semilunar valve made of three leaflets or cusps, with a 
diameter of 2-3 cm at its annulus. It lies in a plane slightly antero-superior to the aortic 
valve, at the superior end of the right ventricle. 
2.2.2 Fetal circulation 
The fetal circulation (Figure 2.4) is a shunt-dependent circulation as it relies on the 
presence of intra-cardiac and extra-cardiac shunts for the exchange of oxygenated and 
deoxygenated blood. In fact, gas exchange does not take place in the lungs, but it occurs 
at the level of the placenta: it collects deoxygenated blood from the fetus via the 
umbilical arteries, and returns oxygenated blood taken from the mother circulation 
through the umbilical veins (ductus venosus). The fetal cardiovascular system is 
designed in order to deliver the most highly oxygenated blood to myocardium and 
brain: 50-60% of the placental flow saturated with oxygen bypasses the hepatic 
circulation via the ductus venosus streaming to the inferior vena cava and then to the 
right atrium. In the inferior vena cava (IVC), this blood tends to keep separated from the 
systemic venous blood returning from the lower body. Also, a tissue flap (Eustachian 
valve) located where the IVC connects to the right atrium contributes in directing the 
more oxygenated blood directly to the left atrium, through the foramen ovale (a flap of 
tissue pushed open between the atria). Then, from the left ventricle, this blood is pushed 
into the ascending aorta, and it preferentially perfuses brain and coronary circulation. 
On the other hand, the desaturated blood coming from the upper body and the heart 
muscle perfusion arrives in the right atrium through the superior vena cava where it 
mixes with the part of desaturated blood streaming from the lower body through the 
IVC. From the right atrium, it goes to the right ventricle, and because of the 
considerable pulmonary vascular resistances characterising the undeveloped pulmonary 
fetal circulation, only about 12% of this blood enters the pulmonary arteries for the 
nourishment. The remaining 88% accesses the descending aorta through a shunt 
connecting the aorta to the pulmonary arteries, called ductus arteriosus. 
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Figure 2.4 - A schematic representation of the fetal circulation (on the left), and of the 
circulation at birth (on the right). The intra-cardiac and extra-cardiac shunts 
proper of these circulations are highlighted in the picture. Image taken from 
http://scientificillustration.tumblr.com/post/44638068025/obligatory-anatomy-
diagram-of-the-day-fetal-and. 
The transitional phase from the fetal circulation to the post-natal life (Figure 2.4) 
requires several cardiopulmonary adaptations. First of all, the blood oxygenation has to 
be transferred from the placenta to the lungs. Once the umbilical vessels are closed, the 
ductus venosus will stop being perfused, thus interrupting the flow towards the IVC, 
and in 3 to 10 days after birth it will passively seal. During the last period of gestation, 
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the pulmonary vascular resistances progressively start reducing, and a dramatic fall is 
finally experienced at birth after the lungs’ expansion. The consequent increment of 
pulmonary blood flow increases the pulmonary venous return to the left atrium. This, 
combined with the decreased venous return to the right atrium, leads the two atrial 
pressures to equalise bringing the foramen ovale to its closure within minutes to hours 
from birth. The last of the described shunts, the ductus arteriosus, closes around 4 days 
after the delivery.  
In case the conversion from fetal to neonatal circulation does not progress 
physiologically, several abnormalities in the heart or in the blood vessels can arise, 
known under the name of congenital heart disease (CHD). 
2.3 CONGENITAL HEART DISEASE 
Congenital heart defects include all the malformations affecting the heart originating in 
the fetus during gestation. They represent the major cause of infant morbidity in the 
Western world, with a mortality incidence of 20% (1). Only in the USA, nearly one out 
of 100 infants is born with one or more congenital heart diseases every year. The causes 
are thought to be mainly genetic, and due to mutations in the regulators of the heart 
development, but epidemiological analyses showed that also environmental factors are 
associated to the genesis of CHD. In recent studies, the genetic basis for some defects 
has been disclosed, and the increasing interest on the subject is bringing new insights on 
the genetic dysregulations leading to heart diseases (2).   
In general, CHD can be classified in two categories: those boosting a blood overload 
towards the pulmonary circulation, and those causing an insufficient pulmonary 
perfusion. The first category is composed by those congenital malformations inducing 
oxygenated blood to re-circulate across the lungs before the oxygen is delivered to the 
tissues through the systemic circulation. In the second group, on the other hand, the 
tissues are not perfused by sufficiently oxygenated blood, causing cyanosis in the child. 
Finally, a combination of different defects could coexist, further complicating the 
cardiovascular system. 
A list of common and less common congenital heart diseases with a brief description is 
presented below. Transposition of the great arteries and coarctation of the aorta will be 
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extensively illustrated in Section 2.5 and 2.6 respectively, as patients affected by these 
defects will be further studied in the research presented in this Thesis.  
- Atrial septal defect (ASD): the foramen ovale typical of the fetal circulation does not 
close at birth, thus leaving the communication between atria open.  
- Ventricular septal defect (VSD): orifice of various dimensions and localizations 
between the left and right ventricle, often associated to other abnormalities. 
- Tricuspid valve atresia: absence of the tricuspid orifice and consequent right 
ventricle hypoplasia. This condition is always associated with the ASD to permit the 
life of the newborn by allowing the mixing between oxygenated and deoxygenated 
blood coming from the pulmonary veins and from the venae cavae respectively. 
- Aortic stenosis: valvular, subvalvular of supravalvular narrowing of the aorta. 
According to the location it can cause insufficiency or coronary artery abnormalities, 
while left ventricular hypertrophy is always present. Associated CHD are usually 
patent ductus arteriosus and coarctation of the aorta. 
- Hypoplastic left heart syndrome (HLHS): CHD with an undeveloped left heart, 
including ventricle, valves and aorta. Two other defects are necessary for the life of 
the newborn affected by HLHS: a communication between the atria and a patent 
ductus arteriosus. 
The next group of CHDs shares RVOT obstructions or pulmonary valve complications. 
- Pulmonary atresia: the pulmonary valve does not become patent, thus this condition 
is usually associated with hypoplastic right ventricle and triscuspid valve. 
- Pulmonary stenosis: it consists in a narrowing of the pulmonary valve opening and/or 
the RVOT. Its position can be: supravalvular, compromising the patency of the main 
pulmonary artery, or of the branch pulmonary arteries; valvular, with the leaflets of 
the pulmonary valve abnormally thickened not permitting the full opening; 
subvalvular, restricting the diameter of the RVOT.  
- Absent pulmonary valve: rare defect characterised by underdeveloped pulmonary 
leaflets and thus significant pulmonary insufficiency. 
- Truncus arteriosus: the embryological structure of the truncus arteriosus, which is an 
arterial trunk originating from both ventricles, fails to divide into aorta and main 
pulmonary artery before birth. It is always associated with VSD to allow the 
systemic and pulmonary blood to mix in the ventricles. 
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- Double outlet right ventricle: in such rare disease, associated with VSD, both aorta 
and main pulmonary artery originate from the right ventricle. 
- Tetralogy of Fallot: this malformation presents four pathological conditions: i) 
valvular or subvalvular pulmonary stenosis, ii) VSD, iii) right ventricle hypertrophy, 
and iv) misposition of the aorta above the VSD.  
2.3.1 Repair of CHD 
Surgical repair is usually needed to correct the CHDs described in the previous 
paragraph, from days to months after birth.  
The survival of children born with congenital heart disease has remarkably increased 
since the introduction of cardiac surgery (3). In the last decades, surgical corrections 
evolved and improved, showing encouraging mid-term and long-term clinical outcomes. 
An important role in this success has been played by improvements in early diagnosis, 
due to the advances of fetal echocardiography (4). 
The optimisation of surgical techniques has recently become particularly craved, 
because of a larger inclination to perform the surgical intervention earlier in the life of 
the sick newborn. In the past, the majority of the techniques used were multiple-step-
procedures: usually a palliative intervention was performed soon after birth, and once 
the baby was stable, a later surgery was following to correct finally the defect. 
However, such temporary palliations, as the systemic-to-pulmonary shunts, or the 
pulmonary artery bandings, bear risks of damaging the patient’s circulation causing a 
noteworthy overload to the pulmonary system and a pressure increase in the right 
ventricle. In addition, eventual distortions or interruptions caused to a pulmonary branch 
during the palliation, or shunts and bandings themselves, could make the patient not 
suitable for undergoing the following surgery. 
For these reasons, cardiac-surgeons have abandoned the palliative choice for the better 
perspective offered by one complete repair intervention. Although it needs to be 
advanced in time, exposing the child to a demanding surgery soon after he is born, it is 
able to reduce the mortality associated with the CHD and, at the same time, it can 
prevent damages to the circulation growth and development (5). Though, it must be 
considered that, in the long-term prospective, surgery in infants often remain pure 
palliative, as the allometric growth will inevitably change the relationship between the 
cardiac structures and the implanted device or conduit. And, also those cases planned to 
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be definitive will probably present complications such as cardiac arrhythmia, valve 
dysfunction and heart failure (6) because of the debilitating and invasive approach used 
on neonates. 
In recent years, as the number of tools and devices has markedly grown, an alternative 
to surgery for the treatment of CHD over time has been found in interventional 
cardiology techniques, able to safely delay the need for surgery. One example of 
percutaneous approach to treat RVOT dysfunction resulting from initial surgical repair 
of CHD – percutaneous pulmonary valve implantation – is reported in Section 2.4. 
2.4 RVOT OBSTRUCTION and PPVI 
As briefly described in Section 2.3, some CHD are directly associated with obstruction 
of the RVOT. The obstruction is corrected at birth by surgically reconstructing the 
RVOT with a patch or a conduit, which often leaves the patient with no valve or a 
malfunctioning one. Furthermore, the biological or synthetic materials these patches and 
conduits are made of are prone to degradation and calcification, causing morphological 
and/or functional changes of the new RVOT over time. Therefore, the patient will 
require revision of the first repair. The classic approach to this problem is repeated 
surgical repair. Surgical intervention on cardiac valves is nowadays accomplished with 
low mortality rates. However, it still bears several pitfalls: first of all, the necessity of 
sternotomy and the nature of the intervention which rise the risk of infections; then, the 
use of the heart-lung machine which requires blood anticoagulation drugs, thus 
increasing haemolytic dangers (7); lastly, the economical aspect that cannot be 
neglected due to the high costs related to the heart-lung machine components, the 
intensive post-operative treatments required for the patients, and the long hospital stay 
(8). 
More recently, an innovative percutaneous technique has been developed that allows for 
a minimally-invasive approach to pulmonary valve replacement: PPVI.  
Transcatheter valves were first introduced in 1992 by two research groups, who 
performed studies on animals. Pavcnik and co-workers proved the feasibility of 
transcatheter positioning of a prosthetic caged-ball aortic valve in dogs (9), while 
Andersen succeeded in implanting transluminally a porcine aortic valve in closed-chest 
pigs (7). During the 1990s and at the beginning of the XXI century, further experiences 
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in animals were carried on (10– chronic study in lambs; 11– acute study in pigs; 12– 
acute study in lambs; 13– study in sheep), encouraging the development of this 
procedure.  
The first successful transcatheter valve implantation in man was realised in 2000 by 
Bonhoeffer and colleagues, who created an innovative system to replace the pulmonary 
valve (14). The device used for this procedure (Melody™, Medtronic Inc, Minneapolis, 
MN, USA) was developed from commercially available products: a Contegra conduit 
(Medtronic Inc, Minneapolis, MN, USA) (Figure 2.5) – a segment of bovine jugular 
vein with a native valve in the centre – was sutured to a CP stent  – a Platinum-
10%Iridium balloon-expandable stent. The procedure was performed under fluoroscopy 
guidance in a 12 year-old boy with stenotic RVOT/pulmonary artery after tetralogy of 
Fallot repair. The valved stent was crimped onto a balloon-in-balloon catheter (Figure 
2.5b), and through femoral access, was guided to the RVOT. Once in place, first the 
inner balloon, second the outer balloon, were inflated to deploy the device into the 
patient’s implantation site. 
      
Figure 2.5 - Melody™ device in expanded configuration (a), and during the deployment 
procedure (b). 
Following the success of this first-in-man percutaneous valve implantation, in 2002, 
Cribier and co-workers performed the first clinical transcatheter aortic valve 
implantation (TAVI) (7) to treat a patient for whom open-heart surgery was judged 
prohibitive. The device, consisting of 3 bovine pericardial leaflets sewn inside a balloon 
expandable stainless steel stent (Figure 2.6), was positioned and deployed inside the 
patient’s native stenotic heart valve, without obstructing the coronary flows, neither the 
a) b) 
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mitral valve function. The achieved satisfactory results confirmed the practicability of 
TAVI (15).  
 
Figure 2.6 - Cribier transcatheter aortic valve: a) valved stent crimped onto the balloon 
catheter; b) valve leaflets in closed position; c) valve leaflets in open position 
(16).  
In the last decade, percutaneous valve technology and applications have grown 
exponentially in the aortic, pulmonary and tricuspid position, with several prostheses 
currently under development especially for TAVI applications. In PPVI, two devices are 
clinically available: Melody™ (Medtronic, MN, USA), which received CE approval in 
2006 and FDA approval in 2010, and Edwards Sapien™ Pulmonic Transcatheter Heart 
Valve (Edwards Lifesciences, Irvine, CA, USA). The PPVI population studied in this 
Thesis has been treated with Melody™ which therefore will be the PPVI device 
considered in the reminder of this Thesis.  
2.4.1.1 PPVI devices in this Thesis 
Melody™ is constructed with a valve from a bovine jugular vein, sewn into a balloon-
expandable CP stent. This stent is manufactured from heat-tempered 90%platinum-
10%iridium, 0.33 mm wires with excellent radiopacity that make it easy to visualise 
with x-rays. The wires are formed in a 8 zig pattern, wrapped around a cylinder to create 
a ring and welded at the crown points to other wires to form a cylindrical structure (17). 
The CP stent with a 6 ring configuration is the frame of the PPVI Melody™ device 
(Figure 2.5a). Since the platinum welds were prone to fracture, this component of the 
PPVI was modified during the early clinical experience by introducing a gold braising 
process to reinforce the crowns. The bovine vein is attached to the stent by sutures 
around the proximal and distal rings and at each strut intersection. Bovine jugular 
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venous valves are available only up to 22 mm of diameter, thus limiting the use of this 
minimally-invasive technique to those patients (15%) who have a small implantation 
site. A second generation device is currently under development (18) to treat patients 
with large RVOTs who are unsuitable for PPVI with Melody™. This new device 
consists of 6 nitinol rings interwoven with a polyester graft (Figure 2.7) and a 
pericardial valve. The proximal and distal ends of the stent-graft are larger (up to 40 mm 
diameter) than the central portion (22 mm diameter) which holds the valve, to ensure 
safe anchoring of the device to the implantation site (18). The material of choice for the 
stent, nitinol, is characterised by large, fully recoverable deformations and high fracture 
resistance. Therefore, the design of this new PPVI device should allow minimally-
invasive treatment in patients with larger and more dynamic outflow tracts, with low 
risk of stent fracture.  
 
Figure 2.7 - Second generation PPVI device (18). 
In 2009, a successful first-in-man implantation of this new PPVI device was undertaken 
in a 42-year-old man with congenital heart disease, a previous medical history of four 
open heart surgeries and two additional thoracic procedures. Surgical replacement of the 
severely insufficient pulmonary valve was considered too high risk, whereas PPVI with 
the Melody™ device was prevented by the anatomical dimensions and highly dynamic 
characteristics of the native outflow tract (19). The device is currently undergoing 
preclinical trial in the US and Canada.  
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2.4.1.2 PPVI procedure 
During the procedure in the catheterisation laboratory, the Melody™ valved stent 
assembly is hand-crimped from 18 mm diameter to a size of 6 mm onto a custom made 
delivery system, before being re-expanded inside the patient’s implantation site up to 22 
mm. The delivery system (Ensemble™, Medtronic) comprises a balloon-in-balloon 
(BiB) deployment design with three available outer balloon diameters: 18 mm, 20 mm 
and 22 mm. The inner balloon sizes are half of the outer balloon diameters, and they are 
1.0 cm shorter than the outer balloon lengths. BiB catheters allow the insertion of the 
device in a two-stage process: the inner balloon is the first to be inflated, semi-
expanding the stent into an even cylindrical configuration. This allows (i) a fine 
positioning of the device in the RVOT, before the outer balloon is inflated for the final 
expansion; (ii) and to avoid any wall injuries caused by the dogboning effect during the 
stent inflation. Also, each balloon is provided with two markers, increasing the visibility 
of the delivery system, and permitting the measurements of the functional length 
accurately along the process.  
Over the last 13 years, PPVI with Melody™ has shown a marked learning curve with 
safety and efficacy improvements that have led to successful worldwide clinical use of 
this procedure (>5,000 implants to date).  
Despite the success of this technique, a major technical issue still remains: stent 
fracture. During the preclinical testing phase of this device, stent fracture was not 
identified as a potential problem: the device was mounted inside a cylindrical compliant 
conduit in a mock circuit, and the cardiac pulsatile loading conditions were replicated 
exposing the device to millions of cycles, as requested by standard testing regulations. 
In this set-up, at the end of the testing, the valve showed some tears and became 
sometimes incompetent, while the stent presented no signs of mechanical failure: 
exactly the opposite of what happens in the clinical experience. Finite element analysis 
of the device tested with the same loading conditions for long-term mechanical 
performance (fatigue analysis) gave the same results: no risk of stent fractures. This 
suggests that the preclinical tests simulated incorrectly the in-vivo loading conditions, 
not taking into account the specificity of patients’ anatomies and dynamics. 
PPVI stent fracture occurs in approximately 25% of the treated patients (20), but luckily 
does not cause highly risky hemodynamic or clinical complications because in most of 
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the cases the stent does not lose its structural integrity. When this does happen, and the 
patient becomes symptomatic again, a second PPVI stent can be safely implanted in the 
first (21). In order to minimise the risk of stent fracture, a pre-stenting strategy has been 
developed with the implantation of one or several bare stents before the valved device. 
This technique is feasible and safe, and has been shown to help in relieving eventual 
RVOT obstruction and reducing the risk of developing fractures because it creates a 
reinforced scaffold for the PPVI device (22). However, despite the bare metal stent, 
Melody™ stent fracture remains a problem and close clinical follow-up is required (23). 
Chapter 5 of this Thesis will analyse the problem of PPVI stent fracture in our patient 
population by using engineering tools.  
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2.5 TRANSPOSITION OF THE GREAT ARTERIES AND COMPLICATIONS 
FOLLOWING THE ARTERIAL SWITCH OPERATION 
2.5.1 TGA 
Transposition of the Great Arteries is the most common cyanotic congenital heart 
disease in neonates (24). The incidence of the disease is estimated at 20-30 cases per 
100,000 live births every year, with a 60-70% male predominance (25). 
Although the aetiology of this congenital disease is still unknown, some risk factors 
have been identified: 
- Mother’s age > 40 years 
- Alcoholism 
- Diabetes 
- Poor nutrition during pregnancy  
- Rubella or other viral illness during pregnancy. 
The hallmark of TGA is ventriculo-arterial (VA) discordance, whereby the aorta arises 
from the right ventricle and the pulmonary artery (PA) arises from the left ventricle 
(Figure 2.8b) (26). 
            
Figure 2.8 - Schematic representation of the normal heart (a) opposed to the TGA heart (b).RA, 
RV, LA, LV indicates respectively the right and left  atrium and right and left 
ventricle. The incorrect origin of the aorta (AO) and the pulmonary artery (PA) 
are highlighted in the picture on the right. Image taken from 
http://pediatricheartspecialists.com/articles/detail/transposition_of_the_great_
arteries.  
This anatomical arrangement impacts on the way blood circulates throughout the body; 
in fact, the pulmonary and systemic circulations function in parallel rather than in series. 
a) b) 
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Oxygenated pulmonary venous blood returns to the left atrium and left ventricle, but it 
is re-circulated to the pulmonary vascular bed via the abnormal pulmonary arterial 
connection to the left ventricle. Deoxygenated systemic venous blood returns to the 
right atrium and right ventricle where it is pumped to the systemic circulation, 
effectively bypassing the lungs. 
This parallel circulation results in insufficient oxygen supply to the tissues and 
excessive right and left ventricular workload (27). It is incompatible with prolonged 
survival unless oxygenated and deoxygenated blood are mixed at some anatomic level, 
such as in the presence of atrial or ventricular septal defects acting as left-to-right shunts 
(28). If the pathology is left untreated, the mortality rate is approximately 30% in the 
first week of life, rising to 50% in the first month, and to 90% by the end of the first 
year. On the other hand, early diagnosis and treatment allow the overall short-term and 
mid-term survival rate to exceed 90% (27). 
The most common causes of postoperative mid-term mortality are mainly arrhythmia, 
right ventricle dysfunction and mechanical complications at the level of the intra atrial 
baffle surgically created to treat the defect (emedicine.medscape.com). 
In approximately 60% of patients, the aorta is anterior and to the right of the pulmonary 
artery, while a subset of patients presents the aorta located in front and to the left of the 
pulmonary artery. These two types of configurations are referred to as dextro-
transposition of the great arteries (d-TGA) and levo-transposition of the great arteries (l-
TGA). 
In addition, most TGA patients (regardless of the spatial orientation of the great arteries) 
exhibit a subaortic infundibulum, absence of subpulmonary infundibulum, and fibrous 
continuity between the mitral valve and the pulmonary valve (29). However, several 
exceptions have been observed and cannot be placed in the above classifications (27). 
With regard to ventricular morphology, the patient’s ventricles have normal shape and 
thickness in presence of atrial-septal defect at birth; otherwise the right ventricular wall 
is considerably thickened, with such thickening increasing with growth. Within few 
weeks, the right ventricle often becomes enlarged and hypertrophied. The wall of the 
left ventricle, instead, becomes thinner and compressed (28). 
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The aortic valve plane is rightward and anterior relative to the pulmonary trunk. The 
fibrous continuity of the leaflets of the atrio-ventricular and the ventriculo-arterial 
valves is located on the right side rather than on the left side (28). 
Coronary arterial anatomy in TGA patients is not only significantly different from the 
normal circulatory arrangement, but it can also vary substantially within this patients’ 
group. In most cases, the coronary arteries originate from the aortic sinuses contiguous 
to the pulmonary trunk and run directly toward the atrio-ventricular groove following a 
normal course. In other cases, they originate from different sinuses and have an 
intramural course, or can be characterised by abnormal looping around the vessels (28).  
Another anatomical consideration concerns the pulmonary trunk, which can be larger 
than the descending aorta, particularly in those cases presenting a ventricular septal 
defect. Either isthmic coarctation or interrupted aortic arch are very common in hearts 
with ventricular septal defect (28).  
Following from these considerations, TGA clearly results in a complex anatomical and 
physiological arrangement that requires surgical correction. 
2.5.2 Surgical Repair of TGA: the Arterial Switch Operation 
Repair of TGA has been attempted since the 1950s. The most successful procedures 
were introduced in 1958 by A. Senning (30) and in 1963 by W.T. Mustard (31). Both 
approaches consisted in redirecting blood flow within the atria: the former has the 
advantage of not using foreign material (i.e. atrial patch), the latter of being simpler to 
manage post-operatively (32). The Senning or Mustard procedures represent an ‘atrial 
switch’ and have been used to palliate TGA until a new procedure, referred to as 
‘arterial switch’, was introduced in 1980. The first successful arterial switch operation 
(ASO) was reported by Jatene (33), and it proved to be more beneficial than the atrial 
correction (28), as it avoids arrhythmias and dysfunctions of the systemic ventricle. This 
Thesis will focus solely on TGA patients who underwent ASO procedure, as described 
below. 
In the first day of life, the primary step undertaken to treat a newborn with TGA defect 
is to perform a Rashkind balloon atrial septostomy (26). This minimally-invasive 
procedure uses a balloon catheter to enlarge the foramen ovale (i.e. the hole allowing 
communication between the atria in the fetal circulation) in order to prevent its sealing, 
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otherwise naturally occurring soon after birth. This facilitates blood mixing and 
increases oxygen saturation (Figure 2.9), bridging the patient to the surgery. 
 
Figure 2.9 - Rashkind procedure: the balloon catheter is inserted into the septal defect and 
inflated. After inflation, the catheter is pulled back through the hole 
(http://www.hakeem-sy.com). 
After 10-15 days, the aorta and main pulmonary artery can be surgically repositioned 
(Figure 2.10) performing the actual arterial switch, which requires cardiopulmonary 
bypass and aortic cross clamping.  
One particularly challenging feature of ASO is the relocation of the coronary arteries, in 
order to avoid cardiac hypoxemia and ischemia of the myocardium. The left and right 
coronary arteries ostia are visualised and excised from the aortic root, with adjacent 
aortic wall, as "buttons". In abnormal looping course the dissection of the coronary 
trunk is extended, in order to avoid any stretch or kink during the relocation. The 
coronary artery buttons are then shifted posteriorly and implanted into the facing 
sinuses of the main pulmonary artery root. The left coronary artery is allocated in a low 
position and the right coronary artery in a high position, in order to reduce the risk of 
distortion. A lateral relocation could prevent compression by the pulmonary bifurcation. 
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The aorta is transected in the middle of the ascending portion, in order to lessen the 
amount of reconstructed aorta posteriorly below the transferred pulmonary artery 
bifurcation. The pulmonary trunk is transected 5–10 mm below its bifurcation. Next, the 
main pulmonary artery and its branches are brought forward with a practice that goes 
under the name of Lecompte manoeuvre, and the distal aorta is moved posteriorly (28). 
A termino-terminal anastomosis is then realised between the distal aorta and the root of 
the pulmonary valve. Using a patch of cryopreserved pulmonary artery homograft, the 
pulmonary artery is then reconstructed, and finally the atrial septal defect closure 
completes the arterial switch repair (28). 
 
 
Figure 2.10 - Schematic representation of the arterial switch operation, including relocation of 
coronary buttons (http://radiology.rsna.org). 
2.5.3 Postoperative complications 
Although arterial switch restores normal blood flow with mixing of oxygenated and 
deoxygenated blood, and 90% 10-year survival has been reported to date, indicating the 
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success of the surgery (26), several long-term complications can arise. It should be 
noted that since this procedure has been performed for only approximately 30 years, 
there are no long-term survivors so far, and the possible extent of long-term 
complications cannot be fully appreciated yet (34).  
2.5.3.1 Systemic side 
Aortic wall abnormalities in surgically repaired TGA are likely due to anomalous 
aorticopulmonary septation, damage to the vasa vasorum, and surgical manipulations 
during ASO. Vasa vasorum transections during the procedure, with consequent blood 
ﬂow inhibition, can induce necrosis followed by dilatation. This can lead to impaired 
distensibility of the neoaorta, reported by both invasive and image-based studies (35). 
Kinking of the coronary arteries could also occur, because of the spatial arrangement of 
the vessels, which does not respect the physiological one. Moreover, the length of the 
vessels sometimes is not adequate to easily relocate them, thus they need to be 
stretched. As a result, the coronaries are prone to stenosis, and the occlusion of the 
coronary arteries is not an uncommon event in the follow-up of TGA patients (36). 
Physical manipulations during ASO, such as the reimplantation of the coronary arteries 
and suturing of the two main vessels, can also lead to scarring and changes in the 
neoaortic root wall, resulting in progressive aortic dilatation. Aneurysm formation and 
aortic dissection have also been attributed to the ASO surgical handlings (37).  
After ASO, the neoaortic wall (the former pulmonary artery) is exposed to higher 
systemic pressures. Concern has been raised about the ability of the pulmonary root to 
adapt to a systemic pressure load. A study by Co-Vu and colleagues discussed the risk 
for the native pulmonary root to dilate when implanted in the aortic position, because of 
the histological differences inherent to the vessel walls of the pulmonary and aortic 
arteries. Also, no evidence of stabilization in the root dimensions has been observed yet, 
around 15-20 years postoperatively (38). 
Both aortic distensibility and aortic dimensions are crucial parameters affecting aortic 
valve dynamics. Decreased distensibility of the aortic root increases stress and strain on 
the neoaortic valve leaflets, therefore predisposing for aortic valve dysfunction (37). In 
addition, the risk for neoaortic valve regurgitation appeared to increase with length of 
time after the operation, which parallels the risk for neoaortic root dilation (38). 
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Furthermore, the relocation of the ascending aorta onto the pulmonary valve might 
create an abnormally acute angulation of the aortic arch (Figure 2.11) as a consequence 
of the Lecompte manoeuvre.  
 
Figure 2.11 - Fluoroscopy visualisation of an acute aortic arch, or gothic arch, as a result of 
arterial switch operation. The enlarged aortic root (indicated by the yellow 
arrow) and the indentation resulting from repositioning of the pulmonary 
arteries following the Lecompte procedure (red arrow) can also be appreciated. 
Image modified from (39). 
This postoperative morphological feature has been suggested to induce enhanced 
systolic wave reflection and consequent ascending aortic dilatation (39). The acute 
angulation of the aortic arch, also referred to as “gothic” arch, has been associated with 
compromised exercise capacity in these patients (40). Furthermore, the increased 
impedance due to a stiffer and abnormally shaped aortic arch is likely to impinge on the 
VA coupling, as recently indicated by Biglino and co-workers. Thus, it has been 
suggested that TGA repair by ASO can also have consequences on pumping efficiency 
and energetics (41). 
2.5.3.2 Pulmonary side 
Complications on the pulmonary side are mainly identified with the development of 
pulmonary artery unilateral stenosis. Indeed, during the Lecompte maneuver, the 
operation of moving the pulmonary artery in front of the aorta causes a relevant 
stretching of the left pulmonary artery. In addition, it has been observed that the 
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presence of a portion of ductal tissue can cause the so-called coarctation of the left 
pulmonary artery. Here, the LPA narrows where the ductus arteriosus inserts between 
the two arteries, and when relocated during the Lecompte maneuver this can create a 
significant stenosis and flow asymmetry (42). This issue has been reported to occur in 7 
to 28% of ASO cases (43). 
If the asymmetry of the flow is considered to be detrimental for the patient, the most 
common solution for this problem is either stenosis ballooning or stenting. However, 
some cases have been reported with the ballooning not considered as optimal solution 
(36). The percentage success of balloon dilation was assessed around 50% and inversely 
proportional to the age of the patient (43). Dilatation was indicated as not very efficient 
but beneficial in terms of decreased right ventricular pressure, given that it allows 
postponing the surgical approach. On the other hand, it has been demonstrated that 
stenting is a more effective strategy, since the conduit remains patent for a longer time 
(44). 
In some patients, a controversial occurrence was noticed: although a severe unilateral 
pulmonary stenosis was diagnosed from MR examination, no asymmetric flow 
distribution between left and right pulmonary arteries was observed. This phenomenon 
has not been explained yet, and it is likely connected with a change (remodelling) in the 
distal pulmonary vascular resistances that allows for balanced flow-split despite the 
presence of the stenosis.  
2.5.3.3 Remodelling of the pulmonary resistances 
In general, the human organism is able to respond to and partly compensate mismatches 
in order to restore physiological conditions. In the context of variations of pulmonary 
resistance, remodelling can be defined as the ability of vessels to change their structure 
without changing their volume (45). Remodelling can be classified as inward or 
outward: the former leads to a reduction of the lumen, the latter is associated with an 
increase of the lumen. Furthermore, a sub-classification based on the amount of tissue 
belonging to the arterial wall refers to the remodelling as hypotrophic, hypertrophic and 
eutrophic, respectively for a decrease, increase or no change (46) in tissue quantity. 
Remodelling in case of hypertension has been widely studied and discussed in literature. 
Several in-vitro experiments confirmed that an increment in the relaxation of the 
peripheral resistances and in the wall-lumen ratio in hypertensive patients (inward 
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eutrophic remodelling) was not associated with any increase in the total cross sectional 
area of the vessel, at least in the minor vessels. In the great arteries, remodelling brings 
to a wall-lumen ratio rise that always leads to tissue growth (46).  
Hypertension is not the only possible reason for remodelling. Altered blood flow can 
lead to vascular remodelling, influencing vascular tone and attracting inflammatory 
cells (47). This scenario is more representative for the cases here discussed, as the TGA 
patients analysed in this Thesis research did not present any sign of pulmonary 
hypertension. In general, cardiologists accept that pulmonary hypertension occurs where 
pulmonary pressure is greater than 50% of systemic pressure (48), while in the analysed 
cases the pulmonary pressures were in the physiological range. 
Remodelling in small vessels can be due to various reasons. Inflammation or presence 
in the blood stream of certain proteins, growth factors, nitride oxide or enzymes can 
facilitate the onset of vascular remodelling (47). Furthermore, arteries show inward 
remodelling after a reduction in blood flow. The lumen of a vessel shrinks if the flow is 
reduced. Experiments with murine mesenteric artery showed the effect of surgically 
modified blood flow on the arterial diameter. The average in-vivo diameter before flow 
alteration was 193±9 μm. After two hours in un-physiological state, the arteries with 
low flow registered a decrease in diameter of 17±5%, while arteries with high flow 
measured an increase of 17±7% (47; 49). 
Changes in the pulsatility of the flow can also be responsible for the remodelling of the 
vasculature, as shown in patients with Fontan circulation (50). 
2.5.4   Surgical Repair of TGA: an alternative operation 
In a normal anatomy, the aorta and the main pulmonary artery present a spiral spatial 
arrangement, while the ASO with Lecompte manoeuvre, as described in Section 2.5.2, 
does not maintain the spiral relationship of the great arteries. This has been indicated as 
one of the main causes for some of the clinical complications in repaired TGA (51). For 
this reason, a modified ASO by a so-called “spiral reconstruction” (Figure 2.12) has 
been advocated by one group in Taiwan to potentially help in avoiding coronary 
kinking. 
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Figure 2.12 - Comparison between normal heart (C), TGA (A), ASO with Lecompte (B) and 
spiral ASO (D). It is possible to appreciate how the spiral procedure restores a 
more physiological anatomy than the traditional arterial switch operation 
(image from 51). 
The three main differences of the spiral procedure with respect to the previous 
technique have been described by the group who introduced it as follows: (1) the aorta 
is amputated obliquely so that a larger left lip can be used as the ﬂoor of the pulmonary 
pathway; (2) the right posterior part of the pulmonary trunk is divided to make a larger 
ﬂap to be everted to the left and a more leftward pulmonary pathway after neoaortic 
anastomosis and posterior attachment (suturing the caudal edge of the right pulmonary 
artery to the posterior neoaorta) accordingly; (3) the posterior attachment site is 
ascertained after release of the aortic cross-clamp, as in the previous technique (Figure 
2.10). However, to facilitate exposure, the aorta is cross-clamped again distal to the 
deepest site of attachment and then stitched from the right (51). 
Therefore, this procedure restores the high-pressure ascending aorta to its natural 
location, reducing the acute angulation of the aortic arch due to the Lecompte 
manoeuvre and all the resulting issues, such as arch hypoplasia and neocoarctation. 
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2.6 AORTIC COARCTATION AND TREATMENTS 
2.6.1 CoA 
Coarctation of the aorta (CoA) is a narrowing of the aorta typically occurring just distal 
to the head and neck vessels, in the region adjacent to the ductus arteriosus (Figure 
2.13).  
The incidence of such a disease is estimated to be around 0.1% of newborns (52), and 
can be found isolated or in association with other heart defects, such as bicuspid aortic 
stenosed valve (BAV), tricuspid aortic stenosis (53; 54), ventricular septal defect, patent 
ductus arteriosus, mitral stenosis or regurgitation, aneurysm of the circle of Willis (53).  
 
Figure 2.13 - Patient with CoA imaged through unenhanced 3D SSFP magnetic resonance 
angiography (MRA) (a) and contrast enhanced MRA (b). Three-dimensional 
volume rendering of the heart and the aorta with coarctation (c) indicated by 
the arrow. Image taken from 55. 
This condition entails hypertension in the arms, development of an extensive collateral 
arterial circulation connected to the descending aorta and its branches (Figure 2.14a) 
(53), left ventricular failure and aortic dissection (56). Also, the narrowed portion of the 
aorta creates a significant pressure gradient and a flow jet with high velocity (Figure 
2.14b) that can compromise hemodynamic parameters such as pulse blood pressure, 
aortic capacitance and wall shear stress (57). 
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Figure 2.14 - a) Magnetic resonance angiography of a CoA, with intercostals collateral arteries 
indicated by the white arrows (AA=ascending aorta, DA=descending aorta). 
Image taken from Ijland and Tanke, 2009; b) Echocardiography in an aortic 
arch with coarctation, showing a high velocity jet through the narrowing. 
Image taken from 58. 
Native CoA is usually detected during the investigation for systemic hypertension. 
Adults with CoA could be asymptomatic or present symptoms typically associated with 
hypertension. Non-invasive functional assessment consists in the measurement of the 
cuff pressure difference between arms and legs, peak gradient estimation by Doppler 
echocardiography, and flow measurement through 2D or 3D Phase-Contrast MRI (59). 
However, Doppler echocardiography could be obtained only in patients with a 
favourable location of the descending aorta, and usually overestimates the pressure 
gradient (60), while the upper-lower body pressure difference was proven not to be a 
reliable estimate for the pressure loss across the CoA (61). Invasively, the exam used for 
a pre-operative evaluation and a post-operative assessment is pressure measurement by 
cardiac catheterisation. The anatomy is usually determined through MRI, CT, or 
contrast aortography.  
2.6.2 Treatments 
No treatment modality has been widely accepted as optimal. Among the options there 
are various surgical techniques, percutaneous balloon angioplasty, stenting and 
implantation of a covered stent. 
Surgery is generally performed in patients with a pressure gradient across the stenosis 
larger than 30 mmHg (56), using end-to-end resection, patch repair or tube grafts. For 
b) a) 
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years, it has been considered the standard treatment, but, due to the technical 
difficulties, related risks (paraplegia, higher perioperative mortality) and long term 
issues (recurrence of residual CoA, late aneurysm, persistent hypertension) (62) is no 
longer routinely performed (63). 
In 1982, percutaneous balloon angioplasty was first tested to relieve the surgically 
created CoA in newborn lambs (64), and then introduced as a successful treatment in 
humans. However, not all CoA are suitable for balloon dilatation, and also high risk of 
re-coarctation, aneurysm formation and dissection are associated with such minimally-
invasive procedure (62). Stenting (Figure 2.15) has been introduced in the last decade as 
a successful alternative to surgery (65), but without eliminating the risks presented by 
ballooning of aneurysm formation, damage to the aortic wall and vessel obstruction 
(66).  
 
Figure 2.15 - Fluoroscopy images of a CoA treated with stent implantation. Image taken from 
67. 
In 2011, a multicentre observational study tried to compare the three presented options 
(surgical, balloon angioplasty and stenting) for the treatment of native CoA in terms of 
immediate, short-term and intermediate outcomes. The cohort included 350 children 
between 6 and 12 years old from 36 centres. Lower immediate complications were 
observed in the stented patients that together with the surgical patients presented 
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superior hemodynamics and imaging outcomes at short-term and intermediate follow-
up. However, stented patients more likely required a planned re-intervention (68). 
The final alternative consists in implanting covered stents. Results from a single centre 
have shown that covered CP stents, although still bearing with aortic wall 
complications, can be a safer alternative to conventional stenting, also allowing further 
secure later re-dilatation (62). 
Among the potential disadvantages of the covered CP stent are the eventual graft 
ruptures due to balloon re-dilation, the needs of large sheath, and the potential occlusion 
of aortic side branches (62). 
 
The technological and scientific advancements of the last decades have made available 
an increasing number of tools that can help facilitate the diagnosis and guide the 
treatment for several of the CHD and issues described above. In particular, the 
application of engineering methodologies to study the physiology and the pathology of 
the cardiovascular system has provided precious insights and additional directions for 
the treatment of heart diseases. In the next chapter, some of these engineering tools will 
be described.    
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3.1 INTRODUCTION 
The central idea of a scientific model is the representation of a complex system through 
the identification of its target features, and the reduction of its complexities by means of 
simplifications and discretisation in problems of smaller size. Scientific models are used 
to better understand and explore unknown organised structures, and to predict their 
reactions once a precise action is executed on them. The human body is one of the most 
elaborate and dynamic systems, and its modelling has been largely attempted with 
increasing level of detail, for different purposes.  
The concept of modelling in bioengineering and particularly of patient-specific 
modelling is revised at the beginning this chapter. All the steps undertaken for a 
cardiovascular patient-specific model implementation are tackled in the following 
sections: from clinical data collection and acquisition modality (Section 3.4), to 
numerical tools at the basis of the models (Section 3.5), to experimental tools mainly 
used for validation purposes (Section 3.6). 
3.2 MODELLING 
“Model: a simplified description, especially a mathematical one, of a system or process, 
to assist calculations and predictions” (Oxford dictionary).  
“A model is a substitute for a real system. Models are used when it is easier to work 
with a substitute than with the actual system” (69). 
“Models are of central importance in many scientific contexts.... Models are one of the 
principal instruments of modern science.... There are a variety of things that are 
commonly referred to as models: physical objects, fictional objects, set-theoretic 
structures, descriptions, equations, or combinations of some of these” (70). 
“A scientific model seeks to represent empirical objects, phenomena, and physical 
processes in a logical and objective way. All models are in simulacra, that is, simplified 
reflections of reality, but, despite their inherent falsity, they are nevertheless extremely 
useful.” (71). 
“Models are a mentally visual way of linking theory with experiment, and they guide 
research by being simplified representations of an imagined reality that enable 
predictions to be developed and tested by experiment” (72).  
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Four are the main concepts inferable from the above definitions:  
- A model is a simplification of a physical reality 
- A model is representative of a system 
- A model is used to withdraw information on unknown variables 
- A model can assume different shapes. 
The importance scientific modelling has reached in our society is also reflected by the 
interest on the topic from other disciplines. As an example, researchers belonging to the 
field of philosophy of science tried to categorise models on the basis of their 
representational style. Thus, models can be classified as: 
- Scale models: down-sized or enlarged representations of the chosen target system 
(73). 
- Idealised models: simplification of a complex reality with the aim of making it more 
governable and understandable. Such a classification can be also broken down into a 
sub-classification: Aristotelian models, in which all the properties irrelevant to the 
aim of the model are withdrawn (for example the mechanical model of the planetary 
system, with all the planets represented by only mass and shape); Galilean models, 
implicating distortions from the reality to simplify too convoluted issues to deal with 
(for example the model of a point mass moving on a frictionless plane). 
- Analogical models: models based on shared properties, i.e. models that are 
interpretations of the same formal calculus (analogy between sound and light in the 
fact they are both described by the same wave’s mathematical formulation). 
- Phenomenological models: representations of observable properties of their targets, 
leaving off unknown mechanisms. These are models not strictly based on theories, 
but that incorporate principles and laws associated with theories. 
In this Thesis, all the above defined types of models have been used, with different 
modalities, to try and answer specific clinical questions. 
In a biomedical environment, models are usually classified as in-vivo, in-vitro and in-
silico. In-vivo models use a living organism in their normal state as substrate for an 
experimental testing; animal testing and clinical trials belong to this category. In-vitro 
models employ experimental controlled and isolated environments to replicate the target 
system, such as mock circuits composed of a pump and connected pipes trying to 
duplicate parts of the cardiovascular system. Finally, in-silico models are those 
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implemented via computer simulations. These have been recently considered 
constituting a new scientific paradigm with extreme practical significance. Indeed, they 
are the only tool that we have to learn and explore complex dynamical models when 
standard methods fail (70). However, their trustworthiness needs to be questioned 
through two important inquiries: the verification and the validation of such models. The 
verification ensures the model to be respectful of the assumptions and the specifications, 
confirming the model implementation is correct and the computational solution is 
accurate enough. The validation assesses whether the model is really representative of 
the target system for the chosen purpose and application.  
Usually, validation of biomedical computational models happens through the 
comparison of the results generated in-silico and those achieved with an experimental 
set-up representative of the same reality. In case of patient-specific models (whose 
concept will be discussed below), the validation occurs against those data of the patients 
that have not been input into the model as boundary conditions. 
3.3 PATIENT-SPECIFIC MODELLING 
Patient-specific modelling is a new field of biomedical engineering, recently 
experiencing remarkable advancements. It consists in developing computational or 
experimental models replicating the patho-physiology of a single individual. Its utility 
could be found in clinical environments, with the final aim of becoming a standard of 
care. Indeed, such models could be used to improve diagnosis, to tailor specific 
surgeries or treatments for an individual patient and to train clinicians regarding a 
particular surgical/interventional case. Also, they could help in the estimation of 
valuable predictors of diseases that are not directly measurable, such as stresses 
experienced by a vessel’s wall due to specific fluid dynamic conditions or to the 
implantation of percutaneous devices. 
A simple search in the Pubmed database with the key-word “patient-specific” produces 
the following histogram (Figure 3.1) for the number of publication by year, testifying 
the increasing importance given to single individual patient cases (total number of 
publications found almost 400,000).   
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Figure 3.1 - Results from the Pubmed search with the key-word “patient-specific” illustrating 
the progress in this field over the years. 
Combining the search with the additional key-word “model”, a similar exponential 
trend is noticeable, with a total of almost 26,000 titles found (Figure 3.2). Obviously, 
not all publications are related to the cardiovascular field, nor to the more general 
biomechanical field, but it is expected that every research area is developing its own 
tools to the benefit of the individual patients.  
 
Figure 3.2 - Results from the Pubmed search with the key-words “patient-specific” and 
“model” illustrating the progress in this field over the years. 
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In the clinical arena, patient-specific models usually employ a 3D reconstruction of the 
anatomy of interest, typically built using image clinical data. Boundary conditions for 
these models are set using the outcomes of clinical exams, such as flows from MR and 
echo, and pressures from catheterism. For computational applications, the numerical 
methods at the base of modelling include finite volume method, finite element method 
and ordinary differential equations (ODE) methods. For experimental studies, 3D hard 
printing methods, such as the rapid prototyping technique, are adopted to recreate the 
physical anatomy of the patient, while the experimental tools used to run the experiment 
vary according to the application. 
In the cardiovascular field, two main types of problems are modelled: fluid dynamics 
problems and structural problems. The aim of the first category is to replicate the 
physics of the blood flowing into the vessels and the heart, and the principal variables of 
these problems are flows and pressures. The objective of the second category is to 
represent the cardiovascular structures subjected to specific loads and displacements, for 
example after the implantation of a cardiovascular prosthesis. 
When fluid dynamic and structural problems are combined together, a fluid-structure 
interaction (FSI) case arises. In FSI simulations, the movements of the cardiac 
structures are the driving forces for the fluid to flow, and vice-versa, the pressure field 
generated by the flow dynamics is imposed to the solid structures. 
In general, the process for the implementation of a patient-specific model occurs as 
depicted in the graph reported by Neal and Kerchoffs in their publication (Figure 3.3) 
(74). 
The key points of such process can be identified in: 
- Data collection 
- 3D anatomy reconstruction 
- Set-up of the numerical equations or of the experimental mock circuit 
- Model validation 
- Model application to clinical practice. 
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Figure 3.3 - General workflow for the creation and validation of a patient-specific (PS) model. 
IRB = institutional review board. Image taken from 74. 
3.4  CLINICAL DATA 
The clinical data used for the implementation of patient-specific models are mainly the 
results of imaging exams and pressure measurements.  
All patients’ data used in the research presented in this Thesis were acquired as part of 
ethically approved studies (Local Research Ethics Committee Institutional approved at 
all hospitals) and following informed consent from patients and/or parents/guardians. 
In the following paragraphs, a brief description of the imaging methods and pressure 
acquisitions used in this Thesis is reported.  
3.4.1 Imaging methods 
Tremendous advances in the field of medical imaging in the past decades have allowed 
for fine anatomical details to be obtained when performing routine diagnostic exams in 
most radiology departments. Such improvements gave a boost to the development of 
modelling techniques, especially in the context of patient-specific applications. In the 
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cardiovascular setting, 3D visualisation techniques provide details on the vessel 
anatomies and cardiac structures, while 2D modalities supply data on flow fields. A 
brief analysis of the imaging techniques employed in this Thesis is presented below. 
3.4.1.1 Magnetic Resonance Imaging 
Magnetic resonance has become an important imaging technique for the assessment of 
cardiovascular disease in both congenital and acquired heart conditions (75; 76). It 
produces high quality anatomical images of the inside of the human body, as well as 
being able to provide functional information non-invasively through the measurement 
of blood flows, ventricular volumes, stroke volumes and ejection fractions. 
Cardiac motion and function over several cardiac cycles are usually imaged through a 
3D whole-heart sequence, performed with electrocardiographic (ECG) gating. Data-sets 
of heart and great vessels are acquired using balanced steady-state free precession 
(SSFP) (77; 78) that provides good contrast between myocardium and blood (79). Image 
quality can be enhanced using contrast agents, such as Gadolinium (80).   
MR imaging of flow is accomplished using methods that resolve spatial dimensions 
(2D) in individual slices. Quantitative flow assessment through this method offers the 
advantage of a sequential acquisition of flow data in different vessels with individually 
adjusted velocity encodings (81). However, the 2D methods requires repeated planning 
and acquisition at each vessel site which can be time-consuming and limits retrospective 
data analysis only to those vessel sections that were targeted when planning the scan. 
Recently, a new technique has been developed, i.e. 4D magnetic resonance imaging 
flow acquisition (4D MR flow), which allows for acquisition of 3D morphological 
information as well as blood flow velocities in 3 directions for each voxel at each 
measured time point of the cardiac cycle. It provides not only detailed quantitative flow 
and vessel wall parameters, with complete vascular coverage, but also additional 
measurements of derived hemodynamic parameters, such as shear stresses, vortex 
formations, and pressure fields. (82). This technique becomes a resourceful tool in the 
diagnostic work-up of complex CHD that require multiple quantitative flow acquisitions 
in arterial and venous vessels with normal and abnormal flow patterns (81). 4D flow 
acquisition in these cases may reduce scan time, eliminating the need for planning and 
acquisition of multiple 2D flows, thus making the protocol less time expensive and 
demanding for the patient. Furthermore, retrospective data analysis in 4D sequences is 
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not limited to the acquired single predefined 2D image plane, thus avoiding incomplete 
or falsely registered datasets (81).  
4D flow represents a unique source of data to validate in-silico results from CFD 
simulations as this MR sequence return the same information as CFD analysis in terms 
of 3D velocity components over time. However, conventional 4D flow sequences still 
require long acquisition time, in the order of 15 minutes, thus limiting their use in 
patients’ routine scans. 
The main limitation of MR imaging is its suitability to patients with implanted metallic 
devices. Presence of stents or mechanical valves can cause significant signal loss in the 
treated area, creating artifacts and disturbing flow acquisition in the closest regions.  
In this Thesis, cardiovascular MR imaging was performed with a 1.5T scanner 
(Symphony Maestro Series or Avanto, Siemens Medical Systems, Erlangen, Germany) 
based at our Centre and with a 4-element body phased array coil. A 3D gradient echo 
sequence after the administration of Gadolinium was used to extract the anatomy of the 
RVOT of the patient selected from the PPVI population as described in Chapter 5 and 
of the aorta of the TGA patient selected for the study reported in Chapter 6. A 3D 
whole-heart sequence was employed to analyse the pulmonary artery vessels of Chapter 
7. 2D-MR methods were used to extract functional information on the flows which was 
then inputted in the CFD analyses of Chapters 6, 7 and 8. Finally, a 4D MR flow 
sequence was tested and exploited in the in-vitro experiment described in Chapter 6, to 
compare and validate in-silico results against in-vitro results that replicated a patient-
specific TGA aortic anatomy and hemodynamic conditions. 
3.4.1.2 Computed tomography 
Computed tomography is a volumetric imaging technique that has become one of the 
principal methods for cardiac visualisation since it allows 3D anatomy acquisition in 
about 5-10 seconds. This quick examination time presents invaluable advantages 
especially in the assessment of babies and young children who then may not require 
sedation. However, this imaging method employs ionising radiations which carry long-
term risks for the patients (i.e. development of late cancers). CT uses computer-
processed x-rays to generate 2D tomographic images of the patient’s anatomy acquired 
around a single axis of rotation. The back projection of such images allows the 3D 
reconstruction of the volume of interest. CT images are endowed with high resolution 
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and less image artifacts than MR images. With the introduction of 64-slice CT scanners, 
versus the early 4-slice scanners, the tomographic section thickness decreased from 1.25 
mm to about 0.5 mm, and the temporal resolution increased from about 250 ms to 83 ms 
or less (83). This improvement also allowed a better dynamic evaluation of the cardiac 
structure throughout the cardiac cycle by using the so-called 4D-CT. 
Unlike MR imaging, metal implants are not a contraindication for CT examination 
which allows visualisation of metallic devices, and therefore is used also to assess 
potential stent fractures and in-stent restenosis (83; 84). 
In this Thesis, CT was performed using a 64-slice Dual-source multidetector system 
(SOMATOM Definition, Siemens, Germany). CT pulmonary and aortic angiography 
with retrospective ECG-gating was used to acquire patient anatomies for the studies 
described in Chapters 4 and 8, where both patients had previously implanted stents to 
treat pulmonary dysfunction and aortic coarctation respectively. In addition, CT 
accuracy in assessing stent geometry and deformations was compared to the accuracy of 
other imaging methods, such as fluoroscopy and optical imaging techniques, as 
explained in Chapter 4. A similar imaging technique, albeit not used in the clinical 
practice, was employed in the comparison study just mentioned, micro-CT. Micro-CT, 
performed for this research at the Royal Hallamshire Hospital, Sheffield, UK with a 
Skyscan 1172 ex-vivo cone-beam scanner (Bruker, Belgium), is based on the same 
principles of CT, but has an extremely large ionising dose radiation which is irradiated 
over a long acquisition time (a few hours). In addition, in micro-CT the object is placed 
on a rotating plate, while the source of x-rays and the detectors are fixed in space. This 
technique is generally used in experimental studies to produce the computational 
reconstruction of objects with high resolution, to the extent that it is considered the gold 
standard among volumetric imaging methods. However, it is not suitable for patients’ 
examination due to the extremely high radiation dose.  
3.4.1.3 Fluoroscopy 
Fluoroscopy is a 2D intra-operative imaging technique routinely used by cardiologists 
to assess not only the cardiac anatomy of the patient, but also the position of balloons 
and devices during interventional procedures. A fluoroscope is composed by an x-rays 
source and a fluorescent screen, each positioned at the opposite sides of the patient. An 
image intensifier converts the x-rays into visible radiations forming moving images of 
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the interior of the patient, generally broadcasted on a screen in the operating room for 
the doctor to be visualised real-time. Fluoroscopy can be used both with and without 
contrast medium. The contrast is usually employed to check the patency or the size of a 
vessel, and when used, the exam is referred to as angiography.  
Biplane fluoroscopy images for this Thesis were acquired at the Catheterisation 
Laboratory of our Institution, equipped with Axiom Artis Flat Detector system 
(Siemens, Germany), an innovative system that eliminates distortions associated with 
conventional image intensifier technology. This provides excellent image quality (high 
spatial and contrast resolution) and accuracy at minimum radiation dose. Biplane 
fluoroscopy images of a CP stent were acquired for the imaging technique testing of 
Chapter 4. In addition, cine images of PPVI procedures were used to reconstruct the 3D 
geometry and deformations of PPVI stents in-situ as explained in Chapter 4 and 5 in a 
patient treated with the next generation PPVI device and several patients treated with 
Melody™. Procedural protocol required that fluoroscopy was performed with the 
biplane arms catheter positioned in the antero-posterior and perpendicular–lateral 
projections, so that the resulting images were projections of the anatomy and device in 
two orthogonal planes. 
3.4.1.4 Echocardiography 
Echocardiography is an imaging technique based on Doppler ultrasound, able to 
visualise slices of the heart from different angulations, thus allowing clinicians to 
evaluate the heart shape, dimensions, wall and valves. It is a non-invasive technique, 
routinely used in clinical practice to diagnose and follow-up heart diseases. Other than 
anatomical data, it can provide functional information such as estimation of cardiac 
output, ejection fraction and blood velocity through the heart. It can show eventual 
abnormal communications between atria and ventricles, and valvular regurgitations or 
stenosis.  
In this Thesis, echocardiography data were used to measure blood velocity in the aortic 
coarctation in the patient case described in Chapter 8.  
3.4.2 Pressure measurements 
In-vivo intravascular pressures are registered during cardiac catheterisation via pressure 
catheters placed in the vessel of interest. Pressure catheters can be of 2 different types: 
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fibre optic catheters, which are high-fidelity factory-calibrated catheters, whose 
transducer technology is based on a pressure sensitive optical interferometer. The sensor 
element is usually mounted at the tip of an optical fibre; and fluid-filled catheters which 
are based on the principle that a fluid drives the pressure waveform from the catheter 
tip, positioned where the pressure has to be measured, to the other end of the catheter 
that is where the pressure transducer is located, outside of the patient’s body. For safety 
reasons, these catheters are usually filled with heparinised saline, a fluid with 
anticoagulant properties. Fluid-filled catheters are cheaper than the fibre optic version, 
but lack in high precision, due to the fact that the pressure information is easily affected 
by the transition from inside to outside the body. 
Non-invasive but less accurate central pressure assessment can be obtained from cuff 
pressure measurement. 
In this Thesis, intravascular pressure information was acquired in one of the TGA 
patients studied in Chapter 7 and in the coarctation patient during the re-stenting 
catheter procedure (Chapter 8).  
3.5 COMPUTATIONAL TOOLS 
Patients’ data gathered from clinical exams need to be post-processed to become useful 
in model implementation. First of all, the 3D anatomy of the region of interest has to be 
created; then, numerical or experimental tools are used to set-up the model.   
3.5.1 Anatomy reconstruction 
The 3D reconstruction of the cardiovascular structures was performed in this Thesis 
using the commercial software Mimics (Materialise, Leuven, Belgium) for image post-
processing. Raw DICOM images from MR or CT were imported into Mimics where 
they could be visualised in three projection planes: the transverse, coronal and sagittal 
section. To isolate the region of interest in the images, a segmentation mask was created 
by defining the upper and lower thresholds of greyscale values to be included in the 
mask. A region-growing algorithm was then applied to eliminate those pixels not 
connected to the desired selected area. Next, manual editing functions (i.e. pixel 
drawing and erasing) were used to obtain a clear region of interest in all the 2D views, 
free from eventual noise or unwanted contours. At this point, the software generated the 
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3D model using the three bi-dimensional views, and smoothing operations were finally 
performed to refine the contours of the 3D volume, adjusting surface irregularities. The 
accuracy of the reconstructed anatomy strongly depends on the resolution of the 
inputted medical images. 
The generated model was saved as a triangulated surface – file extension STL (Standard 
Triangulated Language) –  and exported either in a meshing software for computational 
model generation, or in the controlling software of a rapid prototyping machine, for the 
creation of a physical 3D phantom. 
3.5.2 Numerical methods 
3.5.2.1 Finite Element Method and Finite Volume Method 
Solid mechanics, as well as fluid mechanics and the other engineering sciences, 
generally use partial differential equations to characterise the complexity of physical 
systems. Indeed, the physics of the continuum mechanics, both solid and fluid, is 
governed by three fundamental principles, generally expressed in the form of partial 
differential equations, and referred to as conservation laws: 
- Conservation of mass 
- Conservation of momentum (Newton’s second law F=m a) 
- Conservation of energy. 
The different behaviour between fluids and solids is then accounted for through the use 
of different constitutive equations (85). 
Most of the time, it is not possible to obtain an exact solution of these partial differential 
equations. Thus, it is necessary to fall back on approximations: the continuum problems 
are therefore approached and resolved by representing the infinite set of values proper 
of the continuum by a finite set of values through the concept of discretisation. 
 The Finite Element method and the Finite Volume method consist in the transformation 
of these partial differential equations into algebraic equations for steady problems and 
ordinary differential equations for transient problems, by using simple approximations 
of unknown variables. The more the number of discrete variables used, the more exact 
the solution will be.  
Both FEM and FVM can deal with complex geometries in multi-dimensional problems, 
as the integral formulations they are based on do not depend on any specific mesh 
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structure (85), unlike their predecessor for the solution of partial differential equations, 
the Finite Difference Method, which is developed upon the differential formulation. 
The main difference between FEM and FVM regards the way the domain is treated: the 
FEM divides the whole domain into elements with finite area and the discretisation is 
based upon a piecewise representation of the solution in terms of specified basis 
functions that can be linear or quadratic polynomial. The dependant values are stored at 
the nodes of the elements, and the solution is considerable continuous up to a point. 
Structural mechanics problems are commonly solved by using this numerical method. 
The FVM divides the whole domain into boxes with finite volume, that are the regions 
of integration, and the dependant values are stored in the centre of the finite volume. It 
provides discrete solutions, and its approach is conservative, as the flux leaving a 
volume is equal to the flux entering the adjacent volume. Thus, this method allows an 
intuitive representation of the fluid dynamics, and it is mainly used for CFD 
applications. 
FEM for structural analyses 
Dhatt and colleagues in their book “Finite Element Method” (86) conveyed that FEM is 
the result of three disciplines: engineering science, numerical methods, and computer 
science. Engineering science describes the physical laws through partial differential 
equations, then elaborated and solved through numerical methods. Finally, computing 
tools are needed to perform the necessary calculations to obtain the solution. The same 
concept regards also the FVM. 
The first time the term “Finite Element Method” appeared was in the 1960s, in a study 
by Clough and colleagues about the calculation of a plane stress in a Delta airplane 
wing. Further research on FE allowed the method to largely improve, and increasing 
applications were found also in other fields of mechanics (87; 88). In the 1970s, 
commercial FE software appeared on the market (Abaqus, Adina, Ansys), and since 
then the rapid development in computer technologies and in programming languages 
made the FE technique increasingly appealing (89).  
Finite element analysis is now considered a valuable method to evaluate the mechanical 
performance of intravascular devices and to quantify stresses and deformations due to 
external loads and boundary conditions that cannot otherwise be readily measured (90). 
Indeed, FDA guidance for computational preclinical testing of intravascular stents 
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recommends durability tests under estimated in-vivo loading conditions. A fatigue life 
analysis method, such as the Goodman criterion, is also requested to provide an 
evaluation of the combined effects of mean and alternating stresses on the device 
fatigue life (91). 
In this Thesis, FE analyses were used to solve structural mechanics problems associated 
with intravascular stents in Chapters 5, 7 and 8. The FE software chosen for the 
implementation and the solution of analysed models is Abaqus (Abaqus/Simulia Inc, 
Providence, RN, USA). A standard formulation was used in those cases where static 
and low-speed dynamic events were represented and where the stresses needed a high 
accurate solution (Chapter 5); while an explicit dynamic formulation was used in those 
cases where large models had to be solved with relatively short dynamic response times 
characterised by largely discontinuous events or processes and that require the use of 
contact algorithms (Chapter 7 and 8). Here, the code applies a large-deformation theory, 
so that the modelled part can undergo large rotations and large deformations. 
FVM for CFD analyses 
The computational fluid dynamic problems discussed in this Thesis were solved using a 
FVM solver. Computational fluid dynamics has been defined as “the art of replacing the 
governing partial differential equations of fluid flow with numbers, and advancing these 
numbers in space and/or time to obtain a final numerical description of the complete 
flow field of interest” (92). As explained by Dr Anderson in his book, the result of CFD 
simulations is a collection of numbers (i.e. a quantitative description of the analysed 
problem) (92). The recent advances in computer technologies have speeded up the 
repetitive manipulation and storage of millions of numbers, remarkably increasing the 
use of computational studies and the complexity of the treated problems.  
The main advantage of CFD simulations lies in a complete 3D representation of the 
flow properties and in the possibility of reproducing the anatomies with high degrees of 
freedom. Also, possessing the flow solution in the whole domain, parameters of interest 
such as flow distribution, pressure gradients and power losses are obtainable at any 
moment without previous planning needed as during experimental tests. Finally, the 
cost of computational simulation is lower than that of experimental set-ups, being only 
related to computer capabilities and software purchase.  
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In this Thesis, the software used for the solution of CFD problems was Fluent (Ansys 
v.14, Fluent Inc. ©, Lebanon, NH). This code was adopted to study the fluid dynamics 
in the aorta of the TGA patient presented in Chapter 6, in the main pulmonary artery 
and bifurcations of patients from Chapter 7 and finally in the aortic coarctation study of 
Chapter 8.  
The CFD method is based on the solution of the Navier Stokes (NS) equations and of 
the mass balance equation in each volume of the grid in which the 3D domain is 
divided. The 3D NS equations are: 
 
where ρ is the fluid density, vi is the component of the velocity vector in the specified 
Cartesian direction (i =x, y, z), t is the time, Fi is the vector of the external body forces 
operating on the fluid, p is the pressure and μ is the fluid viscosity. 
The continuity equation is shown below: 
 
and becomes as follows: 
 
for incompressible fluids (constant density ρ). 
In the simulations of this Thesis, with Ansys Fluent, the Navier-Stokes momentum 
equations were solved with an upwind scheme of the second order. Upwind schemes 
use a solution-sensitive finite difference method to account for the direction in which 
information are propagated in a flow field. Also, they introduce stability in problems 
with high Reynolds numbers, thus facilitating the convergence of the solution. 
However, its accuracy is lower than other schemes, for example the central differencing 
scheme; for this reason, it is preferable to use orders higher than the first to increase the 
spatial accuracy. A standard spatial discretisation was chosen for the pressure, and an 
implicit least-square-cell-based discretisation for the gradient. A SIMPLE (Semi-
Implicit Method for Pressure Linked Equations) pressure-velocity coupling algorithm 
was exploited. The first order implicit transient formulation was chosen to discretise the 
NS equation in the temporal domain, with a time-step Δt of 10-4 s. In all CFD 
simulations, the absolute convergence criterion was the residuals of mass and 
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momentum conservation equations to be less than 10
-4
. Also, vessels with rigid 
properties were assumed in all the simulations, and a no-slip condition was imposed at 
the walls. 
Two are the key factors for obtaining detailed and reliable descriptions of the fluid 
dynamics in any specific case: the boundary conditions and the representation of the 3D 
domain. In cardiovascular applications, the boundary conditions to be prescribed at the 
boundary faces of the 3D model are typically values or tracings of pressure, velocity 
and flow-split derived from medical exams such as catheterism, MR scans and echo 
measurements. Regarding the 3D volume, it is possible to mimic complicated patient-
specific geometries, obtained by advanced medical imaging techniques, such as MR and 
CT (93).  
Hence, in order to computationally reproduce patient-specific fluid dynamics, medical 
images with high resolution and time-varying boundary conditions are required for 
achieving adequate accuracy and reliable outcomes. 
3.5.2.2 Lumped parameter networks 
Lumped parameter networks are electric analogue models that can be used to represent 
complex hydraulic circuits. In particular, pressure and volumetric flow-rate are 
identified with electric tension and current, while the vascular wall’s compliance, the 
viscosity and the inertial properties of the fluid flowing in the circuit are described by 
capacitance, resistance and inductance components respectively. 
This approach represents a valuable tool for calculating pressure drops and flow 
distribution in the network, whether realistic values for all components of the LPN are 
available. However, it does not allow assessment of local information, such as shear 
stresses, velocity and pressure fields. The vascular system can be easily represented 
using this approach which allows modelling of the different portions of the circulation 
with different numbers of lumped blocks according to needs. 
The hemodynamic in each compartment is described through a set of ordinary 
differential equations, derived from the Navier-Stokes model, after opportune 
assumptions and simplifications: 
- The contribution of the convective terms of the NS equation is discarded 
- The fluid is considered as incompressible and viscous 
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- Velocities are not treated by means of their distribution on the cross-section, or their 
variation along the conduit, but rather using the corresponding cross sectional 
average velocity. 
A deformable vascular conduit with reduced length can be modelled using three lumped 
parameters: a capacitance C, an inductance L, and a resistance R. According to the 
available boundary conditions, one of the following four configurations can be chosen: 
L network, inverted-L network, T network and π network (Figure 3.4). 
 
     
 
 
Figure 3.4 - Four possible configurations to represent a deformable vascular conduit through a 
LPN block: a) L network, b) inverted-L network, c) T network and d) π network 
(94). 
 
Figure 3.5 - Scheme of a deformable vascular conduit. Pressures and flows are indicated 
through P and Q respectively. The upstream and downstream sections of the 
conduit are indicated as up and dw (94). 
a) b) 
c) d) 
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The mean pressure and the mean flow-rate at the inlet section Γup are identified in 
Figure 3.5 as Pup and Qup, while Pdw and Qdw are those at the outlet section Γdw. The 
subscript m is instead used for the internal section Γ.  
The physical network is mathematically represented through a system of ordinary 
differential equations, with appropriate boundary conditions. The equations 
representative of the generic scheme shown in Figure 3.5 are the following: 
 
where: 
          
with υ, E, l, R0 and h the Poisson modulus, the Young modulus, the conduit length, its 
undeformed radius and the wall thickness, respectively. Viscosity and density of the 
fluid are indicated with μ and ρ. In the ODE system the variables are Pdw, Qup, Qdw, Pin. 
The state variables are the pressures where a C is present and the flow-rates where the 
equation is written for an L component (94). 
The major advantage of such a method is the reduced computational cost and time: 
simulations last up to a few minutes on a personal computer. In addition, once a 
network representing a particular district or the overall circulation has been developed, 
it can be easily adapted to represent different patients or different pathological scenarios 
just by changing the values of the interested parameters (R, L, C). Indeed, in most cases, 
the mathematical skeleton of the LPN represented by the algebraic and differential 
equations is left unvaried. 
In this Thesis, the LPN equations were written in the programming code C, and worked 
out with the compiler Bloodshed Dev C++ (Free Software Foundation, Inc., Cambridge, 
MA, USA). The ordinary differential equations in the LPN were solved with the explicit 
Euler time forward scheme, using a time-step Δt of 10-4 s: 
 
where f
*
(t) is the approximation of the function at the current time-step.  
LPNs were set up in the studies presented in Chapter 7 and 8 to take advantage of this 
technique fast response. In the first case, several simulations had to be carried out to 
characterise the pulmonary circulation of 15 TGA patients. This would have required 
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many months using a traditional 3D CFD approach with the currently accessible 
calculation power. In the second case, LPN represented a fast tool to help cardiologists 
decide the optimal treatment for a patient with aortic re-coarctation in a timely manner. 
3.5.2.3 Multi-Domain simulations 
As for other engineering problems, also in the biomedical field a problem can show 
peculiar behaviours at different scales. One of the major difficulties is to identify the 
correct scale to approach the problem: if the scale is too big, there is the possibility to 
neglect some significant events occurring at the microscale, while if the scale is too 
small, evaluation of macroscopic phenomena may be inaccurate. 
The attempt to simulate all the relevant dimensions of a problem with common 
numerical techniques would be far too complex to be solved, requiring a high number of 
variables and also of computer power. A possible solution could be to neglect the less 
influent scales, such as for instance the microscale. However, this is not always 
permitted, as sometimes the non-linearities present at smaller scales significantly 
influence the solution of the problem (95). 
Often in cardiovascular models, details of the local fluid dynamics inside a vessel have 
the same importance as the influence exerted by the global impedance of the arterial 
bed. To represent local and global fluid dynamics at the same time, a multi-domain 
approach should be used: it consists in coupling a 3D geometry of the district of interest 
(local fluid dynamics), solved with the CFD methods, with a LPN reproducing a section 
of the vascular tree (global fluid dynamics).  
The coupling between the CFD model and the LPN can be implemented through 
pressure and flow information exchanged in correspondence of the boundary faces (96). 
In order to have a coherent transfer of information it is important to convert the 
exchanged data in the scale of the receiving model. To move from the 3D domain to the 
0D (of the LPN) domain there is a loss of spatial information, thus the data exchanged 
have to be integrated on the considered section. The opposite transfer, on the other 
hand, requires the amplification of a defective knowledge, being scalar. This difficulty 
can be overcome by arbitrarily defining a profile on the boundary face for the 
exchanged variables, and, in this Thesis, a uniform profile was adopted. In particular, 
the pressures elaborated from the network were fed into the 3D model, and the flows 
calculated from the CFD software were imposed as inlet to the LPN.  
Chapter 3  Engineering methodologies 
 83 
The equations translating this concept are reported below. The time-dependent pressure 
applied to the generic outlet boundary section j of the 3D domain is calculated as: 
 
where k is the generic cell face belonging to the face j, and Ph,j(t) is the instantaneous 
hydrostatic pressure of the j
th
 interface calculated by the LPN. The flows computed by 
the CFD solver are passed to the LPN according to the following equation: 
 
where Γj is the surface of the 3D model outlet section, and n  is the outward versor 
normal to the j
th
 interface.  
The general equations for the mass and momentum conservation laws for each 
compartment of the LPN are the following: 
 
          in case of linear resistance 
 
 
      in case of non-linear resistance 
 
where Qin(t), Pin(t) indicate the instantaneous volumetric flow rate and pressure at the 
inlet of the compartment, while Qout(t), Pout(t) are flows and pressure at the outlet. 
The ordinary differential equations are resolved through the explicit Euler numerical 
method, using a time-step Δt of 10-4 s (as done in case of pure LPN, Section 3.5.2.2). 
Basically, the multi-domain approach provides the 3D geometry with realistic time-
varying boundary conditions, allowing the CFD calculation to be influenced and 
influence the solution of the LPN. 
The major drawback of multi-domain simulations consists in the significant 
computational time and power required to run the simulations. Usually, four cardiac 
cycles with a CFD model of about 800,000 volumes and a LPN of about 10 ODEs 
require 4-5 days on a personal computer with 4 CPUs. 
Multi-domain simulations were carried out in this Thesis to validate the results of the 
simplified LPN representing the pulmonary circulations of TGA patients in Chapter 7. 
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3.6 EXPERIMENTAL TOOLS 
The complexity of an experimental setup varies according to the problem at hand, and 
depends on the purposes of the study, influencing the choice of model (e.g. pure 
resistance, lumped parameter model, distributed, linear model or distributed, non-linear 
model) (97).  
Experimental setups for hydrodynamic testing can take the form of mock circulatory 
loops, whereby a network of tubing and lumped resistive and compliant elements are 
assembled to reproduce a part or the whole of the circulatory system. Such mock loops 
can include a detailed anatomical element if a specific morphology is deemed important 
or is being investigated. Anatomical elements can be either idealised (98) or patient-
specific (99). An arrangement including a detailed 3D component and lumped elements 
representing the remainder of the circulation can be broadly defined as “multi-scale” or 
multi-domain (100). 
3.6.1 Rapid Prototyping technique 
The rapid prototyping technique known as PolyJet technology (101) is the process of 
making 3D physical phantoms of digital models. It can be used to manufacture 3D rigid 
or compliant parts suitable for insertion in a mock circulatory loop.  
Application of such a technique to the field of patient-specific modelling are evident: 
3D digital anatomies reconstructed from MR\CT data, as explained in Section 3.5.1, can 
be exported as an STL file compatible with 3D printing. Materials with different 
properties can be used for the printing process: transparent or opaque, rigid or 
compliant. Rigid models, admittedly not reproducing realistic vessel wall distensibility 
and the associated recoil effect, have been used in several studies in the literature for 
investigating vascular anatomies (99), providing valuable hemodynamic data. It should 
be noted that they serve the purpose of collecting validation data for a computational 
study where the 3D models in the CFD study also present rigid walls. Regarding the 
transparency of the resin, its advantages could be the visualisation of air bubbles in the 
circuit (thus facilitating de-airing operations), and of eventual pressure catheters (to 
control the correct positioning). 
In this Thesis, 3D printing was used in three cases for different purposes. In Chapter 4, 
it was employed for the production of a deformable opaque mould representative of the 
Chapter 3  Engineering methodologies 
 85 
RVOT of a patient, to be used as a support for a PPVI stent apposition for experimental 
imaging purposes. In Chapter 6, a transparent and robust resin was chosen to print the 
aorta of a patient, later integrated in a mock circuit to conduct a fluid dynamic in-vitro 
study. Finally, in Chapter 8, the peculiar anatomy of a patient with stented coarctation 
of the aorta was printed with rigid materials for didactic and visualisation reasons.   
3.6.2 Hydraulic circuit components 
Hydraulic circuits with the aim of representing the patient’s cardiovascular system are 
generally formed by a pump, compliance chambers, valves, reservoirs and measuring 
equipments. The components selected for the experimental set-up of Chapter 6 that 
replicated the circulation of a TGA patient are described in the following paragraphs. 
A pulsatile mechanical pump (Harvard Apparatus Inc., Natick, MA) simulated the 
ventricular pumping action through silicone rubber-covered heart-type ball valves. This 
pump has an adjustable stroke volume range between 15 and 100 ml and a frequency 
range between 10 and 100 bmp.  
Arterial compliance was simulated using Windkessel (= “air chamber” in German) 
elements, according to the theory of compliant air element. In particular, compliance 
chambers were here reproduced through Perspex cylinders with a 3-way valve fitted at 
the top in order to control the amount of air to regulate the stiffness of the circuit.  
Increasing the stiffness of the whole system rises the amplitude of the pressure 
waveform. The compliance value is calculated as:  
 
in which V is the volume of air in each cylinder, Pm is the mean pressure and Patm the 
atmospheric pressure (760 mmHg).  
Metered needle-pinch valves were used to simulate the resistance of downstream 
districts of the circulation. Such taps have the advantage of being easily adjustable with 
reproducible settings, allowing for simple regulation of the mean pressure in the circuit. 
However, they are strongly flow-dependent and thus implement a non-linear resistance. 
Each tap resistance was characterised using a simplified steady flow circuit. A known 
flow was imposed with a continuous pump (Q), and the pressure drop (ΔP) across the 
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tap (R) was measured with two pressure catheters (ΔP=R∙Q), respectively positioned 
just before the tap and 5 cm downstream, to allow for pressure recovery. 
An ‘atrial reservoir’ was implemented through a chamber filled with fluid up to a 
certain level to guarantee the chosen atrial pressure, given by the hydraulic head. 
Pressures in the circuit were measured with high-fidelity factory-calibrated fiber optic 
catheters (Samba Preclin Samba sensors AB; Vastra Frolunda, Sweden). The transducer 
technology is based on a pressure sensitive optical interferometer (Fabry-Perot 
manufactured in silicon). The sensor element (0.36-0.42 mm of diameter) is mounted on 
the tip of an optical fiber (0.25-0.40 mm of diameter). The pressure catheter was 
calibrated prior to the experiment with the methods of “column of water”, associating 
the console’s read-out in Volts with known heights of water implementing known 
hydrostatic pressure values (1 mmHg = 1.36 cmH2O). Thus, a correlation between 
pressure read in Volts by the catheter and the corresponding mmHg value was 
established (Figure 3.6).  
 
Figure 3.6 - Catheter calibration: on the x-axis the output of the console and on the y-axis the 
associated pressure in mmHg. 
A Transonic 400-Series Multi-Channel Flowmeter Consoles & Modules for Laboratory 
Research was used to monitor flows. It consists in four transducers (piezoelectric 
crystals) that alternately emit sound rays to form an ultrasound beam. As the beam 
transverses a vessel, each ray undergoes a phase shift in transit time proportional to the 
average velocity of the liquid times the path length over which this velocity is 
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encountered. With wide-beam ultrasonic illumination the receiving transducers integrate 
these velocity and yields volume flow. The probe was calibrated before the experiments 
using the method of “timed collection”, whereby increasing steady flows were set with 
a continuous pump (Sicce Multifunction Pump 2500), and the amount of water gathered 
in ml was quantified using a measuring cylinder; these values where then compared 
with the respective Volts measured by the probe.  
During the experiments, a data acquisition System (BIOPAC System Inc., Goleta, CA, 
USA) was used to record pressure and flow output gathered from the catheter and the 
probe. Data were acquired at 250 Hz (AcqKnowledge 4.1.1, BIOPAC System Inc.). 
 
The engineering and clinical tools described in this chapter were employed in the 
research of this Thesis for patient-specific modelling in CHD cases. As previously 
discussed, a computational model, to be used in clinical practice, requires verification 
and validation. Therefore, the patient-specific complex models presented in the 
following chapters will be preceded by the validation of the developed and implemented 
methodology, starting from the image analysis of PPVI stent fractures (Chapters 4 and 
5).  
 
 
  
CHAPTER 4 
STENT IMAGING TECHNIQUES 
 
 
The content of this chapter is the result of a collaboration within the MeDDiCA network with the 
University of Sheffield, and in particular with Iwona Zwierzak and Dr. Andrew Narracott. 
Part of the work presented in this chapter is currently under 2nd review with the Journal “Medical 
Engineering & Physics”. 
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4.1 INTRODUCTION 
Imaging techniques can be used to assess stents statically and dynamically both in-vivo 
and in-vitro to evaluate device performance. Assessment of the accuracy of the imaging 
methods adopted is important, particularly in the context of data used to inform 
numerical analyses of device behaviour. The aim of this chapter is to assess the ability 
of fluoroscopy in describing PPVI stent geometry and dynamics. A set of fluoroscopy 
images is available for each patient who undergoes PPVI since these images are used to 
guide device delivery. Therefore, if accurate, they could be used to help predict stent 
fracture, important for example in the PPVI Melody™ stent where the incidence of such 
event is >25%.  
The chapter is divided in two parts: accuracy and reproducibility of the stent geometry 
reconstruction process using biplane fluoroscopy static images was studied by 
comparison with micro-CT, considered the gold standard technique for stent imaging, in 
the first part (Section 4.2). Also in this part, an extensive comparison with other 
available imaging techniques was performed, including conventional CT with two 
different radiation doses and optical stereo-photogrammetry. The stent investigated in 
this first study is the CP stent used to treat several congenital heart disease cases, but 
also importantly as the frame housing the biological valve in the PPVI Melody™ device 
(Section 2.4.1.1). 
In the second part, I compared the performance of dynamic biplane fluoroscopy 
acquisitions against 4DCT imaging technique in assessing 3D stent deformations 
(Section 4.4). For this part, the analysed images were from a patient who underwent 
PPVI with the next generation device. The validation process consisted in the 
comparison of some geometrical parameters derived when imaging the same stent with 
the different imaging techniques. The reconstruction errors associated with each 
imaging method and their differences were analysed. Section 4.4.2 presents the results 
obtained in terms of the spatial resolution of each technique, the errors associated with 
repeatability and post-processing and the relative accuracy of each technique.  
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4.2 STENT GEOMETRY ACQUISITION 
A number of two-dimensional (2D) or three-dimensional (3D) imaging techniques have 
been employed both in-vivo and in-vitro to assess stent geometry in the past. 2D 
methods include conventional angiography/fluoroscopy, which are currently used to 
assist the interventional cardiologist in accurate stent placement, and static x-rays for 
follow-up examination (20; 102). Also, radiology-based imaging techniques have been 
employed in-vitro to assess the expanded shape of different stents in idealised (103; 
104), and patient-specific vessel geometries (105). Extension of imaging to 3D in-vivo 
has been achieved using CT to assess the anatomy of implantation sites prior to stent 
deployment (106), during follow-up for stent fracture investigation (84) and in the 
assessment of in-stent restenosis (83). More recently, my research group started working 
on 3D reconstructions from biplane fluoroscopy images to assess the in-vivo geometry 
of the PPVI Melody™ stent (79), but no thorough analysis of this reconstruction 
methodology has been carried out. In the bench setting, x-ray micro-tomography or 
micro-CT allows high resolution visualisation of metallic devices at spatial resolution in 
the range 9-17 μm (107). In-vitro studies demonstrated micro-CT to be suitable for the 
imaging of small metallic stents for coronary and carotid applications deployed in latex 
or silicone mock stenotic arteries (108). In addition, a stereo-photogrammetric optical 
imaging method was found to be robust for assessment of coronary stent expansion 
(109). At larger scales, similar techniques have been used for tracking transcatheter 
aortic valve implantation stent deformation in translucent artificial vessel phantoms 
(110) including comparison with assessment using micro-CT. 
Despite this interest in the application of imaging techniques to the study of stent 
geometry, there are few reports of quantitative evaluation to determine the optimum 
imaging method for stent visualisation. At small scales, Lim et al. compared the 
capability of CT angiography and fluoroscopy to identify strut fractures of three 
coronary stents designs deployed both in-vivo and in-vitro, concluding that CT 
angiography is preferable. In this case, quantitative assessment of the maximum 
bending experienced by the stents and the maximum inter-strut distances was reported 
(84). At larger scales, Nordmeyer et al. proposed an in-vitro study to evaluate the 
diagnostic performance of different MR imaging sequences, CT and conventional 
angiography to image three different great vessel stents (nitinol, platinum-iridium and 
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stainless steel stents). They found the diagnostic accuracy of CT comparable to 
conventional angiography, and particular MR sequences, despite image artefacts, were 
proven reliable for stent stenosis assessment. However, as this study focussed on the 
visualisation of lumen patency and not the geometry of the deployed stent, only stent 
lumen diameters were measured in each image (81). 
A quantitative comparison of outcomes of different imaging modalities to evaluate the 
best method for the assessment of local geometric features of stents in-vivo and in-vitro 
has not been undertaken. Thus, the first aim of this chapter is the evaluation of the 
variance in geometric measurements of the same great vessel stent when imaged with 
different static techniques (including established volumetric methods and two methods 
for reconstruction of 3D geometries from stereo planar views). In view of the following 
chapter, considering micro-CT as the gold standard, the error associated with the 
biplane fluoroscopy reconstruction technique will be assessed, together with the error 
associated with the other methods.  
4.2.1 Materials and Methods 
In order to evaluate the relative accuracy of a number of imaging techniques for the 
assessment of 3D stent geometry, each imaging technique was applied to the same 
deployed stent geometry to provide a direct comparison. The stent investigated in the 
first part of the study was the CP stent, employed in the PPVI Melody™ device (Section 
2.4.1.1). 
4.2.1.1 Stent mounted on a realistic implantation site model 
A realistic implantation site geometry – RVOT of a PPVI patient – was reconstructed 
from MR images using Mimics as explained in Section 3.5.1 to ensure a realistic 
anatomy of the stent is represented in the imaging assessment. 
The surface of the reconstructed RVOT was extruded internally with a 3 mm thickness 
(Figure 4.1a) and a 3D compliant mould of the obtained volume was produced as 
described in Section 3.6.1 with a flexible elastomeric material (TangoPlus Full-Cure® 
930 compound, Objet Ltd, Rehovot, Israel) (Figure 4.1b). The CP stent was mounted 
onto this implantation site model by compressing the mould inside the semi-expanded 
CP stent. Once the stent was correctly positioned, the mould was re-shaped to the 
implantation site geometry, thus deforming the stent to the geometry of the underlying 
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vessel. Six metallic spherical markers were glued in a number of positions on the RVOT 
model around the stent to provide reference points as shown in Figure 4.1c. 
 
Figure 4.1 - Reconstructed (a) and printed (b) RVOT model. Valve stent deployed on the model 
with markers (c). 
4.2.1.2 Image acquisition 
The stent mounted on the realistic implantation site geometry was imaged using micro 
computed tomography (μCT), conventional CT, biplane fluoroscopy and optical stereo-
photogrammetry techniques (Figure 4.2). Representative images obtained using each of 
these techniques are shown in Figure 4.3, along with an image obtained during in-vivo 
assessment of a PPVI device. 
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Figure 4.2 - Imaging systems used to acquire the geometry of the stent mounted on the realistic 
implantation site: a) micro-CT, b) CT, c) fluoroscopy, d) optical stereo-
photogrammetry. 
a) b) 
c) d) 
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Figure 4.3 - Representative images from each imaging technique (a) Single projection image 
from uCT, prior to volume reconstruction and (b) cross-sectional image after 
volume reconstruction. (c) High-dose and (d) Low-dose clinical CT cross-
sectional image.  (e,f) Biplanar fluoroscopy images in vitro in two orthogonal 
projections. (g)  In vivo fluoroscopy image of a deployed stent in a patient 
during PPVI. (h,i) Stereo optical images for a single stent position. 
Micro-CT (μCT): The model with deployed stent was placed vertically in the scanner 
mounted on a metal plate secured with hot melt adhesive (ethylene vinyl acetate 
copolymers) to ensure model stability during scanning process (Section 3.4.1.2). The 
voxel size was 17.2µm x 17.2µm x 17.2µm with scanning parameters: 100kV, 100 µA, 
Aluminium/copper filter, 360° rotation with a 0.7° rotation step resulting in 514 
projection images. The stent was scanned as a 3 part oversized scan.  
CT: Two sets of images were acquired: one with high dose of radiation and one with 
low dose of radiation relative to the standard cardiac protocol used in patients. The CT 
acquisition parameters were as follows: 
- CT high dose (hCT): collimation 16×0.6 mm, rotation time 1.0 s, pitch 0.8, 120 kVp, 
250 effective mAs per rotation; 
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- CT low dose (lCT): collimation 64×0.6 mm, rotation time 0.5 s, pitch 1.0, 80 kVp, 60 
mAs per rotation (effective mAs 16 using tube current modulation).  
Fluoroscopy (F): Biplane orthogonal fluoroscopy images were acquired according to the 
protocol described in Section 3.4.1.3 with the arms of the fluoroscopy system positioned 
in the antero-posterior (AP) and lateral view. The acquisition was repeated three 
additional times by rotating both fluoroscopy arms of 22.5°, 45° and 67.5° in order to 
assess the influence of their orientation with respect to the imaged object.  
Optical stereo-photogrammetry (OP): Acquisitions were carried out at the Royal 
Hallamshire Hospital, Sheffield, UK with a purpose-built stereo camera rig with camera 
separation of 45°. Two Flea2 fire-wire cameras were controlled using FlyCap2 software 
(Point Grey, Canada). A checkerboard grid pattern containing 28 squares (2x2 mm 
each) was captured in seven different orientations to calibrate cameras with the Bouguet 
Calibration Toolbox (111; 112) for Matlab (The MathWorks Inc., Natick, MA, 2000). A 
checkerboard grid (27 x 21 mm) control object was imaged to assess calibration and 
reconstruction accuracy by reconstructing a reference distance (the 3 mm length of the 
internal grid). The optical system was designed to provide a field of view of around 30 
mm along the maximum image dimension and to ensure adequate depth of field of 20 
mm to maintain focus over the stent geometry. To characterise the entire stent geometry 
the stent was imaged in eight positions, rotating the stent in increments of 45°.  
4.2.1.3 Image post-processing 
μCT, hCT and lCT: The 3D volumetric image data were post-processed using Mimics 
(Figure 4.4) (Section 3.5.1).  
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Figure 4.4 - 3D volumetric image data post-processed with the software Mmimics. 
3D volumes were computed using two different smoothing factors (S1 and S2) to assess 
the potential distortions on the 3D volume reconstruction (S1 and S2 both employed a 
smoothing factor of 1.0 using 2 and 4 iterations respectively). This resulted in two 3D 
models for each imaging method, hereby referred to as [μ-h-l]CT-S1 and [μ-h-l]CT-S2. 
STL files of the reconstructed stents were then exported into the computer aided design 
(CAD) software Rhinoceros (McNeel, USA). The centre of each crown weld was 
identified by selecting four points around the circumference of the weld and taking the 
mean value of these points, as shown in Figure 4.5a. Three estimates of the weld centre 
position were obtained, one with smoothing factor S1 and two with smoothing factor S2 
(named [μ-h-l]CT-S2-P1 and [μ-h-l]CT-S2-P2), to assess the repeatability of this 
process. The centres of the welds were connected with straight segments to represent the 
3D stent geometry as a wireframe, as shown in Figure 4.5b.  
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Figure 4.5 - (a) Surface points used to determine the centre of the strut weld from volumetric 
CT data. (b) Wire-frame representation of stent geometry superimposed to the 
volumetric CT reconstruction. 
Fluoroscopy: The biplane fluoroscopy image pairs were post-processed to reconstruct 
the 3D stent shape as follows: the crown points of the struts forming the stent were 
identified in both fluoroscopy images and back-projected into the 3D space by tracing 
parallel rays from the orthogonal projections (CAD software Rhinoceros). The ray 
intersection determines the position of the strut welds in 3D space (Figure 4.6). As for 
the volumetric data, these points were joined with straight segments to define the struts 
of the device reconstructing the full stent geometry. The scaling factor for image 
calibration was based on the distance between reference markers as calculated from the 
μCT reconstruction. To assess the repeatability of the procedure, the stent geometry was 
reconstructed 3 times from the same image pair obtained with the arms in AP and lateral 
position. 
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Figure 4.6 - 3D stent reconstruction process using biplane fluoroscopy images imported in the 
CAD software Rhinoceros. 
Optical stereo-photogrammetry: For each stent position, points at the centre of each 
crown weld of the stent in the left and right 2D camera images were identified (Figure 
4.7). The 3D coordinate of each weld centre point was obtained by triangulation using 
the camera calibration data and the 2D position from left and right images (113). The 
identification of the weld centre was repeated three times using the same image pair to 
test the repeatability of this process. 
  
Figure 4.7 - Post-processing of the pictures obtained from the optical stereo-photogrammetry 
technique. 
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4.2.1.4 Comparison parameters 
The following parameters were defined and calculated for each reconstructed stent 
geometry in order to compare both the repeatability of results obtained using a single 
imaging technique and the agreement between each of the imaging techniques: 
- Strut length L (n = 96 per stent) evaluated as the distance between the two weld 
centre points (x1, y1, z1) and (x2, y2, z2) defining the end of each strut (Figure 4.8a):  
 
- Strut angle β (n = 96 per stent) evaluated using the Law of cosines from the 
dimensions of the triangle to which the investigated angle belongs (Figure 4.8b): 
                                     
- Stent cell asymmetry Ca (n = 40 per stent) calculated as the ratio between the cell 
longitudinal dl and circumferential dc diagonals (Figure 4.8a): 
                        
  
 
Figure 4.8 - Stent parameters used for comparing the different imaging techniques: strut length 
L, circumferential asymmetry Ca = dl/dc, and strut angle β. 
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4.2.1.5 Error evaluation of each image technique  
For each technique the geometric parameters were calculated for multiple 
reconstructions of stent geometry. The repeatability error was assessed by calculating 
the standard deviation, σp, of the parameter values and the maximum percentage 
difference, ∆Pmax, from the average parameter value, P, over all reconstructions, as 
follows:  
 
 
 
resulting in N values of standard deviation and maximum percentage difference for each 
parameter (N = 96 for strut length, N = 96 for strut angle, N = 40 for stent cell 
asymmetry). For the biplanar methods (fluoroscopy and optical), averaging was 
calculated from three reconstructions (n = 3); for the volumetric methods (μCT, hCT 
and lCT), averaging was calculated from two reconstructions (n = 2). 
In addition, for the μCT, hCT and lCT volumetric data, the difference between the stent 
geometry obtained using S1 and S2 smoothing was assessed, again using the standard 
deviation and the maximum percentage difference of each parameter between the two 
reconstructed geometries. Moreover, for the fluoroscopy images, the influence of the 
imaging orientation was evaluated using the standard deviation and the maximum 
percentage difference of each parameter between the reconstructed geometry from each 
of the four rotation angles. 
The maximum and mean of the N values of standard deviation and maximum 
percentage difference are reported in Section 4.2.2.2 as an estimation of the 
reconstruction error associated with each imaging technique. 
4.2.1.6 Differences between image techniques  
The averaged parameter value (L, β, Ca) computed from the two μCT reconstructions 
was used as a gold standard. For all other imaging techniques the averaged parameter 
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values computed from the multiple reconstructions were compared with the μCT data. 
Pearson’s correlation coefficient was calculated between the μCT data and each other 
imaging technique, for all three parameters. For each parameter and for each imaging 
technique a Bland-Altman plot was produced using the μCT data as the comparative 
method in all cases. 
4.2.2 Results and Discussion 
4.2.2.1 Image acquisition and post-processing 
The voxels of the μCT scan were isotropic with a spatial resolution of 17 m. For the 
conventional CT scans, the volume CT dose index (CTDIvol) was 0.242 mGy for the 
low dose sequence and 50.938 mGy for the high dose sequence. The images were 
reconstructed with a pixel size of 127 µm x 127 µm and slice increment of 299 µm 
(slice thickness of 600 µm) for the low dose scan, and with a pixel size of 123 µm x 123 
µm and a slice increment of 299 µm (slice thickness of 600 µm) for the high dose scan. 
Acquisitions with the fluoroscopy scanner resulted in an Image Area Dose Product of 
0.01 Gy·cm
2
 and a pixel spacing of 279 μm x 279 μm. 
The resolution of the optical images was 1288 x 964 pixels with a sensor size of 3.75 x 
3.75 µm per pixel. A lens of focal length 40 mm was used, positioned approximately 44 
mm from the camera sensor, resulting in a magnification of 0.1. This magnification 
results in a field of view of 46 x 38 mm and a spatial resolution of approximately 35 
µm. Calibration and reconstruction of a control object of a known size suggest 
measurement accuracy of the order 25 μm.  
4.2.2.2 Error evaluation  
Table 4.1 reports the variation in the computed parameter values for each technique 
with repeated reconstruction of the stent geometry. For the volumetric methods, the 
results demonstrate that the uncertainty in the computation of all parameters increases 
from μCT to hCT to lCT. For the 2D reconstruction methods, the uncertainty increases 
from the optical stereo-photogrammetry results to the biplanar fluoroscopy results.  
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Table 4.1 - Maximum standard deviations and maximum % differences (with respect to 
average values for each technique) in the strut lengths (L), strut angles (β) 
and circumferential asymmetries (Ca) between repeated point selections 
and smoothing factors. 
 
 
MAX (MEAN) STANDARD 
DEVIATION 
MAX (MEAN) % DIFFERENCE 
 
 Point selection Smoothing Point selection Smoothing 
 
L [mm]     
 
μCT 0.082 (0.021) 0.078 (0.018) 2.07 (0.52) 1.97 (0.45) 
 
hCT 0.136 (0.042) 0.137 (0.040) 3.51 (1.01) 3.25 (0.86) 
 
lCT 0.237 (0.068) 0.228 (0.066) 6.11 (1.75) 6.25 (1.68) 
 
     
 
OP 0.065 (0.020) N/A 2.90 (0.35) N/A 
 
F 0.198 (0.063) N/A 3.79 (0.92) N/A 
 
     
 
β [º]     
 
μCT 1.175 (0.275) 0.977 (0.288) 1.59 (0.43) 1.29 (0.35) 
 
hCT 2.048(0.487) 1.512 (0.526) 2.71 (0.76) 2.01 (0.69) 
 
lCT 3.472 (1.024) 4.354 (1.233) 5.57 (1.64) 4.53 (1.22) 
 
     
 
OP 1.055 (0.356) N/A 1.98 (0.31) N/A 
 
F 2.934 (0.883) N/A 3.60 (0.81) N/A 
 
     
 
Ca [-]     
 
μCT 0.009 (0.003) 0.011 (0.003) 1.21 (0.44) 1.57 (0.45) 
 
 hCT 0.017 (0.006) 0.020 (0.006) 2.58 (0.85) 2.47 (0.86) 
 
 lCT 0.047 (0.013) 0.028 (0.009) 5.76 (1.77) 3.44 (1.20) 
 
     
 
 OP 0.009 (0.004) N/A 1.18 (0.29) N/A 
 
F 0.024 (0.011) N/A 2.78 (0.71) N/A 
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These results are in line with expectations as the μCT data is obtained at the highest 
spatial resolution and the performance of the low dose CT imaging is expected to be 
worse than that of the high dose CT. The uncertainty of the optical stereo results is of 
similar magnitude to that of the μCT data and the uncertainty of the biplanar 
fluoroscopy results is of similar magnitude to that of the high dose CT. This relationship 
between the results of the 2D and 3D methods is in line with the variation in the spatial 
resolution of each technique. 
The uncertainty in stent reconstruction introduced by variation of the smoothing factor 
used to reconstruct the stent geometry for the volumetric methods is of similar 
magnitude to the uncertainty associated with the repeatability in geometry 
reconstruction. These results suggest that the nature of post-processing of the 3D 
volumetric data is unlikely to significantly influence derived geometric parameters.  
Finally, the max (mean) standard deviation and max (mean) % difference between the 
stent reconstructions from the four different fluoroscopy arm positions were equal to 
0.228 mm (0.090 mm) and 4.46% (1.24%) for L, 2.357° (1.100°) and 3.71% (0.99%) 
for β, and 0.034 (0.016) and 4.85% (1.28%) for Ca. Therefore, the uncertainty in stent 
reconstruction due to the orientation of the fluoroscopy arms with respect to the 
stent/RVOT object is also comparable with the repeatability errors of this technique. 
4.2.2.3 Differences between image techniques  
The calculated values of the stent parameters (L, β, Ca) measured using each imaging 
technique were correlated with the corresponding values measured using μCT. 
Pearson’s correlation coefficients were calculated for each parameter and each imaging 
technique and are reported in Table 4.2 and in Figure 4.9.  
Table 4.2 - Values of linear correlation coefficient between values of each parameter 
calculated using μCT and each of the four other imaging techniques. 
 lCT hCT OP F 
L 0.657 0.542 0.906 0.541 
β 0.981 0.993 0.993 0.989 
Ca 0.988 0.993 0.995 0.988 
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Figure 4.9 - Pearson’s correlation plots calculated for L, β and Ca for each image technique 
against the gold standard technique, the micro-CT. 
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The Bland-Altman plots that compare each imaging technique with the μCT results for 
all parameters are shown in Figure 4.11. 
The best linear correlation was observed for the optical stereo method
 
for all three 
parameters analysed (L, β, Ca). Greater variance was observed in the correlation of strut 
length between the methods which may be explained by the clustering of the strut 
length parameter within two distinct ranges, observed in the distribution of values along 
the horizontal axis of the Bland-Altman plots. This clustering demonstrates the relative 
accuracy of all methods in determining stent geometry, as inspection of the stent design 
in these regions confirms that greater strut length parameters are consistent with stent 
fabrication. Indeed, longer stent struts are measured where a weld is used to close the 
extremities of each ring (Figure 4.10). The Bland-Altman plots support observations 
that the closest agreement with μCT data is obtained using the optical stereo method. 
 
Figure 4.10 - Zoom on the stent highlighting the longer struts in correspondence of the welds 
used to close the extremities of each ring. 
The results presented in Table 4.1 and Figure 4.11 demonstrate consistently that the 
performance of biplanar reconstruction methods is comparable with the performance of 
the clinical volumetric CT scans in evaluating 3D stent geometry. Whilst the stereo 
optical method demonstrates higher accuracy than the biplanar fluoroscopy results, the 
increase in the maximum and mean percentage error, reported in Table 4.3, is relatively 
small when compared with the effective spatial resolution of each technique, reported in 
Section 4.2.2.1. These results suggest that consistency in identification of strut landmark 
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points is the dominant factor in determining reconstruction accuracy, independent of the 
spatial resolution of the imaging technique.  
 
 
Figure 4.11 - Bland-Altman plots for each parameter (length L, angle β and circumferential 
asymmetry Ca) showing the differences in the values measured with the micro-
CT (μCT) technique and the other techniques (high dose CT hCT, low dose CT 
lCT, fluoroscopy F, and stereo-photogrammetry OP). The thick line represents 
the mean difference between the value of the parameter measured with the 
considered technique and with μCT. The two dotted lines represent +1.96 and -
1.96 standard deviations of the differences between the two considered 
methods. 
 
Table 4.3 - Comparison of hCT, lCT, fluoroscopy and optical stereo-photogrammetry 
techniques: maximum (mean) % differences of all the parameters 
calculated with respect to μCT. 
MAX (MEAN) % 
DIFFERENCES 
hCT lCT F OP 
L [%] 3.84 (1.04) 5.94 (1.58) 4.26 (1.22) 1.97 (0.18) 
β [%] 3.40 (0.96) 5.87 (1.30) 3.07 (0.89) 3.00 (0.89) 
Ca [%] 2.32 (0.83) 4.43 (1.30) 4.31 (1.18) 3.02 (1.12) 
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4.3 Implications for in-vitro and in-vivo assessment of 3D device geometry 
This first part of the study has demonstrated that, if simultaneous acquisition from two 
biplanar views is possible, 3D reconstruction of stent geometry is feasible. For the 
imaging parameters used in this study, chosen to represent those used during clinical 
assessment of PPVI geometry, the uncertainty on the evaluation of strut length, 
separation angle and cell asymmetry using biplanar fluoroscopy is of the order +/- 0.2 
mm, 3° and 0.03 respectively.   
Comparison between biplanar fluoroscopy and stereo photogrammetry in this study 
demonstrates the improvements in accuracy that can be obtained using high resolution 
optical systems, which maintain the advantage of high temporal resolution in contrast 
with volumetric methods. Whilst optical techniques cannot be employed to evaluate in- 
vivo device performance, these techniques may be preferred for the assessment of stent 
geometry at smaller length scales, such as the assessment of coronary stent implantation 
(114). 
The variations observed in image quality between the micro-CT and clinical modalities 
are similar to those reported by Ionescu et al. (107) who evaluated the effectiveness of 
Multislice-CT, C-arm flat detector-CT and flat panel-CT for imaging a Cypher stent of 
3 mm diameter. At these length scales accurate assessment of local stent features with 
clinical modalities is challenging, with over-estimation of strut thickness and under-
estimation of lumen diameter reported of the order 300% and 30% respectively. 
It is acknowledged that the imaging protocols in this study cannot fully capture the 
results expected during in-vivo assessment of PPVI geometry due to the absence of 
image attenuation from the surrounding tissues. However, qualitative comparison of in-
vitro and in-vivo fluoroscopy of implanted PPVI geometry (Figure 4.3f and Figure 4.3g 
respectively) suggests that the protocols used within this study provide a good 
representation of images obtained in-vivo.  
The protocol here developed has not attempted to directly evaluate dynamic changes in 
stent geometry over a cardiac cycle as this cannot be assessed with micro-CT, which is 
captured over timescales of the order 5 – 10 minutes. This study provides an accurate 
estimation of the accuracy of biplanar methods for dynamic assessment of stent 
geometry provided that the device motion is insignificant during the image acquisition 
period and the temporal offset between the acquisitions of each of the stereo images is 
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minimised. However, for the assessment of PPVI stents, this is not the case as 
significant motion of the implanted stent is observed during the cardiac cycle (79). To 
overcome this limitation, another protocol was designed to assess the accuracy of 
biplane fluoroscopy in evaluating stent deformation, as discussed in the following 
paragraphs.  
4.4 STENT DEFORMATION ACQUISITIONS 
Numerical studies and simulations are often used to examine stent behaviour during 
implantation and to predict the influence of stent design and deployment characteristics 
on the solid and fluid mechanics of the vascular environment (115; 116). Computational 
approaches can describe stent deployment at spatial and temporal resolutions that 
cannot be achieved with clinical or experimental studies. However, as the application of 
simulation to medical device design has evolved from the consideration of idealised 
behaviour (117) to a focus on predictions in patient-specific anatomies (118), the results 
of simulations are becoming increasingly dependent on the quality of the data used to 
describe the patient anatomy and device configuration. 
In-vivo and in-vitro application of 2D and 3D imaging techniques have the potential to 
provide the appropriate data to both inform and validate numerical models of stent 
behaviour. However, to fully characterise device performance, such methods are 
required to reproduce 3D device geometry as a function of time. To ensure accurate 
assessment of stent placement, deployment, final geometry and function, high quality 
visualisation methods are crucial. 
Characterisation of stent dynamic behaviour in patients can be achieved with 4DCT 
which also provides information regarding the cardiac conditions of the individual. 
However, CT investigations of device dynamic behaviour require high radiation dose, 
and as such are undesirable if alternative methods are available which provide 
comparable accuracy.  
To evaluate whether the biplanar 2D fluoroscopy technique previously introduced is 
able to capture stent deformations during the cardiac cycle, a quantitative comparison 
against 4DCT was performed in a patient’s case. 
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4.4.1 Materials and Methods 
The stent here investigated was the new PPVI device described in Section 2.4.1.1 
(Figure 4.12) and implanted in one case under compassionate use (119).  
 
Figure 4.12 - New PPVI device design: lateral view with the nomenclature adopted for the rings 
on the left (RING 1 to 6) and the sections on the right (1P to 6D), P and D 
being proximal and distal respectively. 
Following the procedure, due to the large dynamics of the patient’s implantation site, 
great interest has been directed towards the analysis of stent deformation, in particular 
to monitor for potential strut fractures. Over a 4 year period, volumetric 4DCT and 
biplanar fluoroscopy images were acquired at a number of time points including 
acquisition of both 4DCT and fluoroscopy images during the same session 3 months 
after the procedure (19).  
Using these data, 3D geometry and deformations of the stent in-situ acquired with the 
two different imaging modalities were analysed and compared to assess qualitative and 
quantitative differences.  
4.4.1.1 Image acquisition and post-processing 
4DCT acquisition parameters were as follows: collimation 2 x 32 x 0.6 mm, rotation 
time 0.33 s, pitch 0.2, kVp 100, effective mAs 273, using tube current modulation. 
Effective x-ray dose was 14.54 mSv, calculated as k*DLP, where k depends on body 
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region and is given in the European Guidelines on Quality Criteria for CT [EUR 16262 
EN, May 1999; for the chest k = 0.017 mSv mGy
-1
 cm
-1
], and DLP = dose length 
product = CTDIvol * scan length, calculated by the scanner (120). The 4DCT dataset 
was divided into 10 independent phases during the cardiac cycle and the stent 3D 
volume was reconstructed for each frame using Mimics (Figure 4.13).  
 
Figure 4.13 - 3D stent reconstructed from 4DCT data at one frame of the cardiac cycle, 
superimposed on the 4DCT image. 
Centrelines of the six stent wires were extracted and imported into CAD software 
(Rhinoceros, McNeel, USA) for further measurement.  
During follow-up, simultaneous biplanar fluoroscopy images of the stent were acquired 
in the AP and lateral projection at 15 frames per second. Twelve frames per cardiac 
cycle were acquired for more than 3 complete cycles. In Rhinoceros, back projection of 
stent strut landmark points from the stereo orthogonal image pairs of 12 consecutive 
frames allowed 3D reconstruction of the stent geometry over a complete cycle (Section 
4.2.1.3) (Figure 4.14).  
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Figure 4.14 - Stent reconstructed from the antero-posterior and lateral fluoroscopy images at 
one frame of the cardiac cycle. 
The diameter of a previously implanted prosthetic mitral valve visible in both 
fluoroscopic planes was used for calibration purposes. The stent landmark points 
corresponding to the apices of the strut wires were manually identified in both 4DCT 
and fluoroscopy 3D reconstructions. Three distal (D) and 3 proximal (P) diameters were 
calculated for the first and sixth ring. For the central portion of the stent/graft, 3 
diameters for each of the 5 sections highlighted in Figure 4.12 (2P, 2D, MID, 5P, 5D) 
were measured. It should be noted that the data obtained with each imaging technique 
was derived from distinct cardiac cycles. 
For each measured diameter, the maximum (Dmax) and minimum (Dmin) values over the 
cardiac cycle were identified, and the percentage compression was calculated as 
100*(Dmax - Dmin)/ Dmax. The diameter values were used to compare the outcomes of 
4DCT and fluoroscopy data (Pearson’s correlation coefficient and Bland Altman plots 
using 4DCT as a reference). The percentage compression calculated by each method 
was used to evaluate the deformation of the device during the cardiac cycle and the 
potential risk of fracture. 
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4.4.2 Results 
3D reconstruction of the stent was feasible for all frames of the fluoroscopy and 4DCT 
images. The cusps of the stent struts were identifiable using both image modalities but 
the selection process was easier for fluoroscopy than for 4DCT images due to the 
artefacts caused by the metal stent struts in the CT scanner. In particular, identification 
of the distal and proximal rings was more difficult as they are made of thinner wires. 
Figure 4.15 shows the maximum and minimum diameter during the cardiac cycle from 
4DCT and fluoroscopy reconstructions (top and middle panel) and the percentage of 
compression calculated with both methods (bottom panel). The largest difference 
between the compression values was measured for a diameter in the distal section of 
Ring 1 (7.02% vs 3.48%). Good correlation (R
2
=0.9957) was observed between the 
diameters calculated from the two image method reconstructions. The Bland-Altman 
plot revealed a small systematic bias suggesting that fluoroscopy underestimates the 
4DCT diameter by <1 mm (Figure 4.16). The proximal and distal rings (1P, 6D), 
originally designed with circular shape and 40 mm diameter sections, once released 
inside the patient’s implantation site, assumed elliptical profiles, and experienced the 
largest deformations during the cardiac cycle. The central portion of the stent (2D-5D), 
which holds the valve (not in direct contact with the arterial wall), maintained a circular 
shape and experienced less deformation than the distal and proximal rings (ring 1 and 
6). The largest compression of the stent measured by each method during the cardiac 
cycle was 6.98% (fluoroscopy) and 7.92% (4DCT), both measured in the most distal 
ring (section 6D). Both methods reported an average diameter during the cardiac cycle 
in this section of 27 mm which is ~70% of its original dimension. 
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Figure 4.15 - Maximum and minimum diameter measured for the three diameters of each 
section (from 1P to 6D) from 4DCT (top panel) and fluoroscopy data (middle 
panel). Percentage of compression for the same diameters during the cardiac 
cycle evaluated from the stent reconstructions with both image techniques 
(bottom panel). 
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Section 
1P 1D 2P 2D MID 5P 5D 6P 6D 
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Figure 4.16 - Bland-Altman plot of the differences in diameter values (maximum and minimum) 
measured between 4DCT and fluoroscopy stent reconstructions. The thick line 
represents the mean difference between the value of the parameter measured 
with the 4DCT and with the fluoroscopy. The two dotted lines represent +1.96 
and -1.96 standard deviations of the differences between the two methods. 
4.4.3 Discussion 
In this second part of the study, it has been shown that the stent compression during the 
cardiac cycle measured from 3D reconstructions of simultaneously acquired biplane 
fluoroscopy images is comparable with that measured from 4DCT data. In this case, 
definitive quantification of differences between the techniques could not be carried out 
as the data represent two different cardiac cycles, acquired within 10 minutes. 
Reconstruction of 3D geometry from biplane fluoroscopy provided valuable data on 
both stent deformation during the cardiac cycle and interaction between the stent and 
the implantation site in terms of device anchoring and stability. 
Detailed geometry characterisation at smaller scales is likely to be less successful (121) 
limiting this methodology to stents used in congenital heart disease treatments or heart 
valve replacements (122). In the PPVI case, the temporal resolution of 4DCT and 
fluoroscopy acquisition was different (10 vs 12 frames per cardiac cycle respectively). 
Additionally, the 4DCT scan was gated with the ECG of the patient, while the ECG was 
not monitored during fluoroscopy image acquisition. However, the errors introduced by 
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these different acquisitions are expected to be of smaller magnitude than the variation 
between cardiac cycles. 
4.5 CONCLUSIONS 
In conclusion, this chapter has demonstrated that the performance of biplanar 
reconstruction methods is comparable with the performance of volumetric CT scans in 
evaluating 3D stent geometry and deformation.  
In particular, biplanar fluoroscopy has been shown to be effective in the measurement of 
strut length, separation angle and cell asymmetry. These results support the use of 
biplanar fluoroscopy for the generation of 3D models of stent geometry for assessment 
of stent fracture risk using numerical simulation and provide a quantitative assessment 
of the magnitude of uncertainty in the measurement of geometric parameters derived 
from 3D stent geometry. 
Furthermore, it has been demonstrated that biplanar 2D image techniques can provide 
accuracy of the same order as 3D image modalities to assess not only the geometry but 
also the deformation of stents in-vivo. Also, as a result of its low radiation dosage, the 
biplanar fluoroscopy method may have significant advantages in the measurement of 
dynamic 3D stent deformation. 
These results are promising for the application of biplanar fluoroscopy in-vivo as a tool 
to assess stent geometry and 3D deformation during cardiac cycle. Very importantly, 
these parameters could help predict the risk of stent fracture, which, in the next chapter, 
are demonstrated to be related to variation in stent geometry during the cardiac cycle.  
 
 
 
  
CHAPTER 5 
PPVI STENT FRACTURE RISK STRATIFICATION 
 
 
 
Part of the work presented in this chapter is currently under 2
nd
 review with the Journal “Circulation: 
Cardiovascular Interventions”.
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5.1 INTRODUCTION 
In the previous chapter, the biplanar fluoroscopy has been demonstrated to be an 
accurate tool for assessing in-vivo stent shape and shape variations during the cardiac 
cycle. In this chapter, such a tool will be used to analyse different geometries and 
deformations the PPVI device stent has to cope with in a patient population. Aim of this 
geometrical analysis, supported also by patient-specific FE simulations, was the 
individuation of those parameters responsible for stent fracture.  
Indeed, despite careful patient selection and implantation of one or several bare metal 
stents to create a scaffold for PPVI, stent fracture remains a problem in the Melody™ 
device (Figure 5.1) and close clinical follow-up of the patients is required (23). 
 
Figure 5.1 - Fluoroscopy AP and lateral projections of a Melody™ device implanted in a 
patient that underwent several strut fractures. 
Fracture mechanics indicates two possible types of material fracture: a static fracture 
and a fatigue fracture. The former happens when the stress in the material exceed the 
ultimate tensile strength limit of the material; the latter occurs when a combination of 
mean and alternate stress exceeds the endurance strength limit of the material, caused by 
a cyclic solicitation. Fractured detected in the PPVI stent are included in the fatigue 
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type, and the parameters influencing this adverse event can be traced back to the 
geometry of the stent after the implantation and to the geometry variations during the 
implantation phase and the cardiac cycle. Additional parameters that could be identified 
as potential factors for fracture, though they cannot easily assessed and quantified are: 
- Asymmetry in the manual crimping before PPVI 
- Initial asymmetry of the stent after the inflation of the inner balloon 
- Number of balloon inflations duting PPVI 
- Unexpected events after PPVI 
- Bio-corrosion (even though, to my knowledge, in literature events of Melody™ stent 
fracture for bio-corrosion have not been reported). 
Studies by Nordmeyer and McElhinney  (20; 102) used 2D images from procedural and 
follow-up angiograms and x-rays to identify risk factors associated with stent fracture, 
which include: PPVI in a native RVOT and/or in a non-calcified RVOT; the presence of 
PPVI recoil during balloon deflation; high ratio between AP and lateral PPVI diameter, 
at the proximal level of the stent; severe RVOT obstruction; younger age; elevated pre- 
and post-procedural RVOT gradient; reduced conduit diameter; smaller ratio of the 
measured/original conduit diameter; dynamic compression of the deployed valve and 
substantial apposition to the chest wall. These data indicate that mechanical factors 
related to the implant environment appear to play an important role in the stent fracture 
during and after device deployment.  
The extreme morphological variability of PPVI implantation sites (123) often results in 
asymmetrical expansion of the Melody™ device (79), and combined with the complex 
3D deformations experienced by the stent during both deployment and cardiac cycle, 
form the basis of stent mechanical failure. Therefore, a thorough analysis of these 
parameters may facilitate prediction of stent fracture with greater accuracy and 
precision.  
In this study, the in-situ stent geometry and shape changes of the Melody™ during 
implantation and the subsequent cardiac cycle were analysed using the fluoroscopy 
methodology described and validated in the previous chapter. This data were also used 
to enhance the patient-specific modelling of PPVI loading conditions as a 3D patient-
specific FE analysis was performed for each patient, simulating device deployment and 
cyclical deformations during the cardiac cycle to identify parameters associated with 
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stent fracture. Combining geometric information derived from in-situ stent 
reconstructions, and patient-specific FE modelling of the patient’s stent deformation, a 
risk stratification for stent fracture prediction was performed. 
5.2 METHODS 
5.2.1 Patients’ selection 
PPVI patients treated in our Centre were retrospectively selected for this study (n=42, 
Table 5.2) if the fluoroscopy images acquired during the PPVI procedure were in AP 
and lateral projections and available throughout the stent implantation phases from end 
of balloon inflation to at least one full cardiac cycle. 
Two groups of patients were identified: the first (n=10) experienced fractures in the 1
st
 
year following successful PPVI; the second (n=32) had no adverse events in the same 
timeframe.  
Stent fractures and their location were detected and assessed using routine x-ray images 
acquired post-PPVI. In our Centre, PPVI patients are routinely followed-up at 1 and 6 
months after the implantation, and if no problems are detected, at 1 year and on a yearly 
basis thereafter.  
5.2.2 Reconstruction from fluoroscopy data 
The orthogonal biplane fluoroscopy images of the device acquired during the procedure 
were post-processed to reconstruct the in-situ 3D stent geometry for every patient as 
described in Section 4.2.1.3 (Figure 5.2a). 
Calibration of the fluoroscopy images was achieved by identifying the straightest strut 
of the stent in both projections and by scaling the images so that the reconstructed 
length (Figure 5.3a and Figure 5.3b) of this strut (Lrec) was equal to the real length 
(Lundef=5.78 mm) of the undeformed stent struts. In 16 patients who underwent PPVI 
stent post-dilatation, calibration was also further assessed using the markers of the 
Mullins balloon (NuMed Inc, Hopkinton, NY, US).  
Using this methodology, the in-situ stent configuration was reconstructed for each 
patient at three instants including the end of the final balloon inflation (hereafter 
referred to as pre-recoil), early systole and diastole (Figure 5.2b). The pre-recoil was 
selected from the fluoroscopy images in the frame at the beginning of balloon deflation, 
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while the systolic and the diastolic frames were identified according to the ECG tracing 
synchronised with the fluoroscopy acquisitions.  
 
 
Figure 5.2 - a) Stent 3D reconstruction using orthogonal biplane fluoroscopy images for one 
patient at the end of balloon expansion: AP and lateral projections. The 
markers of the post-PPVI dilatation balloon are reconstructed in light-blue. b) 
3D Stent geometry reconstructed from fluoroscopy images at the end of balloon 
expansion (black), systole (red) and diastole (blue) superimposed with the stent 
at its initial crimped configuration (green). 
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For this patient population, the systolic and diastolic frames corresponded to the instants 
of maximum and minimum diameters during the cardiac cycle. The recoil process 
between the end of balloon inflation and end of balloon deflation includes not only the 
intrinsic elastic recoil of the metal stent, but also the recoil related to the arterial wall 
and surrounding tissues.  
5.2.3 Geometrical parameters 
3D stent shape and geometrical variations after balloon deflation and during the cardiac 
cycle were compared between fractured and non-fractured patient groups.  
 
Figure 5.3 - Stent levels and parameters identified for the 3D geometrical analysis: strut length 
(L), cell longitudinal (dl) and circumferential (dc) diagonals, maximum (Dmax), 
minimum (Dmin) and standard diameter (Dstd). 
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Four levels were identified in the stent geometry (strut, cell, section and stent level), and 
a total of 22 parameters belonging to these different levels were considered per stent 
(Figure 5.3a):  
 Strut level (96 struts per stent): 
- Strut length, L = distance between two junction points belonging to the same 
strut (Figure 5.3a and Figure 5.3b)  
 Cell level (40 cells per stent): 
- Circumferential asymmetry ratio, Ca = ratio between cell longitudinal, dl, and 
circumferential, dc, diagonals (Figure 5.3a)  
- Circumferential asymmetry absolute difference, Ca* = difference between dl and 
dc (Figure 5.3a) 
 Section level (7 sections per stent):   
- Maximum section diameter, Dmax (Figure 5.3b) 
- Minimum section diameter, Dmin (Figure 5.3b) 
- Standard diameter, Dstd = diameter of the section if considered a circle with same 
section perimeter (Figure 5.3c) 
- Radial asymmetry ratio, Ra = ratio between Dmax and Dmin  
- Radial asymmetry absolute difference, Ra* = difference between Dmax and Dmin 
 Stent level (1 per stent): 
- Longitudinal asymmetry ratio, La = ratio between maximum and minimum 
section Dstd 
- Longitudinal asymmetry absolute difference, La* = difference between 
maximum and minimum section Dstd 
- Maximum, minimum, average Ra  
- Maximum, minimum, average Ra*  
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- Maximum, minimum, average Ca  
- Maximum, minimum, average Ca*  
All parameters were measured for each of the 3 reconstructed stent geometries per 
patient (pre-recoil, systole, diastole). Moreover, percentage variations of such 
parameters during balloon deflation as                                                and during cardiac 
cycle as                                        were calculated – named in the text as Δ“parameter”.  
5.2.4 Clinical and Radiographic parameters 
The following parameters, which have previously been associated with the risk of 
fracture were recorded: valve compression, apposition to chest wall, dynamic 
compression, site calcification, PPVI recoil, pre-stenting, implant indication (stenosis, 
regurgitation or both), gender and age. 
5.2.5 Finite element modelling 
The stent geometries reconstructed from the fluoroscopy images were used to 
implement a patient-specific PPVI FE model for each case. The reconstructed stents 
from the 3 instants (pre-recoil, systole, diastole) were superimposed to the stent 
geometry in its initial configuration, while still crimped onto the balloon catheter 
(Figure 5.2b) using a partial Procrustes analysis. This allowed us to measure the 
displacements of every junction point from its initial position to the pre-recoil state, and 
to systole and diastole reducing stent rigid displacements due to heart beating and 
respiration motions. Such displacements were used as boundary conditions to 
computationally deploy the FE model of the PPVI stent. The stent geometry for FE 
analysis was reproduced in the initial crimped status of the device into the catheter 
(Figure 5.7d). The presence of the biological valve sewn inside the stent was not taken 
into account in this study, as it is unlikely that it affect stent fracture. The geometry of 
the stent was drawn from a previous study by Schievano and co-workers (79; 120), who 
obtained the measurements by means of calliper and optic microscope measurements. 
Geometrical and material properties are listed in Table 5.1. Six wires of 0.33 mm in 
diameter were joined together through central parallelepiped links of 0.31 x 1.67 x 0.08 
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mm in correspondence of every central crown weld. The golden coverings were 
reproduced by means of an additional layer of elements of 0.025 mm of thickness 
around the crown weldings. The platinum-iridium alloy was assumed to have isotropic 
properties, and a Von Mises plasticity model was adopted, along with an isotropic 
hardening law. Handbook properties were selected to define the mechanical behaviour 
of the golden reinforcements. 
Table 5.1 - Stent geometrical and material properties. 
Wire diameter 0.33 mm 
Initial internal diameter 4.0 mm 
Initial overall length 34.32 mm 
Central zigzags segment length 5.78 mm 
Terminal zigzags segment length 5.62 mm 
Gold sleeve thickness 0.025 mm 
  
PLATINUM (120)  
Young modulus 224 GPa 
Poisson ratio 0.37 
Yield stress 285 MPa 
Ultimate strength, Sult 875 MPa 
Fatigue endurance strength, Se 263 MPa 
  
GOLD  
Young modulus 80 GPa 
Poisson ratio 0.42 
 
5.2.5.1 Mesh sensitivity analysis 
A mesh sensitivity analysis was performed on a circular cantilever beam, with the same 
diameter as the stent wires (0.33 mm) and with the same length as an internal strut of 
the stent (5.78 mm). 
Seven different structured hexahedral meshes were created, with 6x4, 6x6, 8x8, 8x10, 
10x10, 12x12 and 16x16 elements on the sections respectively (Figure 5.4).  
 
 
Figure 5.4 - Meshes used for the sensitivity analysis: elements on the section of the beam. 
6x4 8x8 8x10 10x10 12x12 16x16 6x6 
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The cantilever beam was constrained at one side, fixing the translational and rotational 
degrees of freedom (Figure 5.5). A concentrated force of 0.16 N, to remain in the 
material elastic field, and directed as the z-axis was applied to the central node of the 
beam section on the opposite side. The same simulation was performed for every mesh, 
using solid elements with 8 points of integration (C3D8) and solid reduced elements, 
with only 1 point of integration (C3D8R).  
 
 
Figure 5.5 - Cantilever beam FE model, constrained at the left side (A), and with a force F 
applied on B, at the central node of the free section. 
The results, obtained in terms of stress and displacement, were compared with the 
analytic solution, where a force of 0.16 N corresponded to a displacement of 0.08 mm 
and a stress of 264.98 MPa.  
To analyse the behaviour of the beam in the material plastic field, an additional set of 
simulation was performed with the same meshes as described before and applying a 
higher concentrated force of 0.5 N. In this case, the results of the simulations were 
compared with the displacements and stresses obtained from the simulation with the 
finest mesh of C3D8 and C3D8R respectively. 
After mesh sensitivity analysis on the beam, 2 different structured hexahedral meshes 
were used for a mesh sensitivity analysis on the whole stent FE model: a coarser mesh 
with 155,680 elements, and a finer mesh of 792,640 elements. The former used 6x4 
elements on the section (for a total of 20 elements), the latter used 8x8 elements (for a 
total of 60 elements). As for the longitudinal development of the mesh, the former used 
10 elements to cover 1 mm, the latter used 19 elements on 1 mm (Figure 5.6). 
 
 
 
 
 
x 
z 
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Figure 5.6 - Comparison between the 2 meshes: details of the coarser mesh on the left, and of 
the finer mesh on the right. 
 
 
Figure 5.7 - FE model of the Melody™ device (d): details of the finest structured hexahedral 
mesh (a), and mesh features at the welding links (b) and at the wire section (c). 
d) 
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A symmetric initial stress condition formerly calculated was assigned to the stent model 
to account for residual stresses caused by the loading of the stent onto the catheter 
balloon in the catheterisation laboratory.  
5.2.5.2 FE stent deployment 
To replicate the patient-specific stent deployment with FE analysis proved challenging 
and several approaches were explored. Firstly, Abaqus Explicit was used to run a quasi-
static simulation to deploy the stent by means of a contact algorithm between the stent 
surface and some cuff structures created around the stent strut junctions and displayed 
in green in Figure 5.8. The displacements measured from the device 3D reconstructions 
at different times of the procedure and cardiac cycle were imposed to the cuffs.  
 
              
Figure 5.8-  FE model of the stent computationally expanded through cuffs (in green) created 
around the strut junctions. 
Plastic, internal and kinetic energy outputs were monitored for these simulations to 
verify the quasi-static hypothesis: kinetic energy was close to zero and kinetic to 
internal energy ratio intersected plastic to internal energy ratio below 5%.  
Secondly, a load control simulation (Abaqus/Explicit) was used to expand the stent 
inside a model reproducing the patient’s RVOT anatomy (Figure 5.9). This was 
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recreated by connecting the struts of the stent shape, reconstructed from the 
fluoroscopic images, with a polysurface, and by meshing it with surface elements. 
Surface elements have no inherent stiffness and can be used to model rigid bodies; they 
do not enter in the stress calculations, thus requiring less computational time. The 
RVOT model resulted in a rough-edged structure that could accommodate the stent 
struts. A contact algorithm was applied between the stent outer surface and the RVOT 
internal surface, and a loading pressure was applied to the internal surface of the stent 
for deployment. Slot Abaqus connector elements were added to the model to virtually 
link every strut junction with their final point on the RVOT surface, thus guiding them 
through the correct displacement as calculated from the 3D reconstructions.  
 
         
Figure 5.9 - FE model of the stent computationally expanded inside a rough-edged rigid RVOT 
model, using connector elements. 
Thirdly, a shell part as offset from the outer surface elements of the stent model was 
created and a contact algorithm between the shell and the outer surface of the stent was 
set up to deploy the stent by applying nodal displacements to the shell (Figure 5.10). 
This was first tested on a single crown of the stent. The shell was created with an offset 
of 0.02 mm and with the same material parameters used for the platinum-10% iridium 
alloy. General contact was imposed between the inner surface of the shell and the outer 
surface of the stent from the beginning of the simulation, and a Standard method was 
used. The same idea was then applied to the entire stent.  
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Figure 5.10 - Stent crown surrounded by a shell, created as a 0.02 mm offset from the external 
elements of the stent crown. 
Finally, nodal displacement boundary conditions were used in Abaqus/Standard to 
deploy the stent according to the calculated displacements (Figure 5.11). In particular, 
after a systematic study to select the optimal nodes for these boundary conditions, the 
displacements calculated from the fluoroscopy reconstruction superimpositions were 
applied to the central node of the wire sections, for the outer crowns, and of the welding 
links, for the internal crowns (Figure 5.7b, Figure 5.7c). The simulations included three 
steps for each patient. First, the stent was expanded from its initial crimped status to the 
final configuration at the end of balloon inflation. Then, displacements recorded during 
systole and diastole were replicated. 
 
Figure 5.11 - FE model of the stent computationally expanded using nodal displacements 
boundary conditions. 
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5.2.6 Stress parameters 
The following 13 parameters were analysed for each stent at 10 equally spaced 
increments during recoil (end of balloon inflation to end of balloon deflation) and 
during cardiac cycle (systole to diastole): 
 Maximum principal stress: maximum, minimum and average values 
 Minimum principal stress: maximum, minimum and average values 
 Von Mises stress: maximum, minimum and average values 
 Stress pressure (i.e. first invariant of stress tensor): maximum, minimum and 
average values 
 Sines equivalent stress for the cardiac cycle step,                                                             
 
where          is the amplitude of the mean square root of the second deviatoric 
stress invariant and αH,m  is the hydrostatic pressure, while Se and Sult are the 
material strength limit parameters (endurance strength limit and ultimate 
strength limit respectively). This stress is compared in the Sines criterion with 
the endurance strength limit (Se) to assess fatigue performance and the risk of 
material fracture. 
5.2.7 Statistical analysis 
The exact location of fractures was detected in the post-PPVI x-rays and attributed to 
the corresponding strut, cell, section and stent level for every specific patient. Using the 
binary fractured/ non-fractured outcomes as response variables, previously described 
clinical or radiographic parameters associated with fracture and the 22 geometrical 
parameters as explanatory variables, multivariate binary logistic regression analysis was 
used to estimate their single and combined predictive values for stent fracture. A 95% 
confidence interval (CI) was considered and a p-value of less than 0.05 was assumed 
significant. A second similar statistical analysis included the geometrical parameters, 
and the 13 stress parameters measured in the FE simulations. The likelihood ratio test 
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was performed to gauge the contribution of individual predictors to the resulting 
models, and the Nagelkerke’s R2 was calculated to assess the appropriateness of the 
models’ fit. In this way the covariates modifying the risk of fracture were identified. 
The analysis was carried out in the commercial software IBM SPSS Statistics (IBM 
Corp., USA).  
5.3 RESULTS 
5.3.1 Reconstruction from fluoroscopy data and Geometrical Parameters 
Patient data are summarised in Table 5.2. The in-situ 3D stent geometry from 
fluoroscopy images was reconstructed for all 42 patients (Figure 5.12) at the 3 time 
points. 
Full elaboration of each set of biplane images took approximately 4 hours. Fractures 
were not detected immediately after the procedure. Subsequent fractures and their 
locations are summarised in Table 5.3.  
For every patient, at least one strut was selected for calibration purposes, and for those 
patients where a post-dilatation balloon was used, the maximum difference between the 
two calibration methods (strut-based and marker-based) was 4.6%. The geometrical 
parameter results are reported in Table 5.4. 
 
Table 5.2 - Patients’ data (average [min, max]) for the fractured and non-fractured 
group. 
 Fractured (n=10) Non-fractured (n=32) 
Age at implant [years] 14 [10, 23] 19[7, 71] 
Gender [F/M] 4/6  11/21 
BSA [m
2
] 1.48 [1.14, 1.90] 1.64 [0.90, 2.20] 
Weight [kg] 49.3 [32.9, 70.0] 58.2 [19.1, 106.0] 
Pre-stent 4 (40%) 16 (50%) 
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Figure 5.12 - In-situ 3D stent geometry reconstructions of the 42 patients at systole. The red 
background denotes the stents that underwent fracture, while the blue 
background is applied to the stents not experiencing fracture in the first year 
after the implantation. 
Table 5.3 - Number of fractured struts at 1, 6, 9 and 12 month (m) follow-up x-ray 
examination, fracture type and RVOT gradient immediately after PPVI and 
at 12m follow-up for each patient. 
Patient 1m 6m 9m 12m 
Fracture 
type at 1 
year** 
Fracture 
progres-
sion 
Gradient 
immedia- 
tely after 
PPVI 
Gradient 
at  
1 year  
follow-up 
1 0 3 NA 8 II NA 25 NA* 
2 0 2 2 2 I NA 10 21 
3 NA NA NA 5 II NA 36 22 
4 0 0 0 1 I NA 19 37 
5 0 1 1 1 I NA 36 25 
6 NA NA NA 2 I 2 (2 years) 46 57 
7 NA NA 4 NA I 11 (2 years) 41 43 (2 years) 
8 NA NA NA 1 I 4 (3 years) 29 29 
9 1 1 1 1 I NA 31 57 
10 0 0 NA 1 I 3 (3 years) 22 29 
NA- not available 
*Difficult imaging window: homograft and PA not well seen 
**Fracture type classification as in 20  
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Table 5.4 - Geometrical parameter results (average [min,max]). 
 Fractured Non-fractured 
 Pre-recoil Systole Diastole Pre-recoil Systole Diastole 
L [mm] 
5.52 
 [4.89,6.10] 
5.52 
 [4.91,6.06] 
5.51 
 [4.98,6.03] 
5.48 
 [4.42,6.06] 
5.50 
 [4.36,6.12] 
5.49 
 [4.39,6.12] 
Ca [-] 
1.16 
 [0.46,3.31] 
1.26 
 [0.55,4.24] 
1.26 
 [0.55,3.85] 
1.21 
 [0.35,3.83] 
1.29 
 [0.37,4.12] 
1.29 
 [0.37,3.99] 
Ca* [mm] 
0.72 
 [-5.43,6.89] 
1.19 
 [-4.14,7.61] 
1.16 
 [-4.39,7.66] 
0.97 
 [-6.17,7.54] 
1.39 
 [-6.25,8.47] 
1.44 
 [-6.39,15.22] 
Dmax [mm] 
20.00 
 
[15.61,24.05] 
19.93 
 
[14.78,24.77] 
19.94 
 
[14.88,24.73] 
19.46 
 
[14.43,24.39] 
19.19 
 
[13.89,23.90] 
19.22 
 
[14.38,24.15] 
Dmin [mm] 
18.40 
 
[14.09,22.61] 
16.87 
 
[11.87,22.36] 
16.68 
 
[11.83,22.32] 
17.97 
 
[11.91,22.16] 
17.11 
 
[12.24,21.95] 
17.04 
 
[12.19,22.17] 
Dstd [mm] 
18.98 
 
[14.87,22.40] 
18.27 
 
[13.54,22.06] 
18.27 
 
[13.40,21.92] 
18.50 
 
[13.79,22.45] 
17.99 
 
[13.79,22.27] 
17.98 
 
[13.67,22.24] 
Ra [-] 
1.09 
 [1.02,1.32] 
1.20 
 [1.01,1.88] 
1.20 
 [1.01,1.89] 
1.09 
 [1.01,1.26] 
1.13 
 [1.01,1.54] 
1.13 
 [1.01,1.60] 
Ra* [mm] 
1.60 
 [0.34,5.12] 
3.06 
 [0.18,10.62] 
3.08 
 [0.21,10.73] 
1.49 
 [0.15,4.23] 
2.08 
 [0.19,7.23] 
2.18 
 [0.16,7.73] 
La [-] 
1.19 
 [1.06,1.38] 
1.21 
 [1.07,1.38] 
1.21 
 [1.06,1.39] 
1.21 
 [1.05,1.35] 
1.24 
 [1.04,1.42] 
1.23 
 [1.04,1.42] 
La* [mm] 
3.17 
 [1.16,6.11] 
3.29 
 [1.31,5.87] 
3.27 
 [1.16,5.94] 
3.46 
 [1.00,5.38] 
3.71 
 [0.77,6.13] 
3.68 
 [0.77,6.14] 
Max Ra [-] 
1.14 
 [1.04,1.32] 
1.32 
 [1.05,1.88] 
1.32 
 [1.04,1.89] 
1.15 
 [1.06,1.26] 
1.20 
 [1.03,1.54] 
1.21 
 [1.06,1.60] 
Min Ra [-] 
1.05 
 [1.02,1.13] 
1.09 
 [1.01,1.29] 
1.09 
 [1.01,1.25] 
1.04 
 [1.01,1.11] 
1.07 
 [1.01,1.28] 
1.07 
 [1.01,1.25] 
Aver Ra [-] 
1.09 
 [1.03,1.23] 
1.20 
 [1.03,1.57] 
1.20 
 [1.03,1.58] 
1.09 
 [1.03,1.17] 
1.13 
 [1.02,1.34] 
1.13 
 [1.03,1.37] 
Max Ra* [mm] 
2.33 
 [0.84,5.12] 
4.60 
 [1.10,10.62] 
4.62 
 [0.81,10.73] 
2.45 
 [0.94,4.23] 
3.05 
 [0.53,7.23] 
3.21 
 [0.93,7.73] 
Min Ra* [mm] 
0.86 
 [0.34,2.51] 
1.56 
 [0.18,4.86] 
1.61 
 [0.21,4.34] 
0.80 
 [0.15,2.03] 
1.26 
 [0.19,4.42] 
1.27 
 [0.16,4.54] 
Aver Ra* [mm] 
1.60 
 [0.63,3.93] 
3.06 
 [0.57,7.91] 
3.08 
 [0.53,8.00] 
1.49 
 [0.58,2.97] 
2.08 
 [0.41,5.28] 
2.18 
 [0.55,5.58] 
Max Ca [-] 
2.12 
 [1.31,3.31] 
2.40 
 [1.34,4.24] 
2.42 
 [1.37,3.85] 
2.08 
 [1.35,3.83] 
2.28 
 [1.45,4.12] 
2.30 
 [1.46,3.99] 
Min Ca [-] 
0.65 
 [0.46,0.83] 
0.70 
 [0.57,0.87] 
0.70 
 [0.55,0.88] 
0.66 
 [0.35,0.99] 
0.70 
 [0.37,1.15] 
0.70 
 [0.37,1.11] 
Aver Ca [-] 
1.16 
 [0.91,1.47] 
1.26 
 [1.01,1.59] 
1.26 
 [0.99,1.58] 
1.21 
 [0.89,1.76] 
1.29 
 [0.92,1.81] 
1.29 
 [0.94,1.81] 
Max Ca* [mm] 
4.72 
 [2.04,6.89] 
5.21 
 [2.16,7.61] 
5.23 
 [2.33,7.66] 
4.64 
 [2.29,7.54] 
5.15 
 [2.93,8.47] 
5.57 
 [3.01,15.22] 
Min Ca* [mm] 
-3.09 
 [-5.43,-0.95] 
-2.69 
 [-4.14,-1.08] 
-2.70 
 [-4.39,-0.99] 
-3.12 
 [-6.17,-0.08] 
-2.77 
 [-6.25,1.06] 
-2.89 
 [-6.39,0.80] 
Aver Ca* [mm] 
0.73 
 [-0.84,2.22] 
1.19 
 [-0.10,2.58] 
1.16 
 [-0.24,2.57] 
0.96 
 [-1.25,2.56] 
1.39 
 [-1.00,3.16] 
1.44 
 [-0.88,3.11] 
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5.3.2 Finite element analysis 
5.3.2.1 Mesh sensitivity analysis 
The results of the mesh sensitivity analysis performed on the circular cantilever beam 
are reported in Figure 5.13 and Figure 5.14, the former referring to the elastic field, the 
latter to the plastic field of the material constitutive behaviour as percentage of 
difference in stress and displacement with the analytical solution for the elastic field, 
and with the finest mesh for the plastic field. 
 
Figure 5.13 - Mesh sensitivity analysis for a cantilever beam in the elastic field: percentage 
differences in displacement (orange) and stress (blue) between different mesh 
with the analytic solution. R stands for reduced elements. 
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Figure 5.14 - Mesh sensitivity analysis for a cantilever beam in the plastic field: percentage 
differences in displacement (orange) and stress (blue) between different mesh 
with the solution from the finest mesh (16x16- PL and 16x16R- PL) . R stands 
for reduced elements. 
In both cases the differences decreased with the increase in the number of elements used 
to create the mesh of the section. In the elastic field, the largest difference in 
displacement is obtained with the 6x4 reduced mesh (13.2%), while in terms of stresses 
is obtained with the 6x6 mesh (13.0%). In the plastic field, the largest difference in 
displacement is 9.6%, obtained with the 6x4 reduced mesh, while the largest difference 
in stress is 8.1%, achieved with the 6x6 reduced mesh. In both elastic and plastic fields, 
the mesh 8x8R presents differences lower than 10% in terms of stress, and 3% in terms 
of displacement. As the number of elements to mesh the stent geometry with 8x8 
elements on the section was 792,640, this mesh type was considered the best 
compromise between accuracy and computational time, and was therefore chosen to 
mesh the entire stent.  
The additional simulation on the stent entire model comparing a 6x4R mesh and 8x8R 
mesh showed that the finest mesh produced a stress distribution more uniform than that 
with the coarsest mesh (Figure 5.15), with also a more uniform deformed stent shape 
(Figure 5.16). 
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Figure 5.15 - Comparison in the Von Mises stress distribution between the coarsest mesh (a) 
and the finest mesh (b). 
 
Figure 5.16 - Comparison between the coarsest mesh (a) and the finest mesh (b) in terms of 
deformed shape. 
5.3.2.2 FE stent deployment 
The first method tested to deploy the stent according to the patient-specific 3D 
reconstructions from fluoroscopy images, using cuff structures, resulted in correct final 
deployment of the stent, but element distortions were present next to the cuffs. 
The RVOT surface coupled with a pressure applied to the internal surface of the stent 
was not a strict enough condition to guarantee the correct deployment of the stent. The 
addition of the slot connector elements proved to be a good solution to achieve the final 
patient-specific geometry of the stent, but the elements surrounding the nodes to which 
the connectors were linked results distorted, thus affecting the stress distribution.  
The use of a shell surrounding the stent structure to impose the displacements to the 
stent was successful in the single crown analysis. However, a problem presented when 
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trying to create a continuous shell around the complex geometry of the full stent with 
the golden covering and links connecting each crowns. 
The displacements applied directly to the nodes of the stent also caused some distortion 
of the elements surrounding the point of displacement boundary condition. However, 
this method proved faster, less computationally demanding and without introduction of 
further simplified hypothesis related to time and energy as in the explicit analysis. 
Therefore, this was the method selected to expand the patient-specific stents where, to 
overcome the distortion problem, the set of elements around the displacement nodes 
were subtracted from the model in the post-processing of the stress results. Fractures at 
the welding junctions have not been reported for the PPVI stent after the golden 
reinforcements were introduced; therefore this subtraction was considered acceptable.  
The stress parameter results are reported in Table 5.5. The maximum values of the Von 
Mises and maximum principal stresses were located for every patient in different struts, 
but always close to the strut junctions, where bending concentrated (Figure 5.17), and 
always during the cardiac cycle. The minimum value of the minimum principal stress 
(negative stress) occurred close to the strut junctions, usually where the maximum Von 
Mises stress was registered. The minimum Von Mises stresses were usually seen in the 
straight segments (Figure 5.17). 
 
 
Figure 5.17 - Von Mises stress (σVM) distribution at the end of the balloon expansion (a), systole 
(c) and diastole (d) for one patient. Zoom in correspondence of the strut 
intersection opening to show the elements with highest stress (b). 
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Table 5.5 - Stress parameter results (average [min,max]). 
 Fractured Non-fractured 
[MPa] Recoil Cardiac cycle Recoil Cardiac cycle 
Max Prin Stress, max 
607.49 
 [572.06,655.23] 
661.69 
 [620.77,743.70] 
599.03 
 [548.29,658.22] 
636.00 
 [565.75,769.37] 
Max Prin Stress, min 
-166.94 
 [-226.33,-109.74] 
-235.92 
 [-315.25,-163.17] 
-143.01 
 [-189.16,-104.57] 
-249.88 
 [-420.38,-137.09] 
Max Prin Stress, aver 
113.38 
 [105.31,119.05] 
85.15 
 [76.20,98.71] 
114.93 
 [110.00,119.39] 
85.13 
 [74.28,110.51] 
Min Prin Stress, max 
202.37 
 [139.79,284.64] 
206.87 
 [141.11,345.59] 
169.29 
 [110.99,361.77] 
197.65 
 [120.79, 344.66] 
Min Prin Stress, min 
-594.88 
 [-667.39,-495.54] 
-664.78 
 [-723.45,-615.60] 
-553.49 
 [-625.05,-475.40] 
-663.71 
 [-878.97,-571.78] 
Min Prin Stress, aver 
-90.89 
 [-94.85,-83.87] 
-86.23 
 [-98.73,-75.35] 
-92.19 
 [-102.83,-88.66] 
-85.33 
 [-111.54,-76.52] 
Von Mises Stress, max 
580.86 
 [556.15,615.62] 
599.11 
 [549.45,666.85] 
576.48 
 [531.24,638.52] 
598.61 
 [544.47,691.75] 
Von Mises Stress, min 
0.57 
 [0.31,0.86] 
0.49 
 [0.22,0.80] 
0.65 
 [0.24,1.22] 
0.68 
 [0.25,1.15] 
Von Mises Stress, aver 
195.88 
 [181.69,202.20] 
161.67 
 [143.59,186.22] 
198.56 
 [191.63,206.46] 
161.20 
 [142.75,210.82] 
Stress Pressure, max 
319.49 
 [239.41,399.29] 
391.45 
 [292.31,490.53] 
283.09 
 [232.23,376.17] 
400.73 
 [278.99,609.21] 
Stress Pressure, min 
-363.19 
 [-453.17,-272.16] 
-359.99 
 [-473.09,-264.93] 
-319.82 
 [-516.12,-253.70] 
-350.78 
 [-563.03,-244.28] 
Stress Pressure, aver 
-8.95 
 [-11.03,-6.77] 
0.44 
 [-0.48,1.47] 
-9.05 
 [-11.61,-4.05] 
0.11 
 [-1.15,1.49] 
Sines Stress, max - 
346.47 
 [299.79,400.25] 
- 
334.07 
 [292.20,377.75] 
Sines Stress, min - 
-176.01 
 [-203.40,-150.43] 
- 
-189.22 
 [-285.12,-140.26] 
Sines Stress, aver - 
77.66 
 [63.97,90.07] 
- 
78.43 
 [64.52,87.31] 
 
5.3.3 Statistical analysis 
For the 10 patients with stent fracture, there were a total number of 26 fractures at 1 
year follow-up, increasing to 38 when most recent follow-up data were available (Table 
5.3). Statistical analysis for all 42 patients was performed using the data from 1 year 
follow-up and the earliest detected fractures for those patients who experienced this 
adverse event. 
A multivariate logistic regression model using only geometric parameters was fitted to 
the data, Table 5.6 (-2 Log likelihood= 20.95, Nagelkerke R
2
=0.676). Three covariates, 
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all at the stent level, were identified to interact in modifying the risk of fracture: change 
in the maximum radial asymmetry ΔRa (Figure 5.18a) and average circumferential 
asymmetry ΔCa (Figure 5.18b) after balloon deflation, and change in the maximum 
circumferential asymmetry ΔCa during the cardiac cycle (Figure 5.18c).  
 
 
Figure 5.18 - a) Change in the radial asymmetry ΔRa from the pre-recoil (black) to the systole 
(red) shown for one patient in the fluoroscopy reconstruction; b) change in the 
circumferential asymmetry ΔCa from the pre-recoil (black) to the systole (red) 
shown for one cell of one patient’s stent; c) change in the circumferential 
asymmetry ΔCa from the systole (red) to the diastole (blue) shown for one cell of 
one patient’s stent 
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Table 5.6 - Logistic regression analysis of 42 patients at 1 year following PPVI 
(geometric predictors only). 
Predictor β SE β Wald’s χ
2 
df p Odds Ratio 
(95% C.I. for OR) 
       
Constant 
 
ΔRa max at recoil 
 
ΔCa max at 
cardiac cycle  
 
ΔCa average at 
recoil  
-5.72 
 
-0.51 
 
0.35 
 
 
0.02 
1.82 
 
0.20 
 
0.16 
 
 
0.001 
9.87 
 
6.64 
 
4.83 
 
 
4.81 
1 
 
1 
 
1 
 
 
1 
0.002 
 
0.010 
 
0.028 
 
 
0.028 
NA 
 
0.950 (0.914-0.988) 
 
1.419 (1.039-1.940) 
 
 
1.002 (1.000-1.003) 
 
Test χ
2
 df P 
Overall model evaluation 
Omnibus tests of Coefficients 
Goodness-of-fit test 
Hosmer & Lemeshow 
 
25.2 
 
4.36 
 
3 
 
8 
 
<0.00001 
 
0.823 
-2 Log Likelihood= 20.95, Nagelkerke R
2 
=0.676, Cox and Snell R
2
= 0.451. NA=Not Applicable. 
 
This means that larger changes in cells shape during cardiac cycle (Odds Ratio OR 
1.419, p=0.028) and following recoil (OR 1.002, p=0.028) increase the stent fracture 
probability, while a preserved stent circularity following deployment (OR 0.95, p=0.01) 
decreases the fracture probability. Fracture happened in 3/10 patients in the cell with 
maximum change in shape during the cardiac cycle; in 4/10 in the cell next to it; in 2/10 
in two cells away from it; and in 1/10 on the opposite side. Furthermore, fracture 
occurred in the section with maximum change in circularity following the recoil in 7/10 
patients, while in the other 3 patients, it happened 2 to 4 sections next to the fractured 
one. Using this model, a predicted probability score of 0.30 correctly predicted fracture 
or no fracture in 90.5% of patients, with sensitivity 0.90 (95% CI 0.55-0.98) and 
specificity 0.91 (95% CI 0.75-0.98), Table 5.7.  
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Table 5.7 - The observed and the predicted frequencies of fracture for PPVI using 
geometric predictors only by logistic regression with the cut-off of 0.30. 
Observed  
Fracture 
Predicted Fracture  
%Correct No Yes 
 
No 
 
Yes 
 
Overall 
 
29 
 
1 
 
3 
 
9 
 
90.6 
 
90.0 
 
90.5 
Note. Sensitivity =0.90 (C.I. 0.55-0.98), Specificity=0.91(0.75-0.98), False Positive=25.0%, False Negative 
3.3%. 
 
By adding the FE simulations results to the explanatory variables, an improved 
multivariate logistic regression model was produced, Table 5.8 (-2 Log likelihood= 
16.68, Nagelkerke R
2
 = 0.756). In this model, two covariates (one geometrical and one 
FE) were found to correctly predict fracture or no fracture in 92.9% of patients, with 
sensitivity 0.90 (95% CI 0.55-0.98) and specificity 0.94 (95% CI 0.79-0.99), Table 5.9: 
change in the maximum radial asymmetry ΔRa after balloon deflation and the minimum 
values of the minimum principal stresses (negative stress) during recoil. This means that 
small changes of the cross-sectional shape from circular to elliptical after balloon 
deflation bear less risk of fracture. Large compressive stresses during balloon deflation 
are likely to increase the risk of fracture. Importantly, the inclusion of previously 
described clinical or radiographic parameters did not improve the risk of fracture in 
either model. 
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Table 5.8 - Logistic regression analysis of 42 patients at 1 year following PPVI 
(geometric and finite element predictors). 
Predictor β SE β Wald’s χ
2 
df   p Odds Ratio 
(95% C.I. for OR) 
       
Constant 
 
ΔRa max at recoil 
 
Min Values of Min 
Princ Stresses 
during recoil 
-51.75 
 
-0.076 
 
-0.078 
 
 
 
21.2 
 
0.03 
 
0.03 
 
 
 
5.96 
 
6.71 
 
5.71 
 
 
 
1 
 
1 
 
1 
 
 
 
0.015 
 
0.010 
 
0.017 
 
 
 
NA 
 
0.927 (0.875-0.982) 
 
0.924 (0.866-0.986) 
 
Test χ
2
 df P 
Overall model evaluation 
Omnibus tests of Coefficients 
Goodness-of-fit test 
Hosmer & Lemeshow 
 
29.4 
 
3.45 
 
2 
 
8 
 
<0.00001 
 
0.903 
-2 Log Likelihood= 16.68, Nagelkerke R
2 
=0.756, Cox and Snell R
2
= 0.504. NA=Not Applicable. 
 
 
 
Table 5.9 - The observed and the predicted frequencies of fracture for PPVI using 
geometric and finite element predictors by logistic regression with the cut-
off of 0.30. 
Observed  
Fracture 
Predicted Fracture  
%Correct No Yes 
 
No 
 
Yes 
 
Overall 
 
30 
 
1 
 
2 
 
9 
 
93.8 
 
90.0 
 
92.9 
Note. Sensitivity =0.90 (C.I. 0.55-0.98), Specificity=0.94 (C.I. 0.79-0.99), False Positive=18.2%, False 
Negative 3.2%. 
 
Chapter 5   PPVI Stent Fracture Risk Stratification 
 143 
5.4 DISCUSSION 
Fracture is a well-known complication of the PPVI Melody™ stent occurring in up to 
25% of patients (20; 23; 102). This is reflected also by our series of patients (n=42) 
where 24% of the cases (n=10) experienced fracture in the first year after implantation. 
However, the reasons for fracture have not been fully identified and the occurrence of 
this adverse event is likely due to a complex interaction between patient and device 
factors.  
In this study, we categorised and evaluated 3D fundamental geometrical and 
engineering parameters that could relate to stent fracture. The set of parameters selected 
takes into account, amongst others, all the clinical risk factors previously identified by 
Nordmeyer and McElhinney (20; 102): morphological characteristics of the RVOT, 
presence of a BMS or calcification in the conduit, location of the device in respect to the 
sternum, stent elastic recoil after balloon deflation, post-PPVI dilatation with a high 
pressure balloon, and asymmetries in the expanded device. All these influence the stent 
final geometry and behaviour during balloon deflation and cardiac cycle. The geometry 
and variation in geometry were fully characterised by dividing the stent in sublevels, 
while the mechanical effects of each stent final shape and deformation were reflected in 
the stress distribution. 
 
Multivariate binary logistic regression analysis was used to identify covariates affecting 
the odds of stent fracture. Two statistical models were developed: the first based only on 
geometrical parameters alone (derived from clinical fluoroscopy at the time of PPVI) 
and a second extended model which also included stress information from FE analysis 
simulations. Both models showed good fit, correctly identifying fracture or no fracture 
in 90.5% and 92.9% of patients respectively.  
The change in the stent section shape after balloon deflation was the most influential 
variable affecting the odds of stent fracture: the balloon deployment forces the 
implantation site and therefore the stent toward a cylindrical geometry, which is 
however lost after balloon deflation due to the recoil of the arterial wall. This makes the 
stent sections deform to an elliptical shape. The less the shape of a given section of the 
stent changes, we show the lower the risk of frame fracture. In addition, the data 
demonstrate that the more the cells’ shape changes during arterial recoil and cardiac 
cycle, the higher is the risk of frame fracture. In general, static asymmetries appeared 
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not to be strongly correlated with fracture, while the dynamics of the implantation site 
wall highly influences this phenomenon. This is indeed supported by a recent study 
reporting on balloon-expandable stent implantation in systemic outflow tracts which 
resulted in fractures in 43% of the cases (124). These results are consistent with the 
clinical findings that pre-stenting, as well as the presence of calcification in the 
deployment region (less compliant and dynamic), reduces the probability of fracture 
(22; 102).  
However, by describing the mechanical basis of these phenomena in our study, the 
statistical models are not further improved by their inclusion. 
Importantly, our analysis shows that changes in PPVI shape at the time of implantation 
may help predict stent fracture. This would enable us to define specific follow-up 
protocols for patients. Using our set statistical criterion, we would categorise 11 patients 
as high-risk for stent fracture with 9 patients fracturing and 2 not; hence, we would have 
potentially submitted 2 patients to have stringent follow-up. For the 31 patients we 
would have placed in the low risk group, 1 patient did have a fracture, but 30 patients 
would potentially have avoided needless follow-up. 
An early, systematic biomedical analysis post device implantation has the potential to 
accurately risk stratify patients, defining follow-up strategies and possibly reducing 
expensive follow-up investigations and clinic time. Further work is now required to 
define what safe follow-up strategies should be used for high and low-risk patients. 
5.5 LIMITATIONS 
Several important limitations in this study should be considered. Follow-up patient data 
at 1 year were available in the form of chest x-rays, but no dynamic fluoroscopy images. 
Despite the excellent radio-opacity of the platinum iridium-alloy, chest x-rays are not 
always optimal to visualise clearly the presence of a stent fracture, whose number may 
have been underestimated in this study. The earliest detected fractures were considered 
for the statistical analysis, but the single first strut to fail could not be identified in 5/10 
patients: the presence of a fracture may result in fracture progression to adjacent struts 
of the stent, thus changing the stent geometry and the stress distribution.  
The FE analysis although comprehensive did not include residual stresses caused by the 
asymmetrical manual crimping of the device onto the delivery catheter and by potential 
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multiple inflations of the post-PPVI dilatation balloon. These residual stresses play an 
important role in fatigue phenomena but could not be estimated for our patient 
population.  
The proposed models were developed in a relatively small cohort of 42 patients; 
therefore, they require validation in a prospective cohort, to overcome the inherent 
possibility of over-fitting in a training data set. However, with this preliminary data we 
have aimed for simple and parsimonious models, with limited explanatory covariates: 3 
in the geometrical model and 2 in the FE model, to reduce the risk of over-fitting.  
Finally, the 3D reconstruction process and measurement of the parameters predictors for 
fracture currently requires technical image processing, unavailable in many clinical 
environments. Translation of this process to the clinical environment will be aided by 
automated image processing techniques, in order to create user-friendly tools easily 
accessible to clinicians.  
5.6 CONCLUSIONS 
Stent fracture is a common adverse event following Melody™ PPVI and other stent 
implantation. For this reason, patients require careful follow-up to ensure that 
device/stent integrity remains. This study highlights that asymmetries in stent section 
geometry and cells shape, particularly during recoil after balloon deflation, are 
important variables associated with stent fracture. We have proposed two parsimonious 
statistical models based on 3D geometrical and stress analysis, to identify whether a 
PPVI patient is likely to incur a subsequent stent fracture. A model including FE 
analysis of stress is superior, however, consideration of geometrical information alone 
performs well, and could be translated to the clinical environment more generally 
without engineering support. Such models will require prospective validation, but could 
be used to risk stratify patients and to strategically plan bespoke clinical follow-up. 
From the next chapter the background will move from structures to fluids. Different 
computational methodologies will thus be introduces to study another CHD: the 
transposition of the great arteries.  
  
CHAPTER 6 
THE FLUID DYNAMICS IN THE NEOAORTA OF A 
TGA PATIENT 
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6.1 INTRODUCTION 
The studies presented in the previous 2 chapters focused on the development of 2D 
image analysis techniques and structural simulations to study the problem of stent 
fracture in PPVI. In this and the following chapter, the research moves to a different 
clinical problem, the long term complications after ASO in TGA patients (Section 
2.5.3), which were analysed using different computational fluid dynamic 
methodologies. In this chapter, a multi-domain approach including the 3D model of the 
neoaorta of a patient following ASO was validated against an in-vitro set-up. In the next 
chapter, this validated methodology further expanded using pure LPN was employed to 
study the pulmonary circulation in TGA patients who presented unilateral pulmonary 
artery stenosis. 
TGA as explained in Section 2.5 is the most common cyanotic CHD, currently treated 
with the arterial switch operation. Although ASO restores normal blood flow, several 
long-term complications can arise and the long-term effects have not been fully 
appreciated yet, as this procedure was introduced only in the 80s. In particular, the 
hemodynamics may be affected by anatomical features such as enlarged aortic root and 
acute aortic arch angulation, typical of TGA repaired by ASO with the Lecompte 
manoeuvre (Section 2.5.2).  
In this chapter, I developed a computational model of the neoaorta of a patient 
following ASO and of the aorta of a healthy control to assess the local hemodynamics 
and associated potential complications that arise after ASO compared to those of the 
normally developed aorta. Different modelling methodologies were explored and 
validated with in-vitro experiments replicating the same patients’ conditions. The 
validated numerical model could be used not only to study and compare the local fluid 
dynamics in different patient-specific morphologies, but also to assess the differences in 
the same patient if a hypothetical virtual surgery like the spiral operation (Section 2.5.4) 
could be performed instead of ASO.  
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6.2 MATERIALS AND METHODS 
6.2.1 Patients’ selection 
One 15-year-old patient with TGA corrected with ASO was selected for the study (1.7 
m
2
 body surface area (BSA), male). An age and BSA-matched healthy control patient 
(1.7 m
2
 BSA, male) was identified from a list of subjects screened at our Centre for 
assessment of possible hereditary cardiomyopathy. Both cases had MR investigation: 
the 2D phase contrast images were used to extract flow-rate information at the level of 
the sino-tubular junction (Section 3.4.1.1); the 3D whole heart acquisitions were used to 
reconstruct the 3D anatomy of the patients (Section 3.5.1), including the aortic root, 
arch and the three brachiocephalic arteries (i.e. innominate, left carotid and left 
subclavian arteries). Furthermore, in consideration of the experimental study, the access 
for a pressure catheter was built and positioned in the model at the level of the 
ascending aorta. Similarly, the inlet (aortic root) and outlets (brachiocephalic vessels 
and descending aorta) were modified in order to facilitate the connection of the 3D 
phantom with the mock circulatory system. The resulting geometry was rapid-
prototyped with the PolyJet technology (Section 3.6.1) using a transparent and robust 
resin (Watershed 11122; DSM Somos, Elgin, IL) (Figure 6.1).  
 
Figure 6.1 - Rapid prototyped rigid 3D models of the aortic arch of the TGA (left) and the 
Control (right) patients. 
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The transparency of the resin allows to identify the presence of air bubbles in the circuit, 
thus facilitating de-airing operations, and to control the correct positioning of the 
pressure catheter in the aortic arch. 
6.2.2 Experimental model 
A hydraulic circuit consisting of a pulsatile pump, compliance chambers, resistances 
and an atrial reservoir as explained in Section 3.6.2 was built incorporating the printed 
3D phantom, as shown in Figure 6.2 and Figure 6.3. The components of the circuit were 
carefully chosen to be MR compatible: all the ferromagnetic parts were located in the 
control room adjacent to the scanner room. As tests were performed inside the MR 
scanner, water was chosen as the flowing medium for hygiene and safety reasons. 
Hydraulic seal between the model, the pipes and the compliance chambers was ensured 
using silicone. 
 
Figure 6.2 - Experimental circuit: I indicates the printed 3D phantom of the patient’s aorta, II 
indicates the compliant chambers, III one of the four taps implementing the 
resistances, and  IV the atrial reservoir. 
I 
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Figure 6.3 - Schematic representation of the circuit: P represents the pulsatile pump, C the 
compliant chambers, R the non-linear resistances. The arrow indicates the 
direction of the flow. 
Heart rate (HR) and stroke volume (SV) were set in the pump in accordance to the 
patient’s data: HR = 70 bpm and SV = 90 ml. Long braided pipes filled with water were 
adopted to allow the Harvard pump to sit in the control room. 
The pressure range at the inlet of the model was set at 115/60 mmHg, according to cuff 
pressure data measured in the TGA patient. 
The values of the compliances obtained according to the formula in Section 3.6.2 are 
reported in Table 6.1.  
Table 6.1 - Compliance values set at each outlet of the model with patient’s mean 
pressure = 77 mmHg. 
 C [m
3
/Pa] 
Innominate 2.2E-09 
Carotid 2.0E-09 
Subclavian 2.8E-09 
Descending aorta 1.8E-09 
 
Resistances of the downstream district of the circulation were set in order to split the 
inflow according to the following physiological proportions: 55% in the lower body and 
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45% in the upper body (of which 15% in the innominate, 10% in the carotid and 20% in 
the subclavian artery). Characterisation of each resistance was performed using a 
simplified steady flow circuit (Section 3.6.2) and the resulting data were interpolated 
with a second-order polynomial equation (Figure 6.4).  
 
Figure 6.4 - Characteristic curves of the resistances set in the circuit for the carotid (blue), the 
innominate and subclavian (red), and the descending aorta (green). 
All outlets of the 3D model drained to a reservoir representing the atrium, from which 
the pump intake the working fluid. This chamber was filled with an amount of water 
suitable to implement a pressure of 9 mmHg (representative of atrial pressure) by the 
hydraulic head. 
The pressure in the aortic arch was measured by means of the high-fidelity factory-
calibrated fiber optic catheter Samba Preclin Samba sensor (Section 3.4.2).  
6.2.3 In-vitro MR Acquisitions 
The 3D model of the TGA patient was assembled in the circuit, and inserted inside the 
MR scanner. The pump was then turned on, setting the appropriate pressure and flow 
waveforms. Acquisitions were gated to the pump’s external trigger, via a BNC 
connection cable. 
Firstly, phase contrast data were acquired for 2D quantification of flow at the inlet and 
at every outlet. The imaging parameter used for the acquisitions were: Venc: 250 cm/s 
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for the outlets and 500 cm/s for the inlet; repetition time/echo time: 29.9/2.18 ms; pixel 
spacing: 1.17 mm; section thickness: 5 mm; flip angle: 30°. 
Then, the 4D (3 spatial dimension and time) acquisitions were performed using two 
different sequences: a standard sequence (Siemens) and a higher temporal and spatial 
resolution sequence, of 15 minutes, and 1 hour and 10 minutes respectively. The 
imaging parameters set for the Standard 4D sequence were: Venc: 200 cm/s; repetition 
time/echo time: 33.4/2.5 ms; pixel spacing: 2.2 mm; section thickness: 2.2 mm; flip 
angle: 5°. The imaging parameters set for the High Resolution 4D sequence were: Venc: 
200 cm/s; repetition time/echo time: 21.4/3.2 ms; pixel spacing: 2.4 mm; section 
thickness: 1.2 mm; flip angle: 5°. 
The same imaging protocol was adopted for imaging the mock circuit when the TGA 
3D model was replaced with the Control 3D model, leaving compliances and resistances 
to the previously set values.  
Flow data were calculated from the phase contrast acquisitions using the imaging 
software OsiriX (Pixmeo, Geneva, Switzerland), a DICOM viewer designed for 
navigation and visualisation of multimodality and multidimensional images. Using a 
plug-in developed in-house at Great Ormond Street Hospital (125), it was possible to 
quantify the instantaneous flow volume at any time during the cardiac cycle through the 
selected region of interest on the planes scanned. The mean velocity was then obtained 
dividing the flow by the area of the region of interest. 
Flow data extracted from the 4DMR acquisitions were analysed with the Siemens 4D 
Flow software. A 3D mask containing the region of interest was drawn by a 
combination of thresholding and segmentation operations. Six planes of interests were 
drawn perpendicular to the direction of flow to extract flow, velocity and area 
information: two at the inlet of the model, one in the aortic root, one before and one 
after the upper branches, and one in the descending aorta. Finally, particle seeds were 
placed on such planes, to allow the visualisation of particle traces and streamlines across 
the aortic arch (Figure 6.5). 
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Figure 6.5 -Particle seeds at different locations along the 3D model then used to generate 
streamlines and pathlines with the Siemens 4D Flow software. 
6.2.4 Computational model 
The TGA and the Control 3D geometries previously reconstructed from the MR images 
were used for the computational study. Computational meshes were created with the 
software ICEM (Ansys Inc., Canonsburg, PA, USA) adopting tetrahedral elements. Five 
different element sizes were used resulting in five different meshes of around 400000, 
500,000, 700,000, 900,000 and 1,200,000 volumes respectively. A sensitivity mesh 
analysis was conducted on such models to identify the best compromise between 
accuracy of the results and computational time required by the CFD simulation to 
converge. The influence of the mesh size was evaluated on the calculated power 
dissipation index calculated as the difference in energy W entering and exiting the 
model: 
 
where ρ is the fluid viscosity, v is the velocity, P is the pressure, and Q is the volumetric 
flow-rate at the inlet (IN) face and outlet (OUT) faces (126; 127). This parameter was 
chosen for the grid independence evaluation as it includes all the type of variables 
monitored in the simulations (velocities, pressures and flow-rates). Also, an indication 
of the energy dissipated by the geometry could be a useful parameter to evaluate the 
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performance of different surgical options for treating the same patient. A negligible 
difference of 1.4% (corresponding to 1·10
4
 W) was recorded in the power dissipation 
index calculated with the 900000 elements and the 1200000 elements meshes, thus the 
former was chosen for the following analyses. 
Ansys Fluent was used to set up and run all the CFD simulations as explained in Section 
3.5.2.1. In order to replicate the in-vitro conditions, the fluid used in the simulations was 
water, considered incompressible and Newtonian, with density ρ=1000 kg/m3 and 
viscosity μ=1 cP. The simulations were run under the hypothesis of no gravitational 
effects, isothermic conditions, with rigid walls and no-slip conditions. The strongest 
assumption made was the use of a laminar solver. Given the fluid properties, the 
anatomical dimensions and the flow conditions, the Reynolds number exceeded the 
laminar limit (i.e. > 1000, 128) during the systolic peak of the simulations. However, 
numerical models that can solve accurately the coexistence of laminarity and turbulence 
have not been fully validated yet and present high computational costs. Thus, in this 
preliminary study a laminar solver was chosen.  
In order to prescribe accurate boundary conditions to the 3D model, a multi-domain 
approach was employed in this study, by coupling the 3D model of the anatomical part 
of interest, with a LPN representing the circulation of the patient. In this case, only the 
systemic circulation was implemented, to replicate the downstream part of the mock 
circuit. At the inlet of the model, a time-varying velocity function interpolating the 
experimental flow curve was imposed through a user-defined function (UDF) script. 
The LPN representing the experimental circuit is shown in Figure 6.6.  
 
 
Figure 6.6 - Multi-domain model: coupling between the LPN of the systemic circulation of the 
patient and the 3D model of TGA patient’s aortic arch. The arrow indicates the 
inlet of the model. 
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The coupling between the CFD model and the LPN was implemented through pressure 
and flow information exchanged in correspondence of the boundary faces at the level of 
the innominate, the carotid, the subclavian and the descending aorta, as explained in 
Section 3.5.2.3.  
The values of the resistances and the compliances were chosen in order to replicate the 
respective components of the experimental circuit. The non-linear resistance R1 
corresponds to the taps of the mock circuit, and is characterised through the pressure 
drop-flow relationship obtained during the tap experimental calibration. The other 
resistances included in the network took into account the distributed and the 
concentrated pressure drops due to the length of the pipes, the presence of connections, 
and the sudden variations in diameter at different sections. In particular, the linear 
resistance R2 represented the pressure drop caused by the connections of the tubes, 
while Rt lumped the final part of the tube connecting all outlets to the right atrium 
reservoir.  
The values of the resistances and the compliances are reported in Table 6.2. 
Table 6.2 - Value of the parameters chosen to characterise each downstream branch j: 
non-linear resistances indicated through the pressure drop (ΔP) across the 
resistance Rj1 (with Q indicating the volumetric flow-rate); linear 
resistances Rj2 to account for the distributed resistances; compliances Cj.   
 
Rj1 
ΔP [Pa] 
Rj2 
[Pa·s/m
3
] 
Cj 
[m
3
/Pa] 
Innominate (j = i) 1.10
13
·Q
2 – 8.106·Q 5·107 1.88·10-9 
Carotid (j = c) 2.10
13
·Q
2 – 5.106·Q 1·108 1.98·10-9 
Subclavian (j = s) 1.10
13
·Q
2 – 8.106·Q 1·107 3.06·10-9 
Descending Aorta (j = d) 8.10
11
·Q
2 – 1.107·Q 2.5·107 1.48·10-9 
Common Section (j = t) - 8·10
7
 0.36·10
-11
 
 
The ordinary differential equations (ODEs) were resolved through the explicit Euler 
numerical method, using a time-step Δt of 10-4 s. 
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6.3 RESULTS 
6.3.1 Experimental model 
The mock circuit proved to be suitable for the representation of the downstream districts 
of the circulatory system, with pressure and flows in a physiological range. Also, the 
replacement of the TGA 3D model with the Control model was feasible, without 
interfering with the settings of the rest of the circuit.  
6.3.2 4D-MR Flow 
The comparison between the two different 4D flow sequences, Standard and High 
Resolution respectively, showed no noticeable difference between the outcomes in 
terms of acquired flow. Both cases were examined against the flows measured with 
OsiriX from the traditional 2D Cartesian phase-contrast flow acquisitions, which was 
taken as reference. The High Resolution sequence presented noisier results, and it 
slightly overestimated the systolic peak at the inlet section of the model, while the 
Standard sequence slightly underestimated it (Figure 6.7). In terms of mean flow 
averaged over one cardiac cycle on the inlet of the model, 5.5 L/min were measured 
with the 2D OsiriX, as well as with the Standard sequence, while with the High 
Resolution 7 L/min were measured per cardiac cycle. From a qualitative point of view, 
the images obtained with the High Resolution settings did not provide any additional 
information when compared with the Standard acquisitions. Figure 6.8 shows the 
streamlines captured in the two cases in the TGA model. The High Resolution sequence 
exhibited a noisier background, likely due to compromised signal to noise ratio (SNR), 
not allowing an accurate mask thresholding for isolating the region of interest. Also, a 
smaller number of streamlines, not sufficient for an adequate representation of the fluid 
dynamics in the aortic arch, was noticed. 
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Figure 6.7 - Flows at the inlet of the model acquired with the Standard (blue) and High 
Resolution (red) 4D Flow sequences, compared with the OsiriX 2D acquisition 
(green). 
 
 
Figure 6.8 - Qualitative comparison of the streamlines of the High Resolution (left) and the 
Standard (right) 4D flow sequences. The first image shows a noisier 
background and visibly less number of streamlines than the Standard one. 
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As a result, the Standard Resolution sequence was adopted also for the test with the 
Control geometry. 
6.3.3 Computational model 
In order to understand whether the computational model was able to accurately 
reproduce the fluid dynamics developed in the mock circuit, data from both tests were 
compared in terms of flows, pressures and streamlines. The mean flows calculated at 
every outlet of the TGA and the Control 3D domains are reported in Table 6.3, while 
the flow-splits among the outlets calculated as a percentage of the inflow are shown in 
Table 6.4. 
Table 6.3 - Mean volumetric flows measured from MR and calculated with the CFD 
simulations at every outlet of the TGA and the Control model. 
 TGA Model Control Model 
 MR [L/min] CFD [L/min] MR [L/min] CFD [L/min] 
Innominate 0.92 0.88 0.85 0.9 
Carotid 0.54 0.56 0.55 0.59 
Subclavian 1.17 1.1 0.9 0.89 
Descending Aorta 2.92 3.01 3.2 3.12 
Table 6.4 - Flow-split calculated as a percentage of the inflow, measured from MR and 
calculated with the CFD simulations for every outlet of the TGA and the 
Control model. 
 TGA Model Control Model 
 MR [%] CFD [%] MR [%] CFD [%] 
Innominate 16.6 15.8 15.5 16.4 
Carotid 9.7 10.1 10.0 10.7 
Subclavian 21.1 19.8 16.4 16.2 
Descending 
Aorta 
52.6 54.2 58.1 56.7 
 
The results of the computational models were in agreement with the flows measured 
experimentally, not only in terms of averages over one cardiac cycle, but also in terms 
of waveforms, as illustrated in Figure 6.9 for the TGA model, and in Figure 6.10 for the 
Control model.  
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Figure 6.9 - Experimental (blue) and computational (red) volumetric flow-rate waveforms 
obtained at the outlets of the TGA model over one cardiac cycle (T = 0.8s). 
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Figure 6.10 - Experimental (blue) and computational (red) volumetric flow-rate waveforms 
obtained at the outlets of the Control model over one cardiac cycle (T = 0.8s). 
 
The pressure measured experimentally inside the aortic arch was compared with that 
calculated computationally on a plane specifically created in the geometry at the same 
level of the dedicated port for the pressure catheter. Figure 6.11 shows the comparison 
between the experimental (blue) and the computational (red) curves in the TGA model, 
while in Figure 6.12 the same variables are reported for the Control model. 
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Figure 6.11 - Experimental (blue) and computational (red) pressure waveforms recorded in the 
aortic arch of the TGA model over one cardiac cycle (T = 0.8s). 
 
Figure 6.12 - Experimental (blue) and computational (red) pressure waveforms recorded in the 
aortic arch of the Control model over one cardiac cycle (T = 0.8s). 
Satisfactory agreement was noted in terms of pressure tracings and pressure values. In 
particular, the TGA mean pressure measured experimentally in the aortic arch was 84.6 
mmHg, while the one calculated in the CFD analysis was 85.7 mmHg (1.3% 
difference). For the Control model, the experimental mean pressure was 87 mmHg and 
the computational pressure value was 83.2 mmHg (4.4% difference). 
6.3.4 Qualitative comparison between 4D-Flow and CFD simulations 
The velocity streamlines are visualised in both geometries at 4 temporal instants over 
one cardiac cycle, with both the 4D flow Siemens visualisation software and Fluent in 
Figure 6.14 to Figure 6.17 for the TGA model, and in Figure 6.18 to Figure 6.21 for the 
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Control model.The frames considered for the comparison were early systole (t1=0.1 s), 
peak systole (t2=0.2 s), late systole (t3=0.4 s) and diastole (t4= 0.6 s), as shown in Figure 
6.13.  
 
Figure 6.13 - Temporal instants considered for the comparison displayed in the cardiac cycle. : 
t1 represents the early systole, t2 the systolic peak, t3 the late systole and t4 the 
diastole. 
A good qualitative agreement was verified between MR and CFD data: the CFD 
simulation was able to reproduce the same flow jet impinging at the top of the aortic 
root wall, and the surrounding whirls visible in the 4D flow images. The range of 
velocities is comparable in both magnitude and distribution. Excellent correspondence 
was noticed all over the cardiac cycle.  
Chapter 6 The Fluid Dynamics in the Neoaorta of a TGA Patient 
 163 
 
Figure 6.14 - Four-D flow streamlines (left) compared with CFD streamlines (right) at t1= 0.1 s 
(early systole) in the TGA model. The range of velocity is the same for both 
images. 
 
Figure 6.15 - Four-D flow streamlines (left) compared with CFD streamlines (right) at t2= 0.2 s 
(peak systole), in the TGA model. The range of velocity is the same for both 
images. 
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Figure 6.16 - Four-D flow streamlines (left) compared with CFD streamlines (right) at t3= 0.4 s 
(late systole), in the TGA model. The range of velocity is the same for both 
images. 
 
Figure 6.17 - Four-D flow streamlines (left) compared with CFD streamlines (right) at t4= 0.6 
s, (diastole), in the TGA model. The range of velocity is the same for both 
images. 
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Figure 6.18 - Four-D flow streamlines (left) compared with CFD streamlines (right) at t1= 0.1 s 
(early systole) in the Control model. The range of velocity is the same for both 
images. 
 
Figure 6.19 - Four-D flow streamlines (left) compared with CFD streamlines (right) at t2= 0.2 
s, (peak systole), in the Control model. The range of velocity is the same for 
both images. 
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Figure 6.20 - Four-D flow streamlines (left) compared with CFD streamlines (right) at t3= 0.4 
s (late systole), in the Control model. The range of velocity is the same for both 
images. 
 
Figure 6.21 - Four-D flow streamlines (left) compared with CFD streamlines (right) at t4= 0.6 s 
(diastole), in the Control model. The range of velocity is the same for both 
images 
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6.3.5 Comparison between TGA and Control geometries 
Given the same inflow and outflow boundary conditions, the solely effects of the arch 
anatomy was investigated using the CFD approach. Mean flow rates and flow-splits at 
the outlet faces of both 3D models are reported in Table 6.5, while the waveforms at 
each outlet are reported in Figure 6.22. 
Table 6.5 - Mean flow-rates and flow-splits obtained computationally at every outlet of 
the TGA and the Control models. Flow-split has been calculated as a 
percentage of the total inflow. 
 Mean Flow Rate [L/min] Flow-split [%] 
 TGA Control TGA Control 
Innominate 0.92 0.86 16.6 16.77 
Carotid 0.54 0.57 9.7 11.20 
Subclavian 1.17 0.87 21.1 16.87 
Descending Aorta 2.92 2.83 52.6 55.16 
 
     
 
     
Figure 6.22 - Volumetric flow-rate waveforms obtained computationally at the outlets of the 
TGA (blue) and the Control (red) models over one cardiac cycle (T = 0.8s). 
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At all outlets, no substantial difference was noticed in the waveforms between the TGA 
and the Control model. 
A comparison between velocity streamlines in the two different anatomies (with the 
same inlet flow and outlet LPN) at the four different temporal frames discussed before 
(0.1 s, 0.2 s, 0.4 s, 0.8 s) is shown in Figure 6.23. 
                          
Figure 6.23 - Velocity streamlines in the Control and the TGA anatomies obtained 
computationally at early systole (t1=0.1s), at peak systole (t2=0.2s), at late 
systole (t3=0.4s), and at diastole (t4=0.6s). 
At early systole (t1 = 0.1 s) the velocity started to increase at the inlet of both models, 
but it was still low in the rest of the arches. In the Control geometry, the majority of the 
streamlines had a straight path following the geometric shape, while in the TGA the 
streamlines followed chaotic paths in the enlarged root, recovering a more regular trend 
in the descending aorta, after the aortic arch.  
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At peak systole (t2 = 0.2 s) the geometries showed different behaviours. In the Control 
model, once again, the streamlines followed the arch. The velocity magnitude remained 
considerably large also at the level of the upper branches. In the TGA model, a flow jet 
through the inlet was clearly visible, and, being not directed as the curvature of the 
geometry, it hit the wall of the enlarged root, losing velocity before reaching the upper 
branches. Also, whirling streamlines, characterised by lower velocity magnitude, 
surrounded the main flow jet. 
At late systole (t3 = 0.4 s) what described for the systolic peak was still visible. In 
particular, higher re-circulation of flow particles around the root were visible for both 
models. 
The diastolic phase (t4 = 0.6 s) presented, as expected, lower velocities, and it should be 
noted that the inlet and all outlets except for the descending aorta were characterised by 
retrograde flow. The enlarged aortic root of the TGA case was perfused by chaotic 
streamlines. 
The velocity vectors (Figure 6.24) at peak systole (t2 = 0.2 s) showed the TGA model to 
have a more complex fluid dynamics than the Control model, with presence of 
secondary flows. While higher velocities in the Control model were clustered in the 
centre of the root mid-sectional plane, in the TGA model they had a random 
distribution.  
                  
Figure 6.24 - Velocity vectors at peak systole (t2=0.2s) in the Control (left) and the TGA (right) 
models.     
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6.4 DISCUSSION 
This study successfully applied a modelling paradigm involving both experimental and 
computational tools to tackle a complex case of congenital heart disease. Specifically, 
TGA is a congenital condition presenting a wide range of complications, such as aortic 
root dilation (35), reduced aortic distensibility (37) and compromised ventricular-
vascular coupling (41) on the aortic side, and unilater pulmonary artery stenosis on the 
pulmonary side (29). The full consequences and effects of TGA repaired with ASO are 
not fully appreciated yet, due to the relatively young age of the patients.  
This work focused solely on the aortic side of the problem, using modelling techniques 
to evaluate the effect of the shape of the neoaorta in this group of patients. Overall, a 
patient-specific approach was chosen, and a validation study was carried out to 
demonstrate the reliability of the computational model.  
Following from the presented results, a relatively simple and compact mock circuit 
proved to be an adequate tool to study TGA experimentally. By setting appropriate R 
and C boundary conditions, the mock circuit was able to accurately reproduce the 
pathological scenario of interest, at a patient-specific level, according to cuff pressure 
measurements. The boundary conditions in fact can be easily tuned manually adjusting 
the stroke volume and the heart rate of the pulsatile pump, the volume of air in the 
compliant chambers and the extent of closure of the taps used to implement vascular 
resistances. Moreover, using the manufacturing technique known as rapid prototyping, 
patient-specific geometries were obtained, and these could be easily mounted into the 
circuit, implementing patient-specific 3D information. This is important not only 
because it allows to take into account the variety in aortic morphology between different 
patients (by testing multiple models), but also because the study focused specifically on 
the hemodynamics within the neoaorta. 
Such hemodynamic features can be appreciated experimentally by taking advantage of 
the imaging technique known as 4D MR flow (131). This requires, first of all, the 
construction of a MR-compatible mock circuit, which was successfully achieved in this 
work. 4D MR flow can be very informative in the field of congenital defects, as in cases 
of Fontan circulation (132) as well as bicuspid aortic valve (133). The advantage of 
using this technique, instead of standard 2D acquisitions, is that there is no need to plan 
flow acquisition prior to acquiring the data, which is collected over a volume of interest. 
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As a result, this can make the technique time-efficient, especially in those cases where 
multiple flows need to be planned and acquired (81), albeit acquisition time remains a 
concerns for clinical application of 4D MR flow, especially in children.   
Furthermore, the post-processing of a 4D flow dataset gives access to exquisite flow 
visualisation, including streamlines and particle tracing, over the 3D volume of interest. 
Only one study recently applied 4D MR flow to the study of TGA in humans (134), 
however there are several advantages linked to using an in-vitro approach. Firstly, the 
use of a hydraulic circuit solves problems related to patient’s motion, which are of 
particular concern especially in younger patients and over a long acquisition (15-20 
minutes, or more).  Moreover, the circuit can be kept inside the scanner for as long as 
required, and this is useful if multiple acquisitions are necessary. For example, in this 
study a 1 hour and 10 minute long high spatial and high temporal resolution sequence 
was performed on the model. The reason to perform this additional scan was to evaluate 
whether increased resolution provided access to meaningful additional fluid dynamic 
details, especially in complex geometries, such as TGA. In this work, because of the 
compromised SNR, it was not possible to get more information than from the standard 
sequence. This point could be tackled in the future from an MR physics perspective, 
trying to acquire high resolution sequences without compromising SNR and ongoing 
work in the MR unit at Great Ormond Street Hospital is evaluating the complexities of 
4D flow acquisition. However, as the results of the ‘standard’ (15 minute) sequence 
were satisfactorily informative for the hemodynamic problem under investigation, 
further work in this context was deemed not necessary. 
Full datasets were ultimately acquired experimentally for the TGA anatomy and the 
age-matched healthy control model. In both cases, pressure values were in agreement 
with cuff pressure readings obtained at the time of the clinical MR scan (Pmean = 80 
mmHg). On the other hand, flow distribution between upper and lower body and in the 
different head and neck vessels was ensured to be realistic but was not set to patient-
specific values, as flow data is not acquired in each brachiocephalic vessel in routine 
clinical scans, so these data were not available. 
All the experimental acquisitions of this work were carried out using rigid models. 
Rigid models are easy to mount and robust. Also, transparency associated with some of 
the rigid resins used for printing rigid models are important for visualisation studies as 
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particle image velocimetry (PIV) (101), albeit not necessary for MR imaging. The 
disadvantage of using a rigid material, on the other hand, is that it does not take into 
account the compliant behaviour of the human vessels and the associated recoiling 
effect in diastole. However, being the computational study designed using 3D rigid-
walled models, validation data was successfully provided from the models printed in 
rigid resin.   
As shown in the results, the CFD simulations are in overall good agreement with the 
experiments. This eventually allows proceeding with a solely computational approach, 
whether different patient-specific anatomies need to be included in the study. Although 
it is possible to properly set the boundary conditions also with an experimental 
approach, a computational approach guarantees their stability. In fact, minor leaks can 
occur while gathering experimental data, especially over long acquisitions (i.e. multiple 
scans in the MR). Also, other changes are not straightforward to monitor, e.g. if a 
solution of water and glycerine were used, its content is prone to changes in viscosity 
with small changes in temperature.  
Computationally, it is also possible to easily undertake parametric studies, simply 
changing one parameter at a time in order to understand its influence on the fluid 
dynamics. The only concern in this case is the computational cost of each additional 
simulation, rather the time associated with re-assembling an experimental rig. It is also 
possible to extract retrospectively other parameters and values of interest at different 
locations in the model, not necessarily planned beforehand, while this is not possible in 
an experimental study. Also, from a modelling point of view, it would be easier to 
implement non-concentrated resistances, avoiding the use of the taps not able to model 
the resistances in a physiological way. 
In this study two different simulations were performed, the only difference among them 
being the 3D element in the multi-scale network. This approach is suitable to 
understand how the geometry alone affects the fluid dynamics, effectively isolating one 
variable in a complex clinical problem. Indeed, making use of the computational 
validated methodology, it would be possible to virtually create aortic morphologies 
resulting from different surgical techniques such as for example the spiral operation 
(Section 2.5.4), it would be possible to evaluate the potential hemodynamics benefits of 
each interventional methodology. 
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Being this a preliminary study, no clinical conclusions can be withdrawn. First of all, 
the use of water instead of a liquid resembling the blood properties limits the reliability 
of the results from a diagnostic point of view. This problem could be easily bypassed at 
this point by running computational simulations with different fluid properties. Also, the 
absence of a valve at the inlet of the model alters the fluid dynamics reproduced 
experimentally. The jet flow impinging on the root wall is more likely due to the design 
of the mock circuit, with a pipe of contained diameter and considerable length 
connecting the outflow of the pump to the inlet of the 3D model, thus creating a high 
velocity jet profile. This profile would be limited by using a higher fluid viscosity, and 
by using a computational model that does not include the extension of the inlet, 
designed only for experimental purposes. 
A more physiological model could give additional and reliable information on the fluid 
dynamics and on the wall shear stress distribution on the wall. The risk of having high 
WSS is potential mechanical damage of the inner wall of the vessel (135; 136), which 
could in turn weaken the vessel and possibly initiate a lesion. The combination of these 
two factors may have an impact in long-term pathologies, in particular the development 
of aortic dilatation (137). This effect, added to the already enlarged root of TGA patients 
because of the surgical operation, may leads to structural failure of the vessels. For this 
reason, a computational study investigating such variables could help the clinicians in a 
better understanding of the ASO drawbacks, and eventually, in the development of 
different surgical approaches. 
Interesting would be the comparison of the in-vitro results with both a CFD model using 
a laminar solver and one using a turbulent solver, to better simulate the systolic peak 
characterised by high Reynolds numbers. Amongst the others, the k-ω model could be 
chosen as literature studies (56; 129; 130) suggest that to be suitable for modelling flows 
where both transitional and turbulent regimes may occur.  
Finally, the compliant behaviour of the wall was not taken into account in this study, 
neither experimentally or computationally. CFD simulations assumed rigid vessel walls, 
so different distensibility was not an issue. Admittedly, such variations in vessel 
compliance have been reported also at young ages (138), but these are not as meaningful 
as much more significant changes in distensibility occurring later on in life. Fluid 
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structure interaction approaches could overcome this limitation, but accurate patients’ 
vessel wall material properties should be known. 
6.5 CONCLUSIONS 
The fluid dynamics of a patient who underwent treatment for TGA and that of a healthy 
subject were successfully modelled experimentally, and afterwards replicated 
computationally using a multi-domain approach. The mock circulatory system, which 
included a rapid prototyped patient-specific 3D element for both the TGA and the 
control case was tuned according to clinical data. CFD simulations coupled with a LPN 
properly tuned in order to exactly replicate the conditions of the experiments were 
performed, thus using the experimental data to validate the computational models. 
Computational results were in good agreement with their experimental counterpart, 
showing that a multi-domain approach provides a reliable methodology for 
hemodynamics evaluations in complex patient-specific models.  In the next chapter, the 
CFD and LPN modelling techniques developed and validated in this study are applied 
and integrated into an innovative framework for better understanding of unilateral 
pulmonary artery stenosis hemodynamics.  
     
  
CHAPTER 7 
UNILATERAL PULMONARY ARTERY STENOSIS IN 
TGA PATIENTS 
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7.1 INTRODUCTION 
In the previous chapter, I created a multi-domain model coupling a 3D volume of the 
region of interest to an open LPN representing the reminder of the circulation. This 
methodology, applied to model the aorta of a TGA patient and of a control subject, was 
validated against in-vitro experiments and provided important information on the local 
hemodynamics. In this chapter, I propose to employ the validated computational 
methodology to further develop engineering tools that would enhance our understanding 
of patient-specific general hemodynamic conditions. In particular, LPNs were used to 
model the pulmonary circulation and study another complication of TGA patients after 
ASO: stenosis of the branch pulmonary arteries (139). Typically, during surgery the left 
pulmonary artery (LPA) of the patient is forced to lengthen in order to allow the 
anastomosis of the pulmonary trunk (PT) to the RVOT (Figure 7.1b-d). This 
complication is usually associated with reduced flow to the affected lung and thus 
abnormal differential pulmonary blood flow. The preferred therapeutic option is balloon 
angioplasty (with or without stenting) which improves pulmonary blood flow to the 
affected lung by reducing the resistance to flow caused by the narrowed artery lumen 
(Figure 7.1a). However, there are cases in which angioplasty or stenting has little effect 
on clinical symptoms. 
In some patients, the expected relationship between stenosis and reduced pulmonary 
blood flow does not hold true, and there is equal flow split to both lungs despite the 
clear presence of an anatomical stenosis. One currently accepted explanation for this 
phenomenon takes into account the remodelling of the peripheral pulmonary vascular 
resistances (PVR) which counteracts the presence of the stenosis, thus readjusting the 
flow split to physiological levels. Raised contralateral PVR may balance the effects of 
the unilateral stenosis and explain the poor results after relieving of this stenosis by 
balloon/stenting procedure on clinical symptoms. 
Further studies assessing the complex haemodynamics of unilateral pulmonary stenosis 
should be carried out to enhance our understanding of this phenomenon and improve 
treatment outcomes. The reference standard method is cardiac catheterisation; however, 
such an invasive test is not warranted in patients who do not undergo 
angioplasty/stenting.  
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Non-invasive imaging modalities, such as cardiovascular MR can be particularly useful 
in the diagnosis and management of these patients, as it provides both anatomical and 
flow distribution data to develop patient-specific computational models. Therefore, in 
this study, I propose to combine MR data and computational models to study patients 
with unilateral pulmonary artery stenosis in order to assess PVR remodelling and acute 
hemodynamic outcomes of stenting procedure, with no need for additional invasive 
measurements. 
 
 
Figure 7.1 - 3D volume rendering of the cardiac structures in a TGA patient corrected by ASO. 
Presence of a unilateral branch pulmonary artery stenosis in the left side (a). 
Relationship between pulmonary artery (blue) and aorta (green) showed in 
(b,c,d)- top and lateral views.  
a) b) 
c) d) 
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7.2 MATERIALS AND METHODS 
MR scans from TGA patients after ASO were used to reconstruct the patient-specific 
3D pulmonary tree anatomy and acquire pulmonary blood flows. Different modelling 
techniques were strategically employed to quantify the hemodynamic effects of the 
stenosis, the amount of peripheral PVR remodelling and the acute outcomes of stenting 
procedure in a patient with severe LPA obstruction. 3D CFD analyses were used to 
characterise the proximal LPA and RPA resistances. A 0D LPN was set up to simulate, 
with low computational costs, the pulmonary tree circulation of each patient. Peripheral 
PVR and compliances were tuned in the LPN until the flows in the computational 
model matched the known MR flow data in the branches for each patient. Finally, a FE 
simulation was carried out to obtain the lumen of the stenotic branch vessel after virtual 
stenting procedure, and to analyse the resulting fluid dynamics after stenosis relief.  
7.2.1 Patient population and MR imaging 
Fifteen patients who underwent ASO for correction of TGA were retrospectively 
selected from our Centre database according to the following criteria: i) cardiovascular 
MR scan performed in the second decade of life, ii) MR images with voxel size < 2mm 
and no visible artefacts, iii) continuity in the inflow-outflow PA balance from MR flow 
data measurements (differences <7% of the inflow considered acceptable), and iv) no 
pulmonary hypertension. 
The MR 3D whole heart sequence was used to reconstruct the blood volume of PT, 
LPA and right pulmonary artery (RPA) before further branching (Section 3.5.1) (Figure 
7.2).  
Patients were divided in 2 groups, according to the presence/absence of pulmonary 
stenosis as stated in the clinical MR report: control group CG (n=5) of patients with no 
pulmonary artery stenosis; and stenotic group SG (n=9) which comprised patients 
diagnosed with LPA unilateral stenosis (n=9). An additional patient with bilateral 
pulmonary stenosis (BPS) was included in the study to validate the developed 
methodology as he underwent diagnostic cardiac catheterisation 16 months after MR 
examination as part of his clinical assessment. 
The degree of stenosis for SG and BPS was quantified from the 3D anatomical 
reconstruction as: 
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where Dstenosis is the diameter at the narrowest section of the vessel and Dvessel is the 
diameter of the vessel downstream the narrowing, with the diameters derived from the 
cross-sectional area of the sections of interest. Stenoses ≤10% were considered 
absent/trivial, between 10% and 40% mild/moderate, and ≥40% severe (Table 7.1) 
(140).  
Inflow (PT) and outflows (pulmonary branches) were calculated from MR phase 
contrast velocity mapping images (Section 3.4.1.1, Table 7.1). LPA flows ranging from 
40% to 50% of the total pulmonary flow are considered physiological due to the 
different morphology of the left and right lung (141). Therefore, 5 out of 9 SG patients 
(SG3, SG4, SG5, SG8 and SG9) had expected reduced flow to the left lung due to the 
LPA stenosis, while the other 4 presented balanced flow split – even slightly higher 
flow towards the LPA – despite the presence of the stenosis.   
Average age at scan was 16 years (12-18 years) for CG and 14 years (9-18 years) for 
SG, while the average body surface area (BSA) was 1.76 m
2
 (1.44-2.00 m
2
) for CG and 
1.56 m
2
 (1.10-2.00 m
2
) for SG (Table 7.1). 
 
Figure 7.2 - Volume rendering of PT, LPA and RPA for each patient included in the cohort.  
BPS 
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Table 7.1 - Patients population and categorisation according to the presence/absence of 
stenosis. 
Patient 
ID 
Gender 
Age at 
scan 
[yrs] 
BSA 
[m
2
] 
LPA 
Stenosis 
degree [%] 
LPA Stenosis 
classification  
LPA:RPA  
flow split  
CG1 F 18 1.88 - - 43:57 
CG2 M 12 1.44 - - 46:54 
CG3 M 17 2.00 - - 50:50 
CG4 F 16 1.60 - - 52:48 
CG5 M 16 1.90 - - 54:46 
SG1 F 18 1.38 7 Trivial 53:47 
SG2 M 11 1.10 23 Mild-moderate 43:57 
SG3 M 16 1.68 39 Severe 31:69 
SG4 M 15 1.80 40 Severe 38:62 
SG5 F 13 1.35 44 Severe 33:67 
SG6 F 14 1.93 58 Severe 50:50 
SG7 F 13 1.70 60 Severe 52:48 
SG8 M 17 2.00 65 Severe 35:65 
SG9 M 9 1.14 70 Severe 38:62 
BPS M 14 1.91 
53 
(RPA 59) 
Severe 
(RPA: Severe) 
52:48 
 
7.2.2 Lumped parameter network 
A schematic representation of the open-loop LPN used to model the pulmonary 
circulation is shown in Figure 7.3, where RRPA and RLPA represent the two proximal 
pulmonary branch resistances, while the downstream arterial circulation and the venous 
circulation are modelled with a 2-element Windkessel blocks respectively on each side 
of the bifurcation. 
RRPA and RLPA were obtained through hydraulic characterisation as described in the 
following paragraph (equations 1 or 2) using stand-alone 3D CFD analyses.  
Allometric equations from literature (126; 142) were adopted to set the relationship 
between peripheral arterial resistance (Ra) and venous resistance (Rv) for each 
pulmonary side (R = right, L = left)                      and between total equivalent 
resistances and compliances                     , with RRtot and RLtot = total equivalent 
resistances for the right and left side respectively, and CRtot and CLtot = total equivalent 
compliances for the right and left side respectively. 
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Figure 7.3 - Schematic representation of the open-loop LPN used to model the pulmonary 
circulation of the TGA patients. 
LPN simulations were set-up and compiled as indicated in Section 3.5.2.2. Twenty 
cardiac cycles were simulated per analysis, with the last used in the post-processing of 
the results.  
7.2.3 Characterisation of the proximal resistances RRPA and RLPA 
A CFD model was created for each patient from the 3D MR reconstructed anatomy. A 
tetrahedral grid mesh with 800,000 volumes (0.5 mm element size) was chosen after a 
sensitivity analysis and an adaptive mesh refinement was further implemented (126; 
127). The blood was assumed to be Newtonian and incompressible (density ρ = 1060 
kg/m
3
 and viscosity μ = 0.003 Pa∙s). CFD simulations were performed using the 
discretisation schemes and the convergence criteria indicated in Section 3.5.2.1 with the 
software Ansys Fluent. For unsteady simulations, a time-step of 10
-4
 s was applied, and 
4 cardiac cycles per analysis were simulated to ensure stable computational solution.  
The main aim of this study was to evaluate the flow distribution between RPA and 
LPA, with no specific focus on the local fluid dynamics; therefore, a laminar solver was 
adopted despite the risk of turbulence generation during the systolic peak in severe 
stenoses.  
Stand-alone CFD steady simulations were carried out to characterise the 3D model of 
the pulmonary branches in terms of hydraulic resistances by inputting 6 different 
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constant flows (0 to 10 l/min), representative of the patients’ flow range, at the inlet, 
and a constant pressure of 8 mmHg, matching the left atrial pressure, at each outlet.  
Pressure drops ΔP, measured in each branch as PPT-PLPA and PPT-PRPA, were plotted 
versus the flow Q streaming in the branch (QLPA and QRPA), and either a linear 
relationship (equation 1) or a second degree polynomial relationship (equation 2) was 
used to interpolate the obtained data points: 
                                      (equation 1) 
                                      (equation 2)                                          
The coefficient Rbranch or the coefficients a and b defined the proximal branch 
resistances in every patient and the characteristic curves were used in the LPN.  
The results were further validated using unsteady simulations which are more 
computationally expensive, but account for the dynamic effects in the bifurcation. In 
these analyses, the time-varying flows measured from patients’ MR were imposed as 
boundary conditions at the inlet and at the right outlet of each model, and a constant 
pressure of 8 mmHg was set at the left outlet.  
7.2.4 Peripheral PVR remodelling  
A first set of LPN simulations was run to quantify the flow split based on pure 
anatomical consideration when assuming that there is no remodelling of the peripheral 
PVRs and compare this with the measured flow split from MR.  
A split between the peripheral resistances RLtot and RRtot = 55:45 was considered 
physiological (141) to account for the different lung morphology, and total peripheral 
PVR was assumed = 1 WU. The difference between the flow-split obtained in the 
hypothesis of no peripheral remodelling and the real flow-split measured from MR was 
adopted as index of the amount of remodelling experienced by the patient. 
7.2.5 Characterisation of the peripheral parameters 
In the LPN, the characteristic curves derived from the CFD analyses were implemented 
for RLPA and RRPA, and the peripheral parameters were tuned by changing the 
percentage ratio between the total right and left resistances, in order to obtain the MR 
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flow split and curves of the patient at the outlets of the model. The time-variant patient 
PT flow was imposed at the inlet of the each model. 
Six simulations were performed for all patients by varying the total peripheral PVR 
between 1 and 10 WU (1, 2, 4, 6, 8, 10 WU) to account for physiological and mild 
hypertensive scenarios (143; 144; 145; 146). The total compliance of the circuit was 
maintained in a physiological range, estimated around 2 ± 1.1 mL/mmHg (126; 142; 
147).  
The tuning of resistances and compliances was considered achieved when the difference 
between the flow split generated by the LPN and that measured from MR was ≤1%. The 
values of the pressures distally to the LPA (PLa) and RPA (PRa) obtained from the LPN 
were compared to physiological values to evaluate the effects of the choice of total 
peripheral PVR. 
In addition, pulmonary artery pressures were available for BPS who underwent 
diagnostic catheterisation. These data were used to calculate the patient’s peripheral left 
and right PVR as follows: 
 
 
with PLa = 14 mmHg and PRa = 15 mmHg pressures measured downstream the left and 
right stenoses respectively. These resistances were compared to those obtained from the 
tuning process of the network created for the BPS patient, and the LPN resulting 
pressures PLa and PRa distal to the stenosis were compared with the patient’s data, in 
both cases: when the newly calculated peripheral resistances were inputted in the LPN, 
and when the LPN was blindly tuned.   
Once the parameters for the peripheral circulations were assessed to reproduce each 
patient’s real flow-split, the proximal resistances RRPA and RLPA were replaced in the 
LPN with the realistic 3D geometry of the bifurcation (multi-domain analysis coupling 
3D and 0D elements) to validate the LPN model of the 3D hydraulic characterisation.    
7.2.6 Simulation of the stenting procedure 
A virtual stenting procedure was performed in a patient with severe LPA stenosis (SG7) 
using Abaqus Explicit. The previously developed computational model of the CP stent 
with 6 crown (Section 5.2.5) was modified into a 3-crown stent and was expanded using 
a uniform pressure (1.0 Pa) in the patient-specific reconstructed LPA anatomy (arterial 
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wall surface) to relieve the stenosis (Figure 7.4a-b). The patients’ arterial wall was 
modelled as a shell with 11,360 triangular elements with reduced integration (S3R) and 
linear-elastic material properties from literature (E=0.7 MPa; ν=0.25) (41; 150). A 
contact algorithm was activated between the outer surface of the stent and the inner 
surface of the LPA.  
          
Figure 7.4 - Simulation of stenting procedure for patient SG7: FE stent expansion in the 
narrowed LPA (a and b), and extraction of the resulting blood volume after 
stenting (c). 
The resulting blood volume with no LPA stenosis was extracted (Figure 7.4c) and 
remeshed with tetrahedaral elements of the same size of the non-stented volume (0.5 
mm element size) to run a new CFD analysis in order to characterise the new RLPA and 
RRPA after stenting. These new values were inputted in the LPN representing the patient 
without changing the peripheral resistances and compliances to assess the acute 
hemodynamic outcomes of the stenting procedure. 
7.3 RESULTS 
7.3.1 Characterisation of the proximal resistances RRPA and RLPA 
The coefficients of the pressure drop equations (equations 1 and 2) over each branch 
were estimated for each patient. Both branches of the 5 CG patients were best 
represented through linear relationships. 5 out of 9 SG patients were modelled with one 
linear (RPA) and one non-linear (LPA) relationship, while in the other 4 and in BPS, 
both branches were represented with non-linear equations. 
In the stenotic vessels, the same non-linear equation best-fitted the results of both the 
steady and the unsteady simulation. In the non-stenotic branches, the unsteady 
a) b) c) 
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simulations showed the presence of a hysteretic cycle, due to inertial effects, with a 
width proportional to the diameter of the vessel. Values of inertia L, estimated from
, were in good agreement with literature data (126; 148). In steady 
simulations, the inertial effects are not included, but it emerged that the best-fitter was 
located in the centre of the hysteretic loop of the unsteady results (Figure 7.5 and Figure 
7.6). Satisfactory results were obtained without the inclusion of the inertial parameter in 
the LPN; therefore, the inertial contribution in the networks was discarded to reduce 
computational time.  
 
 
Figure 7.5 - Characterisation of the hydraulic resistances for the BPS patient: results of steady 
and unsteady simulations superimposed for the RPA. 
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Figure 7.6 – Characterisation of the hydraulic resistances for the BPS patient: results of steady 
and unsteady simulations superimposed for the LPA. 
 
7.3.2 Peripheral PVR remodelling 
The difference between the flow resulting from the LPN simulations in the hypothesis 
of no remodelling and the patients’ flow measured from MR in SG cases is depicted in 
Figure 7.7. The LPN left artery flow was lower than the measured flow meaning that if 
there was no change in the peripheral PVR, the flow to the stenotic LPA should be 
lower due to the presence of the unilateral stenosis as expected. In two patients, SG3 
and SG5, the estimated left flow was slightly higher than the measured one (2% and 7% 
respectively), suggesting that some peripheral remodelling may occur even in the 
opposite direction, thus further unbalancing the flow split. However, such small 
differences may also be ascribed to errors in flow measurements. 
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Figure 7.7 - Flow-split calculated as percentage of flow going to the LPA. Comparison between 
the flow split clinically measured (black bars) and the flow-split obtained from 
the LPN simulation in the hypothesis of no remodelling with PVR ratio set to 
55:45 between LPA:RPA (white bars). Patients ordered according to the 
increasing degree of LPA stenosis. The range of physiological flow-split values 
is highlighted by the black horizontal dotted lines. 
7.3.3 Characterisation of the peripheral parameters 
The six LPN simulations with varying total peripheral PVR, showed, as expected, that 
with the increase of the total resistance, the contribution of the geometry on the flow-
split become less important. The percentage resistance imposed on the left side to obtain 
the desired flow-split is reported as a function of the chosen total PVR, for the CG and 
SG patients in Figure 7.8 and Figure 7.9 respectively. In the CG patients, the branch 
resistances slightly changed with increasing PVR, but in general, from 2 WU, the 
geometry did not have an influence on the flow split. In the SG group of patients, a 
more complex behaviour arose. Indeed, in one of these patients – that with the most 
severe degree of stenosis (SG9, 70%) – it was not possible to reach the measured flow-
split for low values of PVR, as the geometry completely overcame the effect of the 
peripheral resistances in the determination of the flow-split. Although the trend of the 
remaining eight patients was similar to that of CG, some differences were noticed: in 
some cases (SG2, SG3, SG4, SG5 and SG6), the measured flow split was reached with 
PVR almost balanced between the two branches also for low total PVR; in other 
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patients (SG1, SG7 and SG8), the resistance distribution between right and left side to 
reach the desired flow split was particularly asymmetric at low PVR. At higher levels of 
PVR (>4 WU), the percentage of resistance on the left side tended to be equal to the 
value that the left resistance would assume if the 3D geometry was symmetric (Figure 
7.9).  
In terms of pressure, with the increase of total PVR, the pressures raised in both 
branches as shown in Figure 7.10 for CG and Figure 7.11 for SG. 
The hypothesis of total PVR  4 WU was discarded as the resulting mean pressures 
from the simulations were physiologically unacceptable (48; 143). In addition, for SG9, 
the flow-split was reached for a minimum of total PVR = 2 WU with physiological 
resistance distribution between LPA and RPA, but this total PVR was not sufficiently 
low to determine acceptable values of pressure.  
 
 
Figure 7.8 - Control patients: percentage resistance imposed on the left side to obtain the 
desired flow-split reported as a function of the chosen total PVR. 
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Figure 7.9 - Stenotic patients: percentage resistance imposed on the left side to obtain the 
desired flow-split reported as a function of the chosen total PVR. In the legend, 
the LPA stenosis degree is reported for every patient. 
 
 
Figure 7.10 - Mean and systolic pressure obtained at LPA and RPA as function of total distal 
PVT averaged over the control group. 
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Figure 7.11 - Mean and systolic pressure obtained at LPA and RPA as function of total distal 
PVT averaged over the stenotic group. 
For BPS (Table 7.2), the flow-split obtained with peripheral resistances of the network 
calculated from the catheterisation pressure data was 51:49 in favour of the LPA, equal 
to a difference of 1% with the clinical data (52:48) (Figure 7.12 and Figure 7.13). 
Clinical mean pressures were satisfactorily approximated by the LPN obtained by 
blindly tuning the parameters: for total distal PVR = 1 WU, PLa and PRa averaged over 
one cardiac cycle resulted both equal to 15 mmHg, while the pressures measured from 
catheterism were 14 mmHg at both sides. The LPN with peripheral resistances 
calculated from the catheterisation satisfactorily approximated the clinical mean 
pressures in both the left and right branch (6.7 and 7.1% of difference respectively). 
Systolic peaks were slightly overestimated in the LPN by 3 mmHg in the LPA and 2 
mmHg in the RPA, while diastolic pressures were underestimated by 5 mmHg for the 
LPA and 4 mmHg in the RPA. 
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Table 7.2 - Flow split and pressure at LPA and RPA of the BPS patient: clinical 
measurements are compared with the LPN values obtained in case of blind 
tuning of the peripheral resistances and in case of peripheral resistances 
imposed from catheterisation pressure data. 
 
Clinical data  
 
LPN with tuned 
peripheral R 
(PVR=1 WU) 
LPN with 
calculated 
peripheral R 
QLPA [%] 52 52 51 
QRPA [%] 48 48 49 
PLA [mmHg]  14 (24/12) 15 (28/7) 14 (27/7) 
PRA [mmHg] 15 (23/12) 15 (29/7) 13 (25/8) 
 
Results from multi-domain simulations were compared with the respective LPN 
simulations, ensuring the correct representation of the fluid dynamics in the 
bifurcations, in terms of flow-splits (Table 7.3), of pressures (Table 7.4), and of flow 
curves (Figure 7.12 and Figure 7.13). The maximum % difference between the flow-
splits averaged over one cardiac cycle obtained with the LPN and the multi-domain 
models was 6% for SG3. The pressure values obtained (Table 7.4) were within a 
physiological range (48; 143).   
Table 7.3 - Comparison of the flow split between LPA and RPA obtained (i) clinically, 
(ii) with the LPN simulation and (iii) with the correspondent multi-domain 
(MD) simulation for the stenotic patients. 
 
Measured LPA 
flow [%] 
LPN LPA flow 
[%] 
MD LPA flow 
[%] 
SG1 53 53 49 
SG2 43 43 40 
SG3 32 31 37 
SG4 38 37 36 
SG5 33 33 29 
SG6 50 50 48 
SG7 52 52 48 
SG8 35 35 37 
SG9 38 38 36 
BPS 52 52 52 
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Table 7.4 - Comparison of LPA and RPA pressures obtained with the LPN simulation 
and with the correspondent multi-domain (MD) simulation for the stenotic 
patients. 
 LPA pressure [mmHg] RPA pressure [mmHg] 
 LPN MD LPN MD 
SG1 12 (22/8) 11 (21/8) 15 (38/8) 15 (42/2) 
SG2 12 (21/6) 12 (21/5) 14 (33/5) 14 (33/5) 
SG3 14 (27/7) 15 (33/7) 17 (38/7) 16 (36/7) 
SG4 15 (34/7) 14 (29/8) 18 (52/7) 18 (46/8) 
SG5 13 (24/6) 13 (22/6) 13 (26/6) 14 (28/7) 
SG6 16 (30/7) 18(37/6) 18 (34/6) 20 (42/5) 
SG7 11 (16/6) 11 (16/7) 17 (36/5) 18 (36/4) 
SG8 9 (14/7) 10 (17/5) 19 (48/6) 21 (56/3) 
SG9 12 (21/7) 14 (25/7) 30 (100/5) 34 (106/8) 
BPS 15 (28/7) 14 (28/8) 15 (29/7) 15(30/8) 
 
 
Figure 7.12 - Flow curve in the LPA of the BPS case. Comparison between the measured 
clinical flow, the LPN simulated flow and the one obtained with a multi-domain 
(MD) simulation. 
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Figure 7.13 - Flow curve in the RPA of the BPS case. Comparison between the measured 
clinical flow, the LPN simulated flow and the one obtained with a multi-domain 
(MD) simulation. 
7.3.4 Computational Stenting 
The stent was successfully expanded in SG7’s LPA to fully relieve the stenosis. The 
newly patent proximal LPA and the proximal RPA resistances were characterised and 
inputted in the LPN of the patient representing the pre-stenting peripheral circulation. 
The new flow-split between right and left pulmonary artery was unbalanced towards the 
LPA (68%) while the pre-stenting flow split was 52:48 in favour of the LPA, which 
denoted a more balanced condition despite the presence of the stenosis. 
7.4  DISCUSSION 
In this work, the fluid dynamics that develops in the pulmonary circulation of TGA 
patients after ASO was studied using clinical MR images and computational tools. Two 
groups of patients, with and without LPA stenosis, were analysed and compared. In 
addition, a patient with bilateral pulmonary artery stenosis was included in the study as 
a validation case for the proposed methodology since he underwent diagnostic catheter 
procedure a few months after the MR examination. The adopted computational 
methodology allowed for patient-specific characterisation and quantification of 
peripheral vascular resistances thus helping our understanding of unilateral pulmonary 
artery stenosis hemodynamics.   
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The morphological reasons for the development of LPA stenosis as a result of ASO in 
TGA patients are well known, and are connected to the Lecompte manoeuvre that 
requires pulling of the LPA to anastomose the PT to the RVOT when the aorta is moved 
posteriorly (42). However, the hemodynamic physiology that develops in the presence 
of such stenosis has not been fully investigated. Indeed, the discrepancy between 
expected unbalanced flows in the pulmonary branches due to the presence of a stenosis 
and the effective measured flow distribution, which in some cases results balanced, has 
not yet been explained. The widely accepted hypothesis for this phenomenon is that 
remodelling has occurred in the peripheral resistances of the pulmonary bed, but only 
invasive pressure measurements could validate this hypothesis.  
A methodology involving patient-specific LPN and CFD simulations based on MR data 
was developed in this study to overcome the difficulty in acquiring pressure data 
invasively while still trying to explain the hemodynamics in unilateral pulmonary artery 
stenosis. Patient-specific geometries of the main and proximal left and right pulmonary 
arteries were reconstructed from MR data. Steady-state CFD simulations were set up to 
characterise the hydraulic resistances of the proximal pulmonary system; hence, an LPN 
was adopted to represent the full pulmonary circulation and characterise the range of 
peripheral resistances in every patient using only MR derived flow data. Finally, 
stenting implantation was virtually simulated in a severely stenotic LPA to assess the 
immediate post fluid dynamic outcomes of such intervention. 
Patients with no stenosis (CG) behaved as expected in the computational analyses 
showing little influence of the proximal geometry on the flow split for any total PVR. In 
the stenotic patients (SG), increased total PVR resulted in a decreased effect of the 
stenosis, differently for each patient. The BPS case demonstrated that the developed 
framework was able to capture the hemodynamics of these patients, as the simulated 
pressures and resistances were in the correct range for that patient.      
Numerical simulations allowed first to evaluate the difference between the measured 
MR flows and the flow split that should be expected if no remodelling occurred in the 
patients. Clearly, results highlighted the amount of peripheral pulmonary vasculature 
remodelling necessary to explain the unexpected clinically measured flow-split 
Ballooning and/or stenting of arterial stenoses are conventional treatments to relieve the 
obstruction in most vasculature sites in order to decrease the pressure drop across the 
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stenosis and re-establish good flow. However, in the setting of unilateral pulmonary 
artery stenosis treatment remains controversial, as in some cases balanced flow 
distribution between the PAs is measured despite the presence of the severe 
obstructions. Timing of intervention may also present an important factor to consider in 
the long term management of these patients. Indeed, stenting simulation in a patient 
with severe stenosis but well balanced flow split showed how the morphological relief 
of the obstruction worsened the hemodynamic conditions in the immediate post-
operative scenario.  
Peripheral pulmonary vascular remodelling in pulmonary artery stenosis has not been 
fully explained yet. Thus, it is not well known whether such phenomenon is related to 
vasodilatation of the lung vasculature in the stenotic side, vasoconstriction of the contra 
lateral side, or a combination of the previous two adaptation mechanisms. The model 
developed in this work is purely mechanical, not accounting for any cellular level 
information and cannot also distinguish between these two phenomena. . 
 
In a patient with severe stenosis, it was not possible to identify the correct parameters to 
simulate the in-vivo hemodynamic conditions. A source of error for the proposed 
methodology was individuated in the 3D reconstruction of the PAs at the level of the 
narrowing. Indeed, for this patient, the voxel size of the MR images was comparable to 
the dimension of the LPA vessels in the obstruction area (1.5 x 1.5 x 1.5 mm voxel size 
vs 3.4mm vessel diameter) therefore introducing a potential error in the proximal 
resistance characterisation which uses the 3D CFD model. To investigate the influence 
of the reconstruction process on the fluid dynamic outcomes, the geometries should be 
re-analysed by changing the threshold selected to calculate the 3D volume.  
7.5 CONCLUSIONS 
The fluid dynamics in the pulmonary system of a cohort of patients who underwent 
ASO, presenting the long term complication of pulmonary branch stenosis, was 
successfully modelled using CFD, LPN and multi-domain simulations. In particular, 
CFD analyses were used to set-up patient-specific pure LPNs, and multi-domain 
simulations were performed to confirm the accuracy of these pure LPN models. The 
integration of the above mentioned tools allowed the estimation of the peripheral PVR 
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remodelling in the cohort of patients by using only non-invasive MR measurements. 
The workflow was verified simulating a patient case with pressures known from 
catheterisation.  
Furthermore, a virtual stent implantation in one patient with LPA severe stenosis was 
carried out, allowing the evaluation of the acute post-operative outcomes after stenosis 
relief. 
In the next chapter, the framework here developed for the creation of patient-specific 
LPNs from steady-state CFD simulations, and for the evaluation of the fluid dynamic 
outcome after a stent implantation will be applied for the modelling of a clinical case of 
CoA. In particular, the model presented in the next chapter was created to the purpose 
of helping the clinicians in deciding size and position for a safe stent expansion in the 
patient’s aorta, accounting for the effects the stenosis relief will have on the patient’s 
hemodynamics.  
 
  
CHAPTER 8 
COMPUTATIONAL MODEL OF CoA STENTING:     
A PATIENT-SPECIFIC CASE 
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8.1 INTRODUCTION 
The study presented in this chapter integrates all the different modelling techniques 
applied in the previous Chapters (from 4 to 7) with the aim of creating a model to guide 
treatment in a patient with recurrent CoA (Section 2.6). Several image analysis 
methodologies (MR, CT, fluoroscopy and echo) discussed in Chapter 3 are adopted in 
this study to develop the 3D model of the patient’s aorta, and to derive the patient-
specific boundary conditions to be applied to the computational models. The approach 
introduced in the previous chapter for the hydraulic characterisation of the 3D geometry 
through CFD analyses is used for the creation of a LPN representative of the anatomy of 
interest. FE simulations are utilised as in Chapters 5 and 7 to virtually expand a stent, in 
this case up to different final diameters in order to assess the optimal interventional 
strategy for this specific patient.  
In literature, computational studies have investigated the hemodynamics in CoA 
anatomies not only to understand physiology and pathogenesis occurring at the diseased 
zone, but also to predict the effects of different treatments. In this context, models of 
patient-specific anatomies have been aiming at providing better understanding of long 
term morbidity and outcomes of current treatments. CFD analyses have replicated 
realistic conditions including geometric characteristics, physiological boundary 
conditions, and compliance of arterial walls. According to the state of the art, not all 
these factors could be implemented in a single model. However, CFD analyses have 
already offered better insights of specific scenarios. For example, the study by LaDisa et 
al, focused on the patho-physiology of CoA, and showed the differences between 
control subjects and different surgically repaired cases of CoA in terms of wall shear 
stresses distributions. The results showed that in addition to any pre-existing alterations 
in vascular function, locations involving the surgical correction are often those 
associated with potentially deleterious alterations in indices of WSS (149). In this 
scenario, another study by LaDisa’s group investigated less invasive treatments as the 
percutaneous implant of stent. CFD analyses were focused on understanding the impact 
of different stent types on blood flow patterns in the descending thoracic aorta. The 
results highlighted greater WSS along the posterior wall of the descending thoracic 
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aorta distal to the stents as well the anterior wall exposed to low WSS, generally 
associated with the onset and progression of cardiovascular disease (149).  
However, to the best of my knowledge, in literature there are no prospective studies in 
which a developed computational methodology has been applied to predict the results of 
an intervention and support the clinician decision making process for a specific patient 
case. This step is usually complicated by the need for a validated and computationally 
demanding framework on one side and reduced time-frame combined with difficulties 
of translating the available clinical data towards the model, on the other. In this chapter, 
I report the results of the application of the patient-specific methodologies that I have 
developed during my PhD project to optimise the treatment strategy for a patient with 
CoA.  
8.2 MATERIALS AND METHODS 
8.2.1 Patient’s clinical history 
The patient is a 19-year-old male with native CoA and aberrant right subclavian artery 
(ARSA) originating in correspondence of the narrowing (Figure 8.1).  
 
Figure 8.1 - 3D rendering of the patient’s aorta with the origin of the aberrant right subclavian 
artery indicated by the arrow. 
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The coarctation was first treated in 2001 with a Palmaz P308 stent (Johnson & Johnson 
Interventional Systems Co., Warren, NJ) successfully implanted to relieve the pressure 
gradient. In 2007, the patient underwent a first re-dilatation of the bare metal stent that 
reduced the peak systolic pressure gradient across the stent from 13 to 8 mmHg. In 
2011, follow-up catheter examination showed recurrent obstruction (9 mmHg gradient) 
and the formation of a small aneurysm in the proximal portion of the stent (Figure 8.2). 
The risk of aneurysm rupture prevented the clinician to further re-dilate the stent and 
insertion of a covered stent was discussed, but postponed after further investigations 
because of the ARSA origin positioned in the distal portion of the Palmaz stent. After 
this catheterisation procedure, additional image assessment was carried out including a 
CT scan to allow full anatomical understanding of the relationships between the bare 
metal stent, the aneurysm and the ARSA origin, and an MR investigation to assess the 
hemodynamics.  
 
Figure 8.2 - Aortogram showing the presence of an aneurysm indicated by the arrow. 
The CT parameters were the following: pixel size = 0.799 x 0.799 mm with slice 
increment = 0.499 mm; scanning parameters: 100 kV and 145.3 effective mAs per 
rotation. 
MR imaging was performed and analysed as explained in Section 3.4.1.1. In particular, 
2D phase contrast MR images for flow measurements were acquired at the following 
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planes (Figure 8.3): in the sino-tubular junction (STJ), in the ascending aorta (AA), at 
all brachio-cephalic branches originating from the aortic arch (the right common carotid 
(RCC) artery, the left common carotid (LCC) artery, the left vertebral (LVERT), the left 
subclavia (LSUB), the ARSA) and in the descending aorta (DA), soon after the stent 
position and at the level of the diaphragm (DIAG). Flow averaged over one cardiac 
cycle in the AA was 5.25 l/min (distributed according to the following proportion in the 
other vessels: RCC = 8.84%, LCC = 3.79%, LVERT = 1.73%, LSUB=4.65%, ARSA = 
9.52% and DA=71.47%).    
 
Figure 8.3 - Diagram of the planes set for the MR flow acquisitions in the patient’s aorta.  
The additional image information allowed the development of a patient-specific 
modelling framework which together with the set of conventionally acquired clinical 
data, gave confidence to the cardiologists to treat the patient with the insertion of a 
covered stent. The intervention was performed under general anaesthesia and 
AA 
STJ 
RCC 
LCC LVERT 
LSUB 
ARSA 
DA 
DIAG 
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angiographic guidance. Pressures were measured in the aortic arch, descending aorta, 
ARSA, and across the treated CoA before and after the intervention.  
After 3 months, MR follow-up was performed to assess the hemodynamic conditions. 
8.2.2 Patient-specific model 
The interventional cardiologists at our Centre planned to implant a covered CP stent 
inside the CoA region to relieve the stenosis and cover the aneurysm, without 
obstructing the origin of the ARSA. They asked for advice from the engineering team 
working in the Unit to work out the optimal deployment diameter for the covered stent 
in order to achieve those results. Therefore, in less than two weeks from when the 
additional image assessment was performed to the time of intervention, I implemented a 
patient-specific model which aimed i) to identify and predict the optimal stent size in 
order to achieve an optimal compromise between gradient relief, aneurysm treatment 
and ARSA origin patency, thus helping the cardiologist in the decision making process; 
and ii) to compare the results of the modelling prediction with the real outcomes of the 
actual procedure in the patient, in order to evaluate the ability of the developed 
framework in predicting realistic clinical outcomes.  
Prior to the new procedure, clinically acquired image data were used to set-up both 
structural and CFD analyses (Figure 8.4). Previous catheterisation fluoroscopy images, 
CT and echo data were used to build the 3D computational model of the implantation 
site prior to the procedure; the hemodynamic boundary conditions for this model were 
set up using information acquired from pre-procedural MR and catheterism 
examinations. Following stent implantation, the procedural and follow-up data were 
used to compare the real outcomes with the model results in order to assess the 
modelling framework accuracy. In particular, stent size and position were verified using 
the procedural fluoroscopy images – the in-vivo CP stent geometry was reconstructed 
from the biplane fluoroscopy images as described in Section 4.2.1.3 – flow distribution 
and flow waveforms using the follow-up MR images, and pressures using the 
catheterisation data.  
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Figure 8.4 - Imaging data available to set-up the computational model: a) CT, b) MR, c) 
fluoroscopy, and d) echo data.  
 
8.2.3 Anatomical model 
Segmentation of the CT images was performed with Mimics (Section 3.5.1) to create 
the 3D geometry of the patient’s aorta and indwelling bare metal stent. Previous 
fluoroscopy and echo images were used to guide the reconstruction of the stenotic site, 
as ingrowth tissue was not visible from the CT images (Figure 8.5). In particular, echo 
measurements at the level of the narrowing highlighted a peak velocity (v) of 3.6 m/s, 
which was used to estimate the cross-sectional lumen area in this portion of the vessel. 
 
a) b) 
c) d) 
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Figure 8.5 - 3D model of the patient’s aorta with the previously implanted Palmaz stent 
reconstructed from CT images. The tissue growth inside the stent is indicated by 
the arrow. 
A 3D rapid prototyped model was printed (Figure 8.6) to aid the clinicians understand 
the 3D complex morphology and gain confidence in the interventional procedure. The 
model was built using a transparent and robust resin (Watershed 11122; DSM Somos, 
Elgin, IL) for the aortic wall, and an opaque rigid Nylon for the inner stent.  
 
Figure 8.6 - 3D rapid prototyped plastic model of the anatomy prior to the new stent 
implantation. 
Chapter 8 Computational Model of CoA Stenting: A Patient-Specific Case 
 205 
8.2.4 Computational models 
The workflow of the modelling techniques used in this patient-specific study is 
summarised in Figure 8.7. An LPN strategy was adopted to predict in the available 
timeframe the overall hemodynamics resulting from the expansion of the stent to 
different sizes. The pre-intervention 3D model of the patient was first characterised 
using CFD analyses. An extended LPN was created to account for the downstream 
circulation and characterised using the pre-implantation MR patient flow information. 
The stent was implanted in the 3D geometry using FE simulations to obtain the post-
implantation lumen geometry for each of the tested expansion size. This new 3D 
volume was fluid dynamically characterised using CFD and the information inserted in 
the pre-implantation LPN.     
 
Figure 8.7 - Workflow adopted for the implementation of the computational model to be used in 
order to provide an answer to the specific clinical question related to the 
feasibility of the procedure. 
CFD simulations of the hemodynamics before and after the stent implantation were 
carried out using Ansys Fluent with the discretisation schemes and the convergence 
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criteria indicated in Section 3.5.2.1. The vessels of the 3D model were assumed to be 
rigid, and a no-slip condition was imposed at the walls. For the unsteady simulations a 
time-step of 10
-4
 s was applied, and five cardiac cycles were performed to ensure 
stability in the calculated solutions. The blood was modelled as a Newtonian fluid with 
a density ρ of 1060 kg/m3 and a viscosity μ of 0.003 Pa∙s. 
LPN equations were set-up as discussed in Section 3.5.2.2, and in order to guarantee a 
stable solution twenty cardiac-cycles were simulated, selecting the last one for post-
processing the results. 
8.2.4.1 Fluid dynamic model pre-intervention 
The 3D pre-operative anatomy was modified for the CFD simulations by adding 
cylindrical flow extensions to the outlets to assure a fully developed flow at those 
sections, in order not to force the chosen boundary conditions. Different tetrahedral 
element meshes were built using an adaptive mesh refinement to increase the accuracy 
of the solution in the regions of larger pressure variations. A sensitivity analysis was 
performed to select the optimal mesh that compromised between solution accuracy and 
computational time. The decision was based on the evaluation of the power dissipation 
index, calculated as in Pennati 2011 (126), in steady-state CFD analyses: the flow-rate 
measured from MR data in the ascending aorta, averaged over one cardiac cycle, was 
imposed at the inlet of the model, while the MR calculated flow split, averaged over one 
cardiac cycle, was imposed at the outlets. A mesh of 910,329 volumes was finally 
selected to run the simulations.  
In order to characterise the geometric resistances to the blood flow, a set of CFD steady 
simulations was carried out imposing 8 different velocities (0.05, 0.1, 0.2, 0.3, 0.5, 0.7, 
0.8, 0.9 m/s) at the inlet of the aorta, and a zero pressure condition at all outlets. 
Pressure drops (ΔP) were measured in every simulation between the aortic inlet and the 
aortic arch, and between the aortic arch and all outlets. Such pressure drops were 
divided by the flow-rate (Q) streaming through every branch. Plotting the results of all 
simulations in a pressure drop-flow graph, the data points were interpolated with either 
a linear or a second order polynomial equation (Section 7.2.3), to characterise the 
hydraulic behaviour of the whole 3D geometry for different flow-rates. 
The obtained equations were then used to implement a LPN representative of the pre-
operative 3D aortic anatomy of the patient (Figure 8.8).  
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Figure 8.8 - LPN representation of the 3D pre-operative aortic arch of the patient. 
The equivalence between the 3D CFD and the LPN representation of the aortic arch and 
upper branches was verified by performing a time-variant simulation with equal 
boundary conditions with both models. The patient’s pre-operative aortic flow, as 
measured from MR was imposed at both inlets, while a zero-pressure was imposed at all 
outlets. The results were then compared in terms of flow distribution, flow waveforms 
at the outlets and mean pressure.  
The LPN model was then expanded to simulate the whole pre-operative systemic 
circulation of the patient with the addition of 2 two-element (RC) Windkessel blocks 
per branch, representative of the arteriosus and venous systemic compartments. All 
branches were connected to the right atrium with 5 mmHg constant pressure (Figure 
8.9). The resistive and compliant parameters were tuned in order to achieve the same 
flow split and flow curves at the outlets of the patient, when the patient’s inflow was 
imposed at the inlet of the LPN model.   
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Figure 8.9 - LPN of the systemic circulation of the patient prior to the procedure. 
8.2.4.2 Finite element model of the intervention 
A computational model resembling a crimped covered CP stent was built including 5 
platinum-iridium rings and Gore-Tex® graft (Figure 8.10a). Two-dimensional beam 
elements were used to mesh the stent (2,464 beams), while membrane elements were 
adopted for the graft (23,008 quadrilateral elements). In this study, the beam elements 
were adopted to model the stent because of their fast computational time response 
compared to solid elements (150). The geometry of the Palmaz stent in-situ, was 
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obtained from the CT reconstruction, and a FE mesh of such deployed stent was created 
with 2,017 beam elements (Figure 8.10b). The arterial wall model interacting with the 
stents was built using 41,199 triangular shell elements. In addition, an angioplasty 
balloon model (diameter = 3.5 mm) was created using surface elements to be kept 
inflated in the ARSA during the implantation of the covered stent to further protect the 
patency of the ARSA origin according to the protocol planned by the clinicians for the 
procedure (Figure 8.11). The material models and parameters adopted for the different 
FE structures are reported in Table 8.1. 
Table 8.1 - Material properties used for the FE simulation. 
 Material Model E [MPa] ν [-] 
CP stent 
Platinum-
Iridium 
Elasto-plastic 
224000 0.37 
CP graft Gore-Tex® Elastic 500 0.3 
Palmaz stent Stainless Steel Elastic 193000 0.3 
Wall (150) Artery Elastic 0.7 0.25 
Balloon (ARSA) Nylon Elastic 450 0.45 
 
  
Figure 8.10 - Computational model of the covered stent (a) to be implanted inside the patient’s 
aorta (b). 
a) b) 
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The covered CP stent implantation procedure was simulated using Abaqus/Explicit. 
Quasi-static conditions were verified: values of kinetic energy were 5% times lower 
than the internal energy according to Abaqus Simulia user’s manual. Contact constraints 
were imposed i) between the outer surface of the CP stent and graft, and the inner 
surface of the Palmaz stent and of the arterial wall; and ii) between the outer surface of 
the balloon, and the inner surface of the ARSA and the outer surface of the CP stent and 
graft.  
The balloon was first inflated in the ARSA using 0.05 Pa of pressure and kept inflated 
throughout the implantation of the covered CP stent. This was positioned inside the 3D 
CoA patient-specific model in correspondence to the Palmaz stent landmark following 
the interventional cardiologist guidance. Pressure loads (0.004, 0.020, 0.032, and 0.040 
Pa) were applied to the internal surface of the stent/graft to achieve four different 
expansion diameters, 14, 16, 18, and 20 mm.         
The following quantities of interest were considered: device configuration at the end of 
the stent expansion relatively to the origin of the ARSA and to the aneurysm; stress 
distribution on the arterial wall to evaluate whether an adequate contact was achieved 
between device and vessel. 
 
Figure 8.11 - Computational model of the stent expansion. Highlighted in this figure is the 
balloon inflated in the ARSA to assure its patency after the covered stent 
implantation.  
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8.2.4.3 Fluid dynamic model post-intervention  
The geometries resulting from the FE simulations were then used to build a CFD 3D 
model of the resulting post-operative lumen anatomy including the arterial wall and the 
graft (Figure 8.12). Stent struts were discarded in this lumen mesh creation as their 
influence in the flow distribution and pressure drop across the treated coarctation was 
considered small.  
        
Figure 8.12 - CFD models of the post-operative anatomies derived from the FE simulations 
after the covered stent implantation at 16 mm (left) and 18 mm (right). 
The blood volume was meshed with over 910,000 tetrahedral elements with increased 
accuracy in the regions of higher pressure difference. A wall condition was assigned to 
the surface of the graft not allowing blood-flow through it. As previously explained for 
the pre-operative geometry (Section 8.2.4.1), the 3D post-operative lumen anatomies 
were characterised hydraulically through a set of steady-state simulations. The same 
eight inflow velocities conditions as the pre-procedural simulations were imposed to 
both inlets, and a zero-pressure condition was applied to all outlets. The ratio between 
pressure drop and flow streaming through each branch allowed the mathematical 
equations describing the 3D geometries to be inferred. Particular attention was given to 
the ARSA, to evaluate if the graft was obstructing its perfusion. 
From this set of simulations a LPN was created for each post-operative aorta, and a 
time-variant simulation was run applying the same boundary conditions (patient’s pre-
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operative flow-rate applied to the inlets and zero-pressure at all outlets) to both the CFD 
and LPN models, to check the correspondence of flow waveforms and flow distribution. 
Finally, under the hypothesis of no remodelling of the peripheral vasculature after the 
intervention, the extended LPN of the pre-operative systemic circulation was modified 
to represent the post-operative scenarios: the equations representative of the pre-
operative aorta were replaced with the new equations derived for the post-operative 
aortas. Outcome fluid dynamic differences between the expansion sizes of the covered 
stent were evaluated in terms of percentage of the total flow going to the ARSA and to 
the lower body, and the pressure gradient across the treated CoA.    
8.3 RESULTS 
8.3.1 Anatomical model 
The 3D reconstruction of the patient’s anatomy allowed the full assessment of the 
patient’s morphological characteristics with aneurysm size and position in relation to 
the previously implanted stent and origin of ARSA. It also allowed identification of the 
presence of fractures in the Palmaz stent, which was not recognised before (Figure 
8.13).  
           
Figure 8.13 - 3D reconstruction of the patient’s anatomy with the previously expanded Palmaz 
stent. To be noted the aortic aneurysm (left) and the stent fractures (right). 
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8.3.2 Computational models 
8.3.2.1 Fluid dynamic model pre-intervention  
The pressure drop and flow data obtained from the steady-state simulations were used 
for the 3D hydraulic characterisation: the ΔP/Q data obtained for the upper branches 
(RCC, LCC, LVERT, LSUB and ARSA) were interpolated through linear relationships 
(ΔP=R∙Q), while the ascending and descending parts of the aorta (AA and CoA) were 
modelled through second order polynomial equations (ΔP=K∙Q2 and ΔP=a∙Q2+ b·Q 
respectively). The coefficients of such equations are reported in Table 8.4. 
The equivalence between the 3D CFD model of the aorta and the LPN of the aorta prior 
to the operation was confirmed by the results of the time-variant simulations run 
imposing the same boundary conditions to both models: Figure 8.14 and Table 8.2 
report a comparison between flow waveforms and flow-split obtained with both models.  
 
Figure 8.14 - Comparison between the flows obtained with the CFD (solid line) and the LPN 
(dotted line) models of the pre-operative aorta.  
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Table 8.2 – Flow split in the outlets of the aorta in terms of percentages of the total 
inflow for the CFD and the LPN models of the pre-operative patient’s 
aorta.  
PRE-OP 
AORTA 
CFD LPN 
QRCC [%] 16.9 17.97 
QLCC [%] 24.91 25.59 
QLVERT [%] 6.51 7.02 
QLSUB [%] 32.08 31.13 
QARSA [%] 3.44 3.43 
QCoA [%] 16.18 14.87 
 
The extension of the LPN model allowed the modelling of the full systemic circulation 
whose parameters were tuned to obtain the representation of the patient’s fluid 
dynamics. The comparison between the model and the patient’s flow data at all outlets 
and at the inlet are reported in Figure 8.15, while the flow splits are reported in Table 
8.3. The pressure difference measured across the CoA in the LPN was 8.27 mmHg, 
while that measured in-vivo was 9 mmHg.  
 
Figure 8.15 - Flow comparison at the inlet and outlet sections between the LPN model (dotted 
line) of the systemic pre-operative circulation and the pre-operative MR data of 
the patient (solid line). 
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Table 8.3 - Flow split in the outlets of the aorta in terms of percentages of the total 
inflow as measured from the patient’s MR and as calculated from the LPN 
model of the whole systemic circulation before the procedure. 
PRE-OP 
SYSTEMIC 
MR LPN 
QRCC [%] 8.84 9.71 
QLCC [%] 3.79 2.95 
QLVERT [%] 1.73 1.2 
QLSUB [%] 4.65 4.87 
QARSA [%] 9.52 9.24 
QCoA [%] 71.47 72.03 
8.3.2.2 Finite element model of the intervention 
The final aortic configuration obtained after deployment of the CP covered stent in the 
four different sizes is shown in Figure 8.16 in two different perspectives (i.e. lateral and 
sagittal views). Observing these configurations, it is possible to note how the CP stent 
expanded at 14 mm did not achieve contact around the entire structure, while the stent 
opened at 20 mm obstructed the origin of the ARSA. Contrarily, both sizes 16 and 18 
mm showed a good contact with the arterial wall with no risk of obstruction of ARSA. 
Stress distribution is reported in Figure 8.17 for the 16 and 18 mm cases, where the 
areas at higher contact are highlighted.  
                               
 
                
Figure 8.16- FE expansion of the covered stent at four different sizes. Lateral (upper panel) and 
sagittal (lower panel) views.  
14 mm 16 mm 18 mm 20 mm 
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Figure 8.17 – Von Mises stress distribution on the arterial wall after the stent expansion at 16 
mm (a) and 18 mm (b). 
8.3.2.3 Fluid dynamic model post-intervention  
The interpolation functions for the data extracted through the steady-state simulations 
with the two post-procedure 3D models (16 and 18 mm) resulted to be linear for the five 
upper branches (RCC, LCC, LVERT, LSUB and ARSA), and of the second order for 
the ascending (AA) and the descending aorta (CoA). The coefficients of such equations 
are reported in Table 8.4. 
The comparison between the outcomes obtained with the CFD post-procedure aortic 
models and the corresponding LPNs showed a satisfactory agreement in the flow curves 
(Figure 8.18 for the 16 mm model and Figure 8.19 for the 18 mm model) and flow splits 
(Table 8.5). The maximum percentage difference between LPN and CFD in terms of 
flow split was equal to 3.05% in the 16 mm model at the left subclavian artery and to 
3.51% in the 18 mm model at the descending aorta.  
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Table 8.4 - Resistance parameters set in the pre and post-operative LPN models of the 
aorta. 
 
PRE-OP 
POST-OP 
16mm 
POST-OP 
18mm 
RRCC [Pa/m
3
/s] 8.40 E+06 6.68E+06 6.30E+06 
RLCC [Pa/m
3
/s] 5.90 E+06 4.20E+06 4.7E+06 
RLVERT [Pa/m
3
/s] 2.15E+07 2.15E+07 2.00E+07 
RLSUB [Pa/m
3
/s] 4.85E+06 4.10E+06 4.44E+06 
RARSA [Pa/m
3
/s] 4.4 E+07 7.50E+07 6.75E+07 
    
aCoA [Pa/(m
3
/s)
2
] 
bCoA [Pa/m
3
/s] 
9.0E+09 
9.80E+06 
8.20E+09 
1.04E+05 
7.90E+09 
7.40E+04 
 
 
 
Figure 8.18 - Flow comparison at the inlet and outlet sections between the LPN model (dotted 
line) and the CFD model (solid line) of the post-operative aorta with the stent 
expanded at 16 mm of diameter. 
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Figure 8.19 - Flow comparison at the inlet and outlet sections between the LPN model (dotted 
line) and the CFD model (solid line) of the post-operative aorta with the stent 
expanded at 18 mm of diameter. 
Table 8.5 - Flow split in the outlets of the aorta in terms of percentages of the total 
inflow for the CFD and the LPN models of the aorta after stent 
implantation at 16 and 18 mm. 
 16 mm 18 mm 
POST-OP 
AORTA 
CFD LPN CFD LPN 
QRCC [%] 13.94 15.25 13.54 13.90 
QLCC [%] 19.97 19.59 19.42 17.77 
QLVERT [%] 4.67 4.74 4.50 4.47 
QLSUB [%] 23.02 19.97 22.01 19.73 
QARSA [%] 1.10 1.36 1.21 1.30 
QCoA [%] 37.3 39.09 39.32 42.83 
 
The LPN simulations of the complete post-procedural systemic circulation showed 
negligible differences between the 16 and the 18 mm stent expansions. In the former 
case, 5.48% of the total inflow during 1 cardiac cycle was directed to the ARSA and 
-0.00005 
0 
0.00005 
0.0001 
0.00015 
0.0002 
0.00025 
0.0003 
0.00035 
0.0004 
0.00045 
0 0.2 0.4 0.6 0.8 1 1.2 
Q
 [
m
3
/s
] 
Time [s] 
CFD LPN 
Chapter 8 Computational Model of CoA Stenting: A Patient-Specific Case 
 219 
72.69% to the lower body; the latter case presented 5.36% and 73.08% going to the 
ARSA and the descending aorta respectively (Table 8.6). 
The pressure gradient across the treated CoA was reduced to 1.91 mmHg in case of a 16 
mm stent expansion and to 1.81 mmHg in case an 18 mm stent was implanted.  
Following the results of the FE and LPN simulations, a deployment of the covered CP 
stent between 16 and 18 mm diameter was suggested to the interventional cardiologist 
for the procedure. 
Table 8.6 - Flow split in the outlets of the aorta in terms of percentages of the total 
inflow for the CFD and the LPN models of the whole systemic circulation 
after the stent implantation at 16 and 18 mm. 
POST-OP 
SYSTEMIC 
LPN 
16 mm 
LPN 
18 mm 
QRCC [%] 8.75 8.49 
QLCC [%] 4.91 4.88 
QLVERT [%] 1.82 1.73 
QLSUB [%] 6.35 6.46 
QARSA [%] 5.48 5.36 
QCoA [%] 72.69 73.08 
8.3.3 Intervention 
The procedure was successfully carried out according to the planned strategy. The 
interventional cardiologists implanted a CP covered device expanded inflating an 18 x 
45 mm balloon-in-balloon system to a final diameter of 16 mm (Figure 8.20a). This size 
was in the range suggested by the modelling analyses. 
             
Figure 8.20 - Fluoroscopy image of the covered stent implanted in the patient with a 16 mm 
diameter size (a), and 3D in-situ reconstruction with the biplane fluoroscopy 
method. 
a) b) 
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The procedural biplane fluoroscopy images were processed to obtain the 3D geometry 
and position of the CP stent in-situ (Figure 8.20b). In the axial direction, the maximum 
distance between the vertexes of the stent in the 16 mm computational prediction and in 
the reality was 2.5 mm. In terms of diameter, the difference between the two cases 
varied between 2.3 % and 6.1% measured respectively in the proximal and distal ring 
(Figure 8.22). The ARSA remained patent after stenting also thanks to the presence of 
an Opta Pro 7 x 20 mm balloon inflated in the subclavian artery during the covered stent 
implantation. Repeated angiograms showed good perfusion of the ARSA and across the 
stented CoA, as predicted by the computational analyses. Neither extravasations nor 
dissections were noted, and the patient remained stable throughout the all procedure. 
Catheter measurements before stent implantation showed no significant pullback 
pressure gradient between the ascending and the descending arch, while 15 mmHg 
pullback gradient was recorded across the existing CoA stent. The pressures obtained 
after the covered stent positioning, under general anaesthesia, were 65/42/52 mmHg 
(max/min/mean) in the ascending aorta, and 69/40/51 mmHg in descending aorta. The 
gradient from pull back measurement across the device was reduced to approximately 1 
mmHg. 
The CFD model was able to predict the reduction in pressure difference across the 
coarctation and the perfusion of the ARSA after covered stent implantation. However, 
the post-operative LPN was not able to fully capture the flow split as measured from the 
post-operative MR flow data (Table 8.7 and Figure 8.21). The maximum difference was 
recorded in the left subclavian artery: 2.92% of the total inflow from MR measurements 
vs. 6.25% from the LPN predictive model.  
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Figure 8.21 - Flow comparison at the inlet and outlet sections between the LPN model 
prediction (dotted line) and the patient’s MR data (solid line) of the post-
operative systemic circulation. 
Table 8.7 - Flow split in the outlets of the aorta in terms of percentages of the total 
inflow for the LPN models of the whole systemic circulation after the stent 
implantation at 16 and the post-operative patient’s MR data. 
POST-OP 
SYSTEMIC  
MR LPN 
16 mm 
QRCC [%] 8.93 8.75 
QLCC [%] 7.56 4.91 
QLVERT [%] 3.44 1.82 
QLSUB [%] 2.92 6.35 
QARSA [%] 4.12 5.48 
QCoA [%] 73.03 72.69 
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Figure 8.22 - Superimposition of the computational FE results and the angiographic images 
taken after the intervention. 
8.4 DISCUSSION 
In this study, a patient-specific modelling methodology was developed to help clinicians 
select a successful strategy for the treatment of a patient with recurrent CoA. This work 
showed the benefits of integrating modelling techniques into patient’s conventional 
clinical assessment to support the clinical care team and optimise treatment in complex 
cases.  
The various engineering modelling techniques adopted in this work provided different 
information to the clinicians improving their confidence in the procedure. The 3D 
reconstruction and the physical rapid prototyping model of the patient’s anatomy fully 
informed the interventional cardiologists on the 3D spatial relationships between the 
indwelling stent, the ARSA, the aneurysm and the rest of the descending aorta. 
Computational models allowed testing different scenarios in a virtual reality that 
realistically replicated the patient’s condition. The results of the virtual procedures 
could be not only visualised in 3D, but also quantified, thus enabling an extensive 
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comparison between the different procedural options to highlight the optimal stenting 
approach. The computational modelling techniques included FE analyses that were used 
to identify the most favourable stent deployment diameter for this specific CoA patient 
and to define aneurysm treatment, and fluid dynamic simulations with 3D CFD models 
and LPN equivalent systems, which confirmed that favourable hemodynamic outcomes 
would be achieved with the FE indicated stent size i.e. patency of the ARSA and 
pressure drop reduction across the narrowing.  
The modelling results were presented and discussed during the multidisciplinary 
meeting along with the rest of the conventional clinical assessment carried out for the 
patient, and formed part of the decision for this patient’s care. The study was also 
presented to the patient/parents before treatment and in the discharge letter here 
reported, underlying how the modelling framework was considered useful by the 
clinicians:  
“We had some expert help from our engineers who created a rapid prototyping three-
dimensional model of his aorta and indwelling stent, and we were able to see the 
relations of his indwelling stent to his aberrant subclavian and his descending aorta.  
We were also able to ask the engineers to perform computer modelling using 
computational analysis, and they showed that there would be room to insert an 18 mm 
covered stent whilst protecting the origin of the right subclavian with a small balloon.  
In fact, we moved forward and performed that yesterday, and it went very well.  
Following the procedure, the gradients from pull back of 15 mmHg across the stent was 
reduced to approximately 1 mmHg.” 
Importantly, in this patient-specific case, the computational models were all based on 
available clinical data routinely acquired prior to the intervention. The 3D geometry was 
reconstructed from CT images integrated with fluoroscopy angiograms and echo data. 
Fluid dynamics boundary conditions were set using MR derived flows and 
catheterisation data. However, patient’s data were collected using the different imaging 
modalities over a year time. For example, in terms of pressure, a gradient of 9 mmHg 
was used in the implementation of the pre-operative model based on the last 
catheterisation available before the procedure, which however was dated back to about 
one year before the CT and MR assessment. At the time of cover stent implantation, the 
Chapter 8 Computational Model of CoA Stenting: A Patient-Specific Case 
 224 
pressure gradient was increased up to 15 mmHg, showing progression of the occlusion 
in the region of the CoA. 
The modelling results were compared with the procedural and follow-up clinical data to 
evaluate the reliability of the developed computational framework in predicting stenting 
outcomes. FE results differed by a maximum of 6.1% in terms of expansion diameter 
compared to the real stent expansion as reconstructed from fluoroscopy images. Fluid 
dynamic outcomes were in satisfactory agreement with the values of pressures 
measured during the catheterisation at the end of the procedure, and the flows from 
follow up MR. The largest difference between computationally predicted and real flows 
was registered in the left subclavian artery (3.4%). Once again, it must be considered 
the timing of post-operative MR examination that was performed three months after the 
intervention. In this period, the patient’s vascular resistances may have remodelled, 
adapting to the new flow regime and consequently the flow distribution among the 
vessels could have changed accordingly. 
In the light of translating results of computational analyses to meet clinical needs, some 
modelling simplifications were adopted in order to translate computational analysis 
results to clinical inputs and effectively meet clinical needs such as the limited time for 
producing the requested results. LPNs were preferred to multi-domain simulations as 
their computational time is conspicuously reduced. This approach did not allow for 
visualisation of the local fluid dynamics, but the parameters of interest to answer the 
clinical question were still represented. The definition of the LPN through CFD 3D 
model characterisation and peripheral parameter tuning was  time consuming but, once 
set up, presented the advantage of allowing very fast simulation of several different 
scenarios by tuning of a limited number of parameters. With regards to FE simulations, 
a beam formulation was preferred to the conventional solid element formulation to 
model the stent structures. Also in this case, fast simulation response was favoured over 
accuracy of the results in terms of stress distribution in the stent. The FE analysis was 
designed to predict the final configuration of the stented aorta and obtain the lumen after 
the procedure to use as an input in the CFD 3D model, which could be achieved with 
the use of beams to model the stent. An accurate 3D distribution of stress parameters 
which could be used to evaluate the stent mechanical performance is not provided by 
beam elements, but this evaluation was not required.  
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8.5 CONCLUSIONS 
The case study presented in this chapter has allowed me to apply most of the image 
methodologies and engineering tools that I have analysed, developed, tested, and 
validated during my PhD programme to support clinicians in treatment planning for a 
specific patient, and has shown how engineering models can be successfully applied to 
real prospective clinical cases. 
The key aspects for successful patient-specific modelling emerged from this work: 
- Access to a wide range of clinical data 
- Use of fast and validated engineering methodologies 
- Strong collaboration between clinicians and engineers. 
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9.1 OVERVIEW 
The overall aim of this work was the application of engineering tools to clinical practice 
in the sphere of patient-specific modelling. During my PhD, I was in the privileged 
position of working in an engineering team based in the Cardiorespiratory Unit of Great 
Ormond Street Hospital for Children. Hence, this Thesis is the result of a continuous 
close collaboration between engineers on one side and clinicians on the other, sharing  
ideas, better understanding the mutual skills and needs, exchanging advices, influencing 
each other decisions, with the common objective of delivering better solutions to the 
patients and improve healthcare.  
The general idea of this Thesis was to provide an overview of the current methodologies 
available to the bioengineers to build patient-specific models and frameworks in the 
cardiovascular field, to verify their accuracy and to validate them. From this, the work 
has found application of such tools to a few clinical areas of interest and cases to answer 
specific clinical questions in the context of congenital heart disease. 
Cornerstone of the research was to comply with the principles of translational research, 
“from bench-to-bedside”: this approach leads directly from computational models and 
laboratory experiments through clinical research to patient care. Such research does not 
require to produce extremely complex models, but rather adaptable, simpler and faster 
tools that have practical benefits and can be used to improve the clinician’s delivery of 
patient care. For this reason, some of the modelling methodologies implemented in this 
Thesis privileged clinical applicability to complexity, according to the needs and the 
time available to set-up the models. 
Exemplar application of translational research is the patient-specific model required by 
the clinicians to support their decision-making process presented in Chapter 8. The time 
available to set-up the model was less than two weeks. Therefore, fast computational 
approaches were needed to solve the problem and answer the clinical question in a 
timely manner. In this case, the clinical question was related to the feasibility of an 
interventional procedure to relieve the pressure drop experienced by a patient across his 
previously stented CoA. Complications were represented by the presence of an 
aneurysm and of the origin of the subclavian artery at the location of the implantation 
site. The clinical decision was to deploy a new covered stent inside the previous one to 
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treat the aneurysm, but this intervention had the risks of covering the access to the 
aberrant subclavian artery of the patient, originating at the level of the CoA. Hence, the 
question of the clinicians regarded the position and the best size for the covered stent to 
be deployed in order to relieve the pressure drop, cover the aneurysm, and leave the 
subclavian artery patent. The engineering approach in this case was to reconstruct the 
pre-operative 3D anatomy of the patient’s aorta from clinically acquired images; to use 
3D CFD steady-state analysis to derive hemodynamic information on the studied pre-
operative geometry then converted in a fast 0D LPN; to simulate with FE method and a 
fast beam element formulation the stent deployment at different sizes; to convert these 
post-operative anatomies in LPNs (through CFD simulations) in order to investigate the 
fluid dynamic outcomes of the different interventional choices, and finally select the 
best compromise between pressure drop release and vessel perfusion. In this case, a 
positive outcome resulted from the modelling approach, as the clinicians, driven by the 
engineering results, successfully treated the patient. 
Engineering tools not only can be helpful in the clinical decision-making process, but 
they could also provide useful information on how to understand specific phenomena 
and subsequently tailor follow-up for each patient. An example of this is the study 
conducted on the patient population of 42 individuals who underwent PPVI, reported in 
Chapter 5. This case was different from the previous in terms of modelling choices, as 
time was not an issue. Aim of this research was the individuation of those factors 
responsible for PPVI stent fracture, and the implementation of a statistical model able to 
identify the risk of device failure for a specific patient just using imaging information 
routinely acquired during the procedure. The statistical rule created on a cohort of 42 
patients used in-situ stent geometrical parameters and their variation measured during 
the deployment and the cardiac cycle. The geometry of the expanded stent in-situ was 
derived by means of a newly tested approach that allows the 3D stent to be 
reconstructed from biplane fluoroscopy images. Such reconstruction process and its 
accuracy were validated in Chapter 4. Also, fluoroscopy imaging outcomes were 
compared to those of other static imaging methods, such as micro-CT, CT and stereo-
photogrammetry (however limited by its exclusive in-vitro usage). Also, Chapter 4 
assessed the biplane fluoroscopy method for capturing dynamic deformations of a stent. 
Indeed, its accuracy was compared with that of 4DCT, confirming the value of this new 
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approach. Therefore, patient-specific stent deformation can be extracted from 
fluoroscopy acquisitions and imposed to the FE model of a stent to realistically replicate 
the deployment history and in-situ loading conditions. Outcomes of these simulations 
can provide valuable information on the stresses experienced by the device not only 
during implantation but also from a fatigue point of view. The statistical model 
developed only on geometrical parameters successfully predicted the stent fracture in 
90% of the analysed patients. While the combination of geometrical parameters and FE 
results permitted the implementation of a statistical model with 93% of accuracy in stent 
fracture prediction for each patient.  
Moving to the fluid dynamic issues, the research presented in Chapter 7 successfully 
addressed a clinical question raised by the clinicians during MR investigation of the 
pulmonary system in patients with TGA corrected with ASO. Indeed, ASO is often 
associated with stenosis of one of the two pulmonary arteries, typically the LPA. 
Examining patients with unilateral stenosis, it was observed that some cases presented 
substantially unbalanced blood flow between the stenotic side and the non-stenotic one, 
as expected. In other cases, however, LPA and RPA flows were relatively balanced, 
despite the presence of a moderate or even severe stenosis. One currently accepted 
hypothesis for this takes into account the remodelling of the distal pulmonary vascular 
resistances (PVR) which counteracts the presence of the stenosis, readjusting the flow 
split towards more physiological levels. Thus, a model was created to evaluate this 
hypothesis and eventually estimate the amount of remodelling using anatomical 
imaging information and flows obtained from MR. A multi-domain approach was used, 
in which the 3D anatomy of the PAs of 15 TGA patients after ASO was coupled to a 
patient-specific LPN representative of the distal pulmonary circulation. Also, the 
consequences on the flow distribution when treating the unilateral stenosis with a stent 
implantation despite the presence of a physiological flow split was investigated, by 
integrating the CFD solution with a FE simulation.  
Most of the fluid dynamic numerical methodologies utilised in the study of Chapter 7 
where first tested and validated in the research presented in Chapter 6 using an in-vitro 
set-up. A computational model of the neoaorta following ASO and of an healthy control 
was used to validate the multi-domain approach and to compare the local fluid dynamics in 
the two different anatomies. The mock circuit was purposely designed for this experiment 
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choosing MR-safe and compatible components, as it was planned to be MR scanned to 
acquire 4DMR flows on the patient-specific aortas, physically reproduced through the 
rapid-prototyping technique. The in-silico model was set to reproduce exactly the same 
boundary conditions applied in-vitro. Velocity pathlines, flows and pressures inside the 3D 
aorta were compared in the two cases, and satisfactory results obtained.  
9.2 FUTURE WORKS 
The research presented in this Thesis has covered a broad range of topics, using 
different engineering tools, demonstrating how they can be used to address clinical 
questions. Modelling of a dynamic and complex system such as the human being, 
constantly under regulation by the nervous system, and with a large number of closed 
loop feedbacks, is tricky and demanding. Important simplifications and assumptions 
have to be made in case data are missing or unclear to compensate for this. In addition, 
for easiness of representation, the compartment of interest is usually isolated, not 
accounting for the influences exerted by all the other systems. 
The rapid technological advancements already allowed the science of computational 
modelling to improve remarkably over the past few years, and this increase in 
computational power and speed is expected to continue. New modelling tools will thus 
become available, opening to new methodological opportunities in less computational 
time. At the same time, technological improvements will affect the clinical parameter 
acquisition techniques, for example for routinely performed imaging techniques that are 
gaining increasing resolution with faster acquisitions.  
In this section, I will identify general limitations of the models previously presented that 
need improvement and further development, also in view of the potential technological 
advancements above mentioned. 
9.2.1 Process automation  
One of the major issues in patient-specific modelling is that several manual steps in the 
workflow are required, from anatomy reconstruction to the generation of the results. 
The automation of these mechanisms is desirable to speed up the process and to reduce 
operator bias. The 3D stent reconstruction from biplane fluoroscopy images reported in 
Chapter 4 and used in Chapter 5 could remarkably benefit from such improvement 
because the currently manually performed reconstruction requires long operator’s times. 
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Automatic reconstructions would allow not only to use the statistical model for stent 
fracture prediction immediately after device implantation, but also to analyse 
considerably more frames during stent implantation and cardiac cycle (Section 4.4). 
Acquisition of a know phantom with the same parameter settings for table and 
fluoroscopy arms as those used during the procedure would allow to automate the 
reconstruction process and an algorithm to perform this is already under development. 
Another framework step which would benefit from automation is the reconstruction of 
the 3D anatomical models from medical imaging. Current image post-processing 
programs are constantly improving, but manual corrections to refine the volumes or 
their automatically generated meshes are still required to obtain the correct patient-
specific morphology and a mesh accurate enough for numerical simulations. In both 
cases, operator’s experience plays an extremely important role, which better automated 
reconstructing and meshing functions could reduce.  
9.2.2  In-vitro compliant model and FSI 
Certainly, one aspect to take into consideration for further studies is the compliant 
behaviour of the physiological vessels for fluid dynamic analyses. While gross 
differences in flow split or mean pressures are not expected, a compliant model, both in-
vitro and in-vivo, reproducing realistic distensible behaviour would be helpful to study 
local hemodynamics.  
A first attempt towards this was carried out in the in-vitro study described in Chapter 6; 
however, the material chosen for manufacturing the compliant TGA model did not 
withstand physiological pressures for the whole time needed for a full MR acquisition. 
The material (i.e. TangoPlus) suffered structural failure at the arch, so different 
materials are currently being evaluated. Silicone-based compounds may represent a 
valid alternative in this regard.  
Computationally, if significant differences are observed experimentally between a rigid 
and a compliant model, it would be possible to simulate such compliant behaviour also 
numerically, by means of fluid-structural interaction (FSI) simulations. One problem 
typically related to this methodology is the lack of information of patient-specific 
vessels’ material properties. In the first instance, this issue could be bypassed by using 
an artificial material which experimentally reproduced the compliant behaviour of the 
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vessel considered. In this way the elastic characteristic would be known, facilitating the 
FSI simulations. 
The fluid dynamics models presented in Chapter 7 and 8 would also benefit from the 
reproduction of compliant vessels but again the estimation of the in-vivo vessels’ 
properties is not straightforward, and it usually changes along the vessel. For this 
reason, it must be carefully evaluated when adding compliant characteristics to the 
simulations is necessary and when it might add further important uncertainties to the 
model.    
9.2.3 Evaluation of in-vivo material properties 
The patient-specific anatomy is now usually easy to create but, as mentioned in the 
previous paragraph, the patient-specific in-vivo material parameters are still missing. 
Large variations from individual to individual are present, especially in the CHD 
population, and therefore they cannot be considered the same for all (74) to create 
predictive patient-specific models (see the stent implantation modelled in Chapter 7 and 
Chapter 8). This could have been also a problem for the FE simulation performed to 
study the covered stent insertion in the CoA patient of Chapter 8. However, in this case, 
a metallic stent was already present in the region of implantation; therefore the response 
to the new stent deployment depended by the combination of the properties of the 
previously implanted stent and the vessel which were thus playing a less important role.  
Several methods have been proposed in literature to overcome this problem combining 
numerical and experimental approaches (151; 152). In our team, we are working on 
imaging techniques such as 4DCT and 4DMR that could be employed to identify the 3D 
temporal deformations of different vessel regions throughout the cardiac cycle, which 
synchronised with pressure information inside the vessel, would allow an indirect 
estimation of the distensibility for each patient. 
9.2.4 Inlet/Outlet velocity boundary conditions 
4D MR flow is a novel imaging technique that could be used not only to validate a 
computational model, as shown in Chapter 6, but also to set more accurate velocity 
boundary conditions. In fact, using these data, it is possible to acquire all inlet and outlet 
information simultaneously and also extract the x, y and z velocity components in time 
in each of the voxels of one section. Imposing these values to each corresponding 
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element of the mesh at the inlet of the computational model, instead of the spatial 
average as typically done, could allow a more detailed characterisation of the complex 
fluid dynamics, e.g. whirling and recirculation in the aortic root. However, the time 
required for the simulations would considerably increased, while the flow split and 
overall pressure distribution would not be affected by this different approach. A first 
attempt was performed in the study presented in Chapter 6, using 2D Cartesian flow 
acquisitions, in order to explore the methodological aspects. To reduce the high 
computational cost a coarsen mesh (300,000 elements) was considered, but this was not 
fine enough for this complex simulation. Therefore, convergence was not reached and 
further studies are required, taking advantage in the future of more powerful calculation 
machines. 
9.3 CONCLUSION 
The use of computational modelling is nowadays integrated in many industrial 
processes, and is also considered a mandatory step for the development and 
optimisation of a medical device, before FDA approval. What is not yet established is 
the systematic use of computational modelling into the clinical environment. This 
Thesis has shown possible applications and potentialities of computational engineering 
tools to address specific clinical questions. The models here presented do not intend to 
give any sort of “dogma” or ineluctable rule to the clinicians, but they represent an 
additional tool that could be used in the decision making process. Several steps need to 
be improved before a patient-specific model could be adopted as a clinical standard of 
care, and at the moment the bottleneck lies in the manual executions these models 
require to be implemented, in the need for model standardisation, and systematic 
validation (74), in the time sensitivity, and sometimes in the lack of the necessary 
clinical data such as material properties. Once all these technical problems are solved, 
the final difficulty will consist in the integration of such models in the clinical 
workflow. Researchers are already putting lots of efforts in trying to overcome these 
limitations, and, in my opinion, key to the success of patient-specific modelling is the 
establishment of a multidisciplinary team, with clinicians and engineers working 
together to enhance patient healthcare.  
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